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Abstract	  	  	  	  	  	  
	   	  
RNA	   localization	   is	  a	  widely	  used	  mechanism	  to	  regulate	  gene	  expression.	   It	  provides	  various	  cells	  
with	   a	   means	   to	   target	   proteins	   to	   distinct	   subcellular	   compartments	   and	   establish	   cell	   polarity.	   In	  
neurons,	   RNA	   localization	   and	   local	   translation	   in	   axons	   and	   dendrites	   allow	   growth	   cones	   and	  
postsynaptic	   sites	   to	   instantly	   refine	   their	   protein	   composition	   in	   response	   to	   environmental	   cues.	  
Consequently,	   these	   mechanisms	   critically	   contribute	   to	   axon	   growth	   and	   pathfinding,	   dendritic	  
branching,	  as	  well	  as	  dendritic	  spine	  morphogenesis.	  Furthermore,	  localization	  of	  mRNAs	  near	  synapses,	  
followed	   by	   tight	   control	   of	   their	   translation	   in	   space	   and	   time,	   contributes	   to	   their	   autonomous,	  
independent	  and	  rapid	  modifications.	  It	  is	  therefore	  of	  particular	  importance	  for	  mechanisms	  of	  learning	  
and	  memory	  and	  has	  recently	  attracted	  emerging	  interest.	  
mRNAs	  are	  transported	  in	  ribonucleoprotein	  particles	  (RNPs)	  to	  the	  sites	  of	  need	  in	  a	  translationally	  
repressed	  form.	  The	  composition	  of	  neuronal	  transport	  RNPs,	  the	  function	  of	  specific	  components,	  the	  
mechanisms	  of	  RNA	  transport	  towards	  axons	  and	  dendrites	  and	  their	  translational	  control	  are	  still	  under	  
debate.	   In	   this	  work,	   I	   investigated	   the	   functional	   roles	  of	   two	  key	  RNP	  components	   in	   the	  context	  of	  
translational	   control	   and/or	   RNA	   stability	   in	   RNA	   localization.	   In	   addition,	   I	   generated	   tools	   for	   the	  
investigation	  of	  microRNA-­‐dependent	  translational	  control	  and	  isolation	  of	  novel	  RNA-­‐binding	  proteins	  
involved	  in	  RNA	  transport	  and	  localization.	  
In	  the	  first	  part	  of	  my	  thesis,	  I	  show	  that	  mammalian	  Pumilio2	  (Pum2)	  controls	  the	  expression	  of	  the	  
key	   initiation	   factor	   eIF4E	   in	   neurons.	   Furthermore,	   eIF4E	  misregulation	   itself	   has	   effects	   on	  dendrite	  
development	  and	  dendritic	  spine	  morphology	  of	  hippocampal	  neurons	  similar	  to	  those	  observed	  upon	  
misregulation	   of	   Pum2.	   This	   led	  me	   to	   conclude	   that	   the	   effects	   observed	   upon	   Pum2	  misregulation	  
might	   not	   be	   caused	   by	   direct	   action	   of	   Pum2,	   but	   by	   translational	   regulation	   of	   factors	   involved	   in	  
neuronal	  development	  and	  function.	  	  
In	   the	   second	   part,	   I	   further	   characterized	   the	  mammalian	   double-­‐stranded	   RNA-­‐binding	   protein	  
Staufen2	   (Stau2),	  which	  has	  been	   implicated	   in	  mRNA	   localization.	   For	  Stau2,	  no	  direct	   target	  mRNAs	  
are	  known	  so	  far,	  and	  its	  physiological	  role	  remains	  unclear.	  My	  data	  demonstrate	  that	  Stau2	  is	  localized	  
to	  all	  neurites	  of	  developing	  neurons	  as	  distally	  as	  in	  growth	  cones	  of	  both	  future	  dendrites	  and	  axons.	  
The	  actin	  cytoskeleton	  was	  affected	  upon	  loss	  of	  Stau2.	  As	  the	  mRNA	  of	  the	  actin	  cytoskeleton	  regulator	  
RhoA	  was	   found	  enriched	   in	  Stau2	   immunoprecipitations,	   I	   investigated	   if	  Stau2	  could	  affect	   the	  actin	  
cytoskeleton	   indirectly	   via	   RhoA,	   potentially	   representing	   a	   functional	   link	   between	   the	   role	   of	   Stau2	  
and	  its	  effect	  on	  the	  actin	  cytoskeleton.	  Depletion	  of	  Stau2	  led	  to	   increased	  RhoA	  mRNA	  levels	  and	  to	  
increased	  expression	  of	  an	  EGFP-­‐RhoA	  construct.	  In	  light	  of	  preliminary	  data	  in	  the	  lab	  that	  loss	  of	  Stau2	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leads	  to	  defects	  in	  axon	  outgrowth,	  a	  novel	  mechanism	  for	  Stau2	  in	  axon	  outgrowth	  emerges	  that	  could	  
be	  based	  on	  regulation	  of	  the	  cytoskeleton	  via	  stabilization	  of	  β-­‐actin	  mRNA	  and	  an	  effect	  on	  RhoA.	  	  
Taken	  together,	  my	  work	  has	  shed	  new	  light	  on	  the	  roles	  of	  two	  prominent	  RNA-­‐binding	  proteins,	  
Pum2	  and	  Stau2,	   in	  distinct	  steps	  of	  neuronal	  RNA	  localization.	  Whether	  those	  functions	  also	  apply	  to	  
other	  targets	  of	  Pum2	  and	  Stau2	  will	  be	  addressed	  in	  future	  work.	  
















1.1 RNA	  localization	  
1.1.1 Definition	  of	  RNA	  localization	  
 
RNA	   localization	   is	   a	   mechanism	   that	   cells	   use	   to	   target	   mRNA	   to	   sites	   where	   the	   encoded	  
proteins	  are	  needed	  (Holt	  and	  Bullock,	  2009;	  St	  Johnston,	  2005).	   It	  further	  represents	  another	  level	  of	  
control	  of	  gene	  expression	  (Figure	  1).	  Gene	  expression	  is	  regulated	  on	  the	  transcriptional	  level,	  further	  
controlled	  at	  the	  level	  of	  RNA	  processing	  and	  nuclear	  export	  and	  also	  underlies	  continuous	  regulation	  in	  
the	  cytoplasm.	  Localization	  and	  transport	   is	  one	  means	  of	  posttranscriptional	   regulation,	  while	  during	  
the	   localization	   process,	   also	   stability	   control	   and	   translational	   regulation	   are	   applied.	   Finally,	   the	  
synthesized	  protein	  itself	  typically	  underlies	  activity	  control	  (summarized	  in	  Alberts	  et	  al.,	  2002).	  	  
RNA	   localization	  has	  been	  shown	  to	  be	  a	  widely	  used	  mechanism,	  which	   is	  conserved	  across	  all	  
Phyla	   and	   has	   important	   functions	   in	   creating	   cell	   polarity	   (Holt	   and	   Bullock,	   2009).	  While	   an	   earlier	  
hypothesis	   stated	   that	   only	   a	   small	   subset	   of	   RNAs	   becomes	   localized	   to	   specific	   subcellular	  
compartments,	   it	   is	   now	   emerging	   that	   a	   large	   fraction	   of	   all	   cellular	   RNAs	   are	   targeted	   to	   specific	  
locations	   (Andreassi	   and	   Riccio,	   2009;	   Holt	   and	   Bullock,	   2009;	   Lecuyer	   et	   al.,	   2007;	   Palacios	   and	   St	  
Johnston,	   2001).	   A	   recent	   study	   estimated	   that	   as	  much	   as	   70%	  of	   all	   transcripts	   are	   asymmetrically	  
distributed	  (Lecuyer	  et	  al.,	  2007).	  Besides	  mRNA	  (messenger	  RNA)	  localization,	  recently	  also	  transport	  of	  
non-­‐coding	  RNAs	  became	  a	  matter	  of	  intense	  investigation.	  Localization	  of	  single	  non-­‐coding	  RNAs	  like	  
brain	   cytosolic	   RNA	   1	   (BC1)	   and	  microRNAs	   (miRNAs),	   e.g.	  miR-­‐134,	   has	   been	   shown.	   Having	   such	   a	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Figure	   1.	   Regulation	   of	   gene	   expression	   in	  mammalian	   cells.	   Gene	   expression	   is	   controlled	   at	   all	   levels	   in	   the	  




1.1.2 Physiological	  importance	  of	  RNA	  localization	  
 
Proteins	  are	  often	  needed	  only	  in	  specific	  compartments	  within	  a	  cell.	  This	  spatial	  restriction	  can	  
either	  be	  achieved	  by	  transporting	  the	  protein	  in	  an	  inactive	  state,	  or	  the	  mRNA	  is	  transported	  and	  the	  
corresponding	  protein	   is	  only	  made	  on	  demand	  at	   the	   site	  of	   function.	  While	   in	  most	   cell	   types	  both	  
mechanisms	   occur	   in	   parallel,	   there	   are	   several	   reasons	   why	   RNA	   localization	   is	   often	   favored	   over	  
translation	  in	  the	  cell	  body	  and	  transport	  of	  the	  protein.	   In	  general,	  RNA	  localization	  is	  mostly	  used	  in	  
highly	   polarized	   cells	   to	   avoid	   long	   transport	   times	   of	   newly	   synthesized	   proteins.	   A	   widespread	  
phenomenon	   in	   which	   RNA	   localization	   is	   involved	   is	   restriction	   of	   protein	   synthesis	   to	   specific	  
subcellular	   compartments.	   This	  bears	   the	  advantage	   that	   the	  activity	  of	   the	  derived	  protein	  does	  not	  
have	  to	  be	  spatially	  regulated,	  and	  potential	  ectopic	  expression	  during	  translocation	  is	  avoided.	  Instead,	  
RNAs	  are	  controlled	  independently	  in	  different	  regions	  and	  at	  times	  of	  demand,	  protein	  synthesis	  can	  be	  
switched	  on	  quickly	  and	  only	  the	  desired	  amount	  of	  protein	  is	  being	  made.	  This	  mechanism	  also	  allows	  a	  
rapid	  return	  to	  steady-­‐state	  levels.	  Spatial	  restriction	  of	  a	  protein	  is	  more	  cost	  effective	  when	  achieved	  
via	  RNA	  localization,	  because	   in	  principle	  only	  one	  RNA	  molecule	  has	  to	  be	  transported	  to	  give	  rise	  to	  
several	   rounds	   of	   protein	   synthesis.	   Another	   advantage	   of	   RNA	   localization	   leading	   to	   local	   protein	  
synthesis	   is	   the	   possibility	   of	   co-­‐translational	   incorporation	   of	   the	   protein	   into	   target	   structures	   by	  
assembling	  macromolecular	  complexes	  (Chang	  et	  al.,	  2006;	  Dahm	  et	  al.,	  2007;	  Holt	  and	  Bullock,	  2009).	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Taken	  together,	  RNA	  localization	  provides	  cells	  with	  a	  mechanism	  (i)	  to	  respond	  fast	  to	  demand	  of	  
certain	  proteins	  at	  certain	   locations,	   (ii)	  create	  another	   level	  of	  control	  of	  gene	  expression	  and	  (iii)	  an	  
economic	  way	  to	  spatially	  restrict	  protein	  activity.	  
	  
1.1.3 Mechanisms	  of	  RNA	  localization	  
 
While	  localization	  of	  specific	  RNAs	  has	  been	  intensively	  investigated,	  the	  underlying	  mechanisms	  
are	   not	   yet	   well	   understood.	   As	   shown	   in	   a	   schematic	   overview	   in	   Figure	   2,	   it	   is	   thought	   that	   RNA	  
localization	  already	  begins	  in	  the	  nucleus	  of	  the	  cell,	  where,	  after	  initial	  processing	  steps,	  the	  cis-­‐acting	  
localization	  elements	  in	  the	  sequence	  of	  the	  RNA	  is	  recognized	  by	  trans-­‐acting	  factors	  (TAFs)	  (Rodriguez	  
et	  al.,	  2008).	  Most	  of	  the	  localization	  elements	  have	  been	  identified	  in	  either	  the	  5’-­‐	  or	  3’-­‐	  untranslated	  
regions	  (UTRs)	  of	  the	  mRNAs,	  like	  most	  other	  regulatory	  sequences	  which	  are	  for	  example	  responsible	  
for	  nuclear	  export,	  degradation,	  translation	  efficiency	  or	  stability	  (de	  Moor	  et	  al.,	  2005;	  Hesketh,	  2004;	  
Wilkie	   et	   al.,	   2003).	   Recognition	   elements	   can	   be	   primary	   sequence-­‐specific,	   but	   also	   formation	   of	  
double-­‐stranded	  stretches	  via	  hairpins	  and	  certain	  3-­‐D	  structures	  can	  form	  the	  sites	  that	  are	  recognized	  
by	  TAFs.	  Low	  conservation	  of	  those	  elements,	  their	  size	  and	  complexity,	  as	  well	  as	  the	  lack	  of	  prediction	  
programs	   that	   are	   able	   to	   recognize	   secondary	   and	   especially	   tertiary	   structures	  makes	   prediction	   of	  
localization	  targets	  very	  difficult.	  
Additionally	   to	   factors	   recognizing	   localization	  elements,	   other	   factors	  bind	   the	  RNA	  within	   the	  
nucleus	   or	   shortly	   after	   export	   out	   of	   it	   that	   carry	   out	   additional	   important	   functions:	   Post-­‐
transcriptional	   regulation	   during	   mRNA	   transport	   includes	   translation	   control	   and	   control	   of	   mRNA	  
stability.	  Translational	  repression	  can	  be	  achieved	  by	  binding	  of	  proteins	  like	  insulin-­‐like	  growth	  factor	  2	  
mRNA	   binding	   protein	   1	   (ZBP1),	   Fragile	   X	   mental	   retardation	   1	   protein	   (FMRP)	   or	   Pumilio2	   (Pum2)	  
(Besse	  and	  Ephrussi,	  2008).	  However,	  recently	  emerged	  an	  alternative	  how	  transported	  RNAs	  could	  be	  
kept	   silent:	   via	   miRNA-­‐based	   translational	   repression.	   It	   is	   currently	   unclear	   in	   which	   structures	   this	  
occurs:	   in	   processing-­‐bodies	   (P-­‐bodies),	   neuronal	   RNA	   granules,	   the	   RNA-­‐induced	   silencing	   complex	  
(RISC)	   or	   alternatively	   in	   the	   cytoplasm	   (Kosik,	   2006;	   Leung	   and	   Sharp,	   2006).	   In	   addition,	   the	   exact	  
composition	  of	  those	  particles	  is	  not	  clear	  yet.	  Most	  likely,	  RNPs	  are	  rather	  dynamic	  structures	  and	  only	  
a	  core	  complex	  is	  adjoining	  the	  RNA	  on	  its	  complete	  way	  to	  its	  destination.	  This	  core	  complex	  is	  likely	  to	  
vary	   from	   cell	   type	   to	   cell	   type	   and	   possibly	   from	   transcript	   to	   transcript.	   Numerous	   approaches	  
currently	   aim	   to	   unravel	   the	   composition	   of	   transport	   RNPs	   (Brendel	   et	   al.,	   2004;	   Elvira	   et	   al.,	   2006;	  
Jonson	  et	  al.,	  2007;	  Maher-­‐Laporte	  et	  al.,	  2010;	  Villace	  et	  al.,	  2004).	  	  
While	  the	  processes	  described	  first	  occur	  in	  the	  nucleus,	  the	  mRNA	  –	  already	  bound	  by	  some	  TAFs	  	  
–	  is	  exported	  and	  further	  processed	  in	  the	  cytoplasm	  and	  then	  targeted	  to	  its	  cellular	  destination.	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To	  obtain	  a	  transport-­‐competent	  RNP,	  molecular	  motors	  have	  to	  associate	  with	  the	  pre-­‐formed	  
RNA-­‐protein	   complex	   (also	   see	  Figure	  2).	  Via	   those	  motors,	  RNPs	  are	   then	  actively	   transported	  along	  
microtubule	   tracks	   for	   longer	   distances,	   or	   alternatively	   along	   actin	   microfilaments	   in	   smaller	   cells	  
(Jansen,	  2001;	  Palacios	   and	  St	   Johnston,	  2001).	  Motor-­‐driven	   transport	   allows	   fast	  movements,	  while	  
passive	  diffusion	  would	  be	  slow	  –	  unless	  it	  is	  supported	  by	  molecular	  motors	  (Brangwynne	  et	  al.,	  2009;	  
Palacios,	  2007).	  Transport	  is	  triggered	  into	  certain	  directions	  for	  example	  by	  gradients	  of	  attractants	  or	  
repellents	  that	  are	  recognized	  by	  factors	  in	  the	  transport	  RNP	  or	  factors	  recognize	  and	  bind	  to	  molecular	  





Figure	   2.	   RNA	   localization	   is	   a	  multistep	   process.	  RNA	   localization	   already	   starts	   in	   the	   nucleus	  where	   the	   cis-­‐
acting	  elements	  in	  the	  mRNA	  that	  harbor	  the	  localization	  signal	  are	  recognized	  (step	  1).	  After	  nuclear	  export	  (step	  
2),	  transport-­‐competent	  RNPs	  assemble	  (step	  3)	  and	  travel	  along	  microtubules	  (step	  4).	  There	  is	  some	  controversy	  
on	  whether	  during	  stress,	  RNA	  is	  stored	  in	  stress	  granules	  (step	  5)	  or	  gets	  degraded	  in	  P-­‐bodies	  (step	  6).	  When	  the	  
transport	  RNP	  arrives	  at	  its	  destination,	  it	  can	  be	  anchored	  (step	  7),	  until	  translational	  repression	  gets	  relieved	  and	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1.1.4 	  Well-­‐studied	  examples	  for	  RNA	  localization	  
 
Localization	  of	  mRNA	  is	  a	  widespread	  mechanism	  that	  was	  shown	  for	  many	  different	  cell	   types,	  
and	  observed	  as	  early	  as	  already	  1983	  for	  β-­‐actin	  mRNA	  (Jeffery	  et	  al.,	  1983).	  Figure	  3	  gives	  an	  overview	  
on	  the	  most	  prominent	  examples	  of	  RNA	  localization	  in	  various	  cell	  types	  and	  organisms.	  The	  probably	  
best-­‐studied	  system	  in	  regard	  of	  RNA	  localization	  is	  the	  embryonal	  development	  of	  Drosophila,	  Xenopus	  
and	   a	   few	   other	   organisms.	   Localization	   of	   maternal	   mRNAs	   in	   Drosophila	   is	   most	   important	   in	  
establishing	  the	  dorsal-­‐ventral	  and	  anterior-­‐posterior	  body	  axes.	  In	  this	  respect,	  bicoid,	  nanos	  and	  oskar	  
mRNA	   are	   the	   most	   important	   cell-­‐fate	   determinants	   in	   Drosophila.	   Similar	   mechanisms	   of	   RNA	  
localization	   to	   serve	   embryonic	   patterning	  have	   also	  been	   shown	   to	  be	   important	   in	   development	  of	  
Xenopus,	   ascidians	   and	   cnidarians	   (reviewed	   in	   Holt	   and	   Bullock,	   2009;	   Jansen,	   2001).	   Neurons	  
represent	   another	  well-­‐studied	   system	   in	  which	   RNA	   localization	   plays	   an	   important	   role	   and	  will	   be	  
discussed	  in	  detail	  in	  the	  next	  chapter.	  	  
While	   RNA	   localization	   plays	   important	   roles	   in	   embryonic	   development	   and	   neuronal	  
mechanisms,	   there	   are	   very	   interesting	   examples	   for	   other	   biological	   processes.	   ASH1	   mRNA	   is	   an	  
example	   for	   RNA	   localization	   in	   yeast,	   where	   it	   is	   asymmetrically	   distributed	   to	   the	   daughter	   cell	   in	  
meiotic	   division	   (Figure	   3G)	   (Bertrand	   et	   al.,	   1998).	   ASH1	   localization	   is	   an	   exceptionally	  well-­‐studied	  
example,	  where	  it	  was	  also	  shown	  that	  a	  protein	  called	  She2	  acts	  as	  factor	  recognizing	  the	  localization	  
elements	  within	  the	  sequence.	  Furthermore,	  She2	  interacts	  with	  She2p	  which	  is	  an	  adaptor	  to	  a	  myosin	  
type	  molecular	  motor	  (Paquin	  and	  Chartrand,	  2008).	  	  	  	  
In	  chick	  embryonic	  fibroblasts,	  β-­‐actin	  mRNA	  is	  localized	  to	  leading	  edges,	  where	  it	  is	  needed	  to	  
enable	   cell	   migration	   (reviewed	   in	   Palacios	   and	   St	   Johnston,	   2001).	   Localization	   of	   β-­‐actin	   mRNA	   is	  
especially	  well	  studied	  and	  one	  of	  the	  rare	  cases	  where	  also	  a	  TAF,	  which	   is	   recognizing	  the	  mRNA,	   is	  
known:	  ZBP1	  is	  required	  for	  β-­‐actin	  mRNA	  localization	  in	  dendrites	  of	  cultured	  rat	  hippocampal	  neurons.	  
It	   recognizes	   β-­‐actin	  mRNA	   via	   a	   zipcode	   element	   (Eom	   et	   al.,	   2003).	   Furthermore,	   chick	   ZBP1	   also	  
modulates	   the	   translation	  of	  β-­‐actin	  mRNA,	  by	  binging	   to	   it	   in	   the	  nucleus	  and	   repressing	   translation	  
initiation.	  Only	  upon	  phosphorylation	  of	  ZBP1	  by	  Src	  kinase	  the	  repression	   is	   released	  (Hüttelmaier	  et	  













Figure	   3.	   Examples	   for	   localized	   mRNAs	   in	   various	   cell	   types.	   (A)	   Localization	   of	   oskar	   and	   bicoid	   mRNA	   in	  
Drosophila	   oocytes	   by	   in	   situ	   hybridization	   (ISH).	   (B)	   Localization	   of	  wnt3	   mRNA	   in	   the	   egg	   of	   Clytia	   (ISH).	   (C)	  
Localization	  of	  sensorin	  mRNA	  at	  synapses	  of	  an	  Aplysia	   sensory	  neuron	  (ISH).	   (D)	  Localization	  of	  hairy	  mRNA	   in	  
Drosophila	  embryos	  (ISH).	  (E)	  Localization	  of	  Pkp4	  mRNA	  in	  cultured	  mammalian	  fibroblasts,	  visualized	  by	  the	  MS2-­‐
GFP	  system.	  (F)	  Localization	  of	  β-­‐actin	  mRNA	  in	  an	  axonal	  growth	  cone	  in	  Xenopus	  (ISH).	  (G)	  Localization	  of	  ASH1	  
mRNA	  to	  the	  tip	  of	  a	  daughter	  cell.	  Panels	  A	  –	  F	  are	  taken	  from	  Figure	  2	  from	  (Holt	  and	  Bullock,	  2009)	  and	  panel	  G	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1.2 RNA	  localization	  in	  neurons	  
1.2.1 Background	  on	  RNA	  localization	  in	  neurons	  
 
Neurons	  represent	  another	  well-­‐studied	  system	  in	  which	  RNA	  localization	  plays	  an	  important	  role.	  
The	   core	   hypothesis	   here	   is	   that	   for	   the	   formation	   of	   long-­‐term	  potentiation	   and	   thereby	  memories,	  
repeated	  synaptic	  signals	  lead	  to	  synapse	  specific	  modifications.	  Those	  cause	  an	  acute	  local	  demand	  of	  
certain	  proteins,	  which	  are	  provided	  by	  the	  cell	  through	  local	  protein	  synthesis.	  Each	  single	  synapse	  can	  
be	   served	   with	   the	   proteins	   it	   needs	   at	   a	   certain	   time	   (reviewed	   in	   Holt	   and	   Bullock,	   2009).	   The	  
hypothesis	   is	   supported	   by	   the	   finding	   that	   protein	   synthesis	   occurs	   close	   to	   synaptic	   sites,	   and	   that	  
polyribosomes	  have	  been	  identified	  there	  (Steward	  and	  Levy,	  1982;	  Steward	  and	  Schuman,	  2001).	  This	  
is	   only	   enabled	   by	   localization	   of	  mRNAs	   close	   to	   synapses.	   Their	   translational	   repression	   is	   relieved	  
upon	  pathways	   triggered	  by	   synaptic	   input	   (Dahm	  and	  Kiebler,	  2005;	  Hüttelmaier	  et	  al.,	  2005).	  These	  
mechanisms	   give	   rise	   to	   synaptic	   plasticity	   and	   fast	   responses	   upon	   synaptic	   activation	   in	   dendrites.	  
Importantly,	  mice	  where	  the	  3’-­‐UTR	  of	  calcium/calmodulin-­‐dependent	  protein	  kinase	  II	  alpha	  	  (CaMKIIα)	  
is	   replaced	   with	   the	   3’-­‐UTR	   of	   a	   non-­‐localizing	   mRNA,	   long-­‐term	   potentiation	   (LTP)	   and	   memory	  
formation	   are	   affected	   (Miller	   et	   al.,	   2002).	   This	   is	   a	   strong	   hint	   that	   localization	   in	   fact	   influences	  
memory	  formation.	  A	  schematic	  overview	  on	  RNA	  localization	  processes	  in	  neurons	  is	  given	  in	  Figure	  4.	  
It	   also	   depicts,	   that	   besides	   synapse-­‐specific	  modifications,	   neurons,	   like	   other	   cell	   types,	   utilize	   RNA	  
localization	   as	  mechanism	   to	   create	   asymmetry,	   which	   is	   of	   high	   importance	   for	   those	   complex	   and	  
highly	   differentiated	   cells	   with	   its	   different	   protrusions.	   It	   was	   especially	   shown	   for	   axons	   that	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Figure	  4.	  RNA	  localization	  in	  neurons.	  After	  nuclear	  assembly	  of	  the	  core	  complex	  and	  export	  from	  the	  nucleus,	  
transport-­‐competent	   RNPs	   assemble	   and	   travel	   along	   microtubules.	   When	   the	   dendritically	   localized	   RNP	   (left	  
neurite)	  arrives	  at	   its	  destination,	   it	  can	  be	  anchored	  or	  translational	  repression	  gets	  relieved	  upon	  and	  synaptic	  
stimulus	   and	   local	   protein	   synthesis	   starts.	   Axonically	   localized	   RNPs	   (right	   neurite)	   can	   be	   anchored	   and	   upon	  




1.2.2 Neuronal	  ribonucleoprotein	  particles	  (RNPs)	  
 
RNA	   transport	   and	   localization	   is	   thought	   to	   occur	   in	  macromolecular	   complexes	   consisting	   of	  
proteins	  and	  RNA,	  and	  therefore	  termed	  ribonucleoprotein	  particles.	  For	  neurons,	  as	  well	  as	  for	  other	  
cell	  types,	  different	  views	  exist,	  how	  these	  particles	  should	  be	  distinguished	  and	  which	  kinds	  of	  particles	  
carry	  out	  which	  function.	  	  
Kiebler	  &	  Bassell	  suggest	  to	  distinguish	  transport	  RNPs	  from	  stress	  granules	  and	  P-­‐bodies	  (Kiebler	  
and	  Bassell,	  2006)	  (see	  also	  Figure	  2).	  Transport	  RNPs	  are	  defined	  as	  transport-­‐competent	  particles	  that	  
contain	   translationally	   repressed	   mRNAs	   and	   translational	   components;	   the	   main	   components	   are	  
Staufen1	   (Stau1),	   Staufen2	   (Stau2),	   FMRP,	   ZBP1,	   heterogeneous	   nuclear	   ribonucleoprotein	   A2	  
Introduction	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(hnRNPA2),	   cytoplasmic	   polyadenylation	   element	   binding	  protein	   (CPEB),	   purine-­‐rich	   element	   binding	  
protein	  alpha	  (Purα),	  and	  survival	  motor	  neuron	  (SMN).	  	  
Stress	   granules	   are	  described	  as	  particles	   containing	   stalled	  mRNAs	   that	   are	   stored	   there	  upon	  
stress	  exposure	  on	  the	  cell.	  The	  core	  components	  are	  cytotoxic	  granule-­‐associated	  RNA	  binding	  protein	  
1	  	  (TIA-­‐1),	  TIAR,	  	  poly(A)	  binding	  protein	  (PABP),	  	  GTPase	  activating	  protein	  (SH3	  domain)	  binding	  protein	  
(G3BP),	  and	  the	  40S	  ribosomal	  subunit.	  In	  P-­‐bodies,	  in	  contrast,	  RNAs	  are	  proposed	  to	  be	  degraded	  or	  
translationally	   repressed.	   They	   were	   proposed	   to	   contain	   the	   RISC	   machinery,	   but	   no	   ribosomal	  
subunits.	   Core	   components	   are	   DCP1	   decapping	   enzyme	   homolog	   A	   (S.	   cerevisiae)	   (Dcp1a),	   like-­‐SM	  
proteins	   (LSM),	   DEAD	   (Asp-­‐Glu-­‐Ala-­‐Asp)	   box	   polypeptide	   6	   (Rck/DDX6/p54),	   and	   Glycine-­‐tryptophan	  
protein	  of	  182	  kDa	   (GW182)	   (Kiebler	  and	  Bassell,	   2006).	  Alternatively,	   some	  authors	   suggest	   that	   the	  
RISC	   pathway	   does	   not	   occur	   in	   P-­‐bodies,	   but	   in	   distinct	   particles	   (Orban	   and	   Izaurralde,	   2005).	  
Hirokawa	  and	  coworkers	  suggest	   that	  mRNAs	  are	  transported	   in	   large	  granules	   (1000	  S)	  associated	  to	  
the	  KIF5	  motor	   (Hirokawa,	   2006;	   Kanai	   et	   al.,	   2004).	   They	   identified	   a	   total	   of	   42	   proteins	   and	  many	  
RNAs	   to	   be	   present	   in	   such	   neuronal	   RNA	   granules,	   together	   with	   ribosomes	   (Krichevsky	   and	   Kosik,	  
2001).	  
The	  exact	  composition	  of	  the	  suggested	  neuronal	  granules	   is	  still	  under	  debate,	  as	   it	   is	   for	  non-­‐
neuronal	  RNPs.	  While	  many	  studies	  are	  ongoing	   that	  aim	   to	   identify	   the	  components	  associated	  with	  
known	   RNA-­‐binding	   proteins,	   increasing	   interest	   is	   emerging	   on	   the	   identification	   of	   the	   complexes	  
interacting	  with	  specific	  mRNAs.	  For	  that	  purpose,	  several	  approaches	  were	  developed	  to	  biochemically	  
purify	  complexes	  assembled	  around	  an	  RNA	  that	  can	  be	  trapped	  on	  a	  column.	  Usually	  these	  approaches	  
are	  based	  on	  an	  RNA	  aptamer	  that	  is	  fused	  to	  the	  target	  RNA	  and	  which	  is	  recognized	  by	  an	  RNA-­‐binding	  
protein	  that	  can	  be	  used	  to	  couple	  the	  complex	  to	  a	  column	  (Walker	  et	  al.,	  2008).	  The	  target	  RNA	  fused	  
to	  the	  aptamer	  can	  either	  be	  in	  vitro	  transcribed,	  or	  transfected	  into	  cells	  and	  expressed	  in	  vivo.	  Where	  
possible,	  in	  vivo	  expression	  should	  be	  favored,	  as	  post-­‐lysis	  artifacts	  are	  probable	  (Mili	  and	  Steitz,	  2004).	  
Methods	   that	  are	  used	   for	   such	  experiments	   include	   (i)	   the	  StreptoTag	  method	  based	  on	  an	  aptamer	  
binding	  to	  the	  antibiotic	  streptomycin	  (Bachler	  et	  al.,	  1999;	  Windbichler	  and	  Schroeder,	  2006),	   (ii)	   the	  
MS2	   system	   that	   can	   be	   adapted	   from	   imaging	   experiments	   (Bertrand	   et	   al.,	   1998;	   Zhou	   and	   Reed,	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1.2.3 Localized	  RNAs	  in	  neurons	  
1.2.3.1 Localized	  mRNAs	  
 
Most	   mRNAs	   referred	   to	   as	   “localized”	   in	   neurons	   are	   either	   found	   at	   dendritic	   or	   axonal	  
compartments.	  Those	  RNAs,	  for	  which	  strong	  evidence	  exists	  that	  they	  are	  localized	  in	  neurons,	  encode	  
for	  proteins	  with	  different	  cellular	  functions	  and	  acting	  in	  different	  pathways.	  They	  are	  not	  present	  in	  all	  
types	   of	   neurons,	   but	   rather	   specific	   for	   certain	   brain	   areas.	   Although	   localization	   alone	   does	   not	  
provide	  evidence	  for	  local	  protein	  synthesis,	  the	  candidates	  visualized	  there	  provide	  good	  candidates	  for	  
further	  studies.	  	  
Localized	   RNAs	   were	   identified	   in	   neurons	   mostly	   by	   in	   situ	   hybridization	   (ISH)	   techniques	  
(Steward	  and	  Schuman,	  2001).	  Tracking	  of	  RNAs	  in	  living	  cells	  now	  became	  possible	  by	  methods	  utilizing	  
green	   fluorescent	   protein	   (GFP)-­‐fusion	   proteins	   that	   bind	   to	   RNA	   aptamers	  which	  were	   fused	   to	   the	  
target	   mRNA	   (Bertrand	   et	   al.,	   1998).	   Also	   biochemical	   approaches	   were	   taken	   by	   isolating	  
synaptoneurosomal	   fractions	   and	   identifying	   the	   RNAs	   yielded	   therein.	  While	   ISH	   provides	   a	   reliable	  
method	   to	   resolved	   subcellular	   localization,	   synaptoneurosomal	   preparations	   are	   –	   at	   least	   in	   this	  
context	   –	   error	   prone	   due	   to	   their	   low	   purity	   and	   data	   have	   to	   be	   critically	   evaluated	   and	   validated	  
(Steward	  and	  Schuman,	  2001).	  The	  most	  reliably	  studied	  mRNAs	  that	  are	   localized	  in	  neurons	  and	  the	  
most	  relevant	  ones	  for	  this	  thesis	  described	  in	  Table	  1.	  	  	  
	  
Arc	  mRNA	  
Activity-­‐regulated	  cytoskeleton-­‐associated	  (Arc)	  is	  an	  immediate-­‐early	  gene,	  whose	  translation	  is	  
only	  initiated	  upon	  activation.	  A	  350-­‐nt	  dendritic	  targeting	  element	  was	  identified	  within	  the	  Arc	  3’-­‐UTR	  
sequence	  (Kobayashi	  et	  al.,	  2005).	  Knockdown	  of	  Arc	  led	  to	  an	  impairment	  of	  the	  consolidation	  of	  LTM	  
by	  hindering	  the	  maintenance	  phase	  of	  LTP,	  while	  the	  induction	  of	  it	  remained	  unaffected	  (Guzowski	  et	  
al.,	   2000).	   Similar	   results	  were	  obtained	   in	   knockout	  mice,	  where	   long-­‐lasting	  memory	   failed	   to	   form	  
(Plath	  et	  al.,	  2006).	  The	  role	  of	  the	  encoded	  protein	  ARC	  was	  related	  to	  AMPA-­‐receptor	  trafficking,	  by	  
activating	   an	   AMPA-­‐receptor	   endocytic	   pathway	   (Chowdhury	   et	   al.,	   2006;	   Rial	   Verde	   et	   al.,	   2006;	  
Shepherd	   et	   al.,	   2006).	   Furthermore,	   it	  was	   shown	   that	   LTP	   elicited	  by	  BDNF	   application	   can	  only	   be	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Table	  1.	  Overview	  on	  mRNAs	   that	   are	  well	   established	   to	  be	   localized	   in	  neurons	   (adapted	   from	  Andreassi	   and	  
Riccio,	  2009).	  




Reference	   Binding	  
proteins	  
Reference	  
β-­‐actin Axonal	  growth	  
cones	  
	   (Bassell	  et	  al.,	  1998)	   	   	  
	   Dendritic	  
filopodia	  
3’-­‐UTR,	  54	  nt	   (Eom	  et	  al.,	  2003;	  
Tiruchinapalli	  et	  al.,	  
2003)	  




Arc	   Dendrites	   3’-­‐UTR,	  350	  nt	  
(strong),	  370	  nt	  
(weak)	  
(Kobayashi	  et	  al.,	  
2005)	  
	   	  
CaMKIIα	   Dendrites	   3’-­‐UTR,	  1200	  nt,	  
30	  nt	  CPE;	  94	  nt	  
(Blichenberg	  et	  al.,	  





al.,	  2008;	  Huang	  
et	  al.,	  2003)	  
Dendrin	   Dendrites	   3’-­‐UTR,	  1000	  nt	   (Kremerskothen	  et	  
al.,	  2006)	  
	   	  
LIMK1	   Dendrites	   	   (Schratt	  et	  al.,	  
2006)	  
	   	  
MAP2	   Dendrites	   3’-­‐UTR,	  640	  nt	  
	  








Dendrites	   5’-­‐UTR,	  24	  nt	   (Pal	  et	  al.,	  2003)	   60	  and	  70	  
kDa	  proteins	  
(Pal	  et	  al.,	  2003)	  
RhoA	   Axons	   	   (Wu	  et	  al.,	  2005)	   	   	  
Tau	   Axon	  hillock	   3’-­‐UTR,	  91	  nt	   (Behar	  et	  al.,	  1995)	   IIf3	  and	  
NP90	  





As	  already	  described	  above,	  β-­‐actin	  mRNA	  was	  previously	  described	  to	  localize	  to	  growing	  edges	  
of	   fibroblasts	   to	   enable	   motility	   (Kislauskis	   et	   al.,	   1997).	   Its	   translation	   is	   blocked	   by	   ZBP1,	   which	   is	  
released	   upon	   phosphorylation	   of	   ZBP1	   by	   Src	   kinase	   (Hüttelmaier	   et	   al.,	   2005).	   In	   neurons,	   β-­‐actin	  
mRNA	  was	  shown	  to	  localize	  to	  growth	  cones	  of	  axons	  (Zhang	  et	  al.,	  2001),	  and	  to	  dendrites	  and	  spines	  
upon	   activity	   (Tiruchinapalli	   et	   al.,	   2003).	   Interestingly,	   β-­‐actin	   mRNA	   seems	   to	   be	   regulated	   by	   the	  
double-­‐stranded	   RNA	   binding	   protein	   (dsRBP)	   Stau2,	   as	   its	   pattern	   is	   altered	   upon	   loss	   of	   Stau2	   in	  
mature	  neurons	  (Goetze	  et	  al.,	  2006).	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LIMK1	  mRNA	  
	   LIM	   domain	   kinase	   1	   (LIMK1)	  mRNA	  was	   only	   recently	   identified	   to	   be	   dendritically	   localized	  
(Schratt	   et	   al.,	   2006).	   It	   encodes	   for	   the	   LIM	   kinase	   1,	   which	   acts	   on	   the	   actin	   cytoskeleton	   by	  
phosphorylating	   and	   thereby	   regulating	   the	   cofilin	   family	   proteins.	   Inhibition	   of	   LIMK1/LIMK2	   activity	  
leads	   to	   reduced	   actin	   filament	   assembly	   in	   peripheral	   regions	   of	   chick	   dorsal	   root	   ganglion	   neurons	  
(Endo	  et	  al.,	  2007;	  Scott	  and	  Olson,	  2007).	  LIMK1	  mRNA	  was	  shown	  to	  be	   regulated	  by	  miR-­‐134,	  and	  
brain-­‐derived	  neurotrophic	  factor	  (BDNF)	  appears	  to	  release	  the	  repression	  (Schratt	  et	  al.,	  2006).	  
	  
RhoA	  mRNA	  
The	  members	  of	  the	  Rho	  family	  of	  guanosine	  triphosphatases	  (GTPases),	  	   ras	   homolog	   gene	  
family,	  member	  A	   (RhoA),	   ras-­‐related	  C3	  botulinum	   toxin	   substrate	  1	   (Rac1),	   and	   cell	   division	   control	  
protein	  42	  homolog	  (Cdc-­‐42),	  were	  initially	  linked	  with	  establishing	  polarity	  in	  yeast.	  They	  are	  regulators	  
of	  the	  actin	  cytoskeleton	  in	  mammalian	  cells	  (reviewed	  in	  Hall,	  1994).	  In	  neurons,	  RhoA	  transcripts	  are	  
localized	   to	   developing	   axons	   and	   growth	   cones	   via	   an	   axonal	   targeting	   element	   in	   its	   3’-­‐UTR.	   Local	  
translation	  of	  RhoA	  is	  induced	  by	  semaphorin	  3A	  (Sema3A),	  which	  is	  necessary	  and	  sufficient	  to	  mediate	  
a	  growth	  cone	  collapse	  (Wu	  et	  al.,	  2005).	  	  
A	   role	   of	   RhoA	   in	   dendritic	   and	   axonal	   development	   was	   proposed	   in	   several	   studies,	   with	  
contradictory	  results.	  In	  one	  study,	  dominant-­‐negative	  forms	  of	  Rac	  or	  Cdc42	  lead	  to	  marked	  reductions	  
of	  primary	  dendrites,	  while	  constitutively	  active	  forms	  of	  Rho,	  Rac	  or	  Cdc42	  lead	  to	  increased	  dendrite	  
numbers	  (Threadgill	  et	  al.,	  1997).	  Later	  on,	  other	  studies	  showed	  that	  more	  active	  RhoA	  leads	  to	  a	  lower	  
complexity	   in	   dendritic	   branching,	   and	   loss	   of	   RhoA	  would	   lead	   to	   longer	   dendrites,	   but	   also	   to	   less	  
dendritic	  spines.	  Dendritic	  development	  benefits	  from	  inactivation	  of	  RhoA	  (Ahnert-­‐Hilger	  et	  al.,	  2004;	  
Lee	  et	  al.,	  2000;	  Nakayama	  et	  al.,	  2000).	  Destabilization	  of	  the	  actin	  cytoskeleton	  by	  inactivation	  of	  the	  
Rho	   family	  members	   in	   neurons	   leads	   to	   outgrowth	   of	  multiple	   axons	   (Bradke	   and	   Dotti,	   1999),	   but	  
axonal	  development	  requires	  activation	  of	  RhoA	  (Ahnert-­‐Hilger	  et	  al.,	  2004).	  A	  study	  in	  Xenopus	  neurons	  
shows	  a	  more	  diverse	  picture	   for	   the	  members	  of	   the	  Rho	  GTPases:	  Rac	  and	  Cdc42	   regulate	  dynamic	  
branch	  additions	  and	  retractions	  and	  the	  addition	  of	  short	  branches;	  RhoA	  regulates	  the	  elongation	  of	  
existing	  branches,	  and	  the	  selective	  extension	  of	  a	  s	  subset	  of	  the	  newly	  added	  branches	  (Li	  et	  al.,	  2000).	  
It	  seems	  clear	  that	  RhoA	  –	  very	  likely	  via	  the	  actin	  cytoskeleton	  –	  affects	  outgrowth	  and	  development	  of	  
both	  axons	  and	  dendrites.	  How	  exactly	   these	  processes	  occur	  and	  how	   they	  are	   regulated,	   is	   far	   less	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1.2.3.2 Localized	  non-­‐coding	  RNAs	  
Non-­‐coding	  RNAs	  emerged	  as	  an	  important	  class	  of	  translational	  regulators	  during	  the	  last	  years.	  
In	   neurons,	   non-­‐coding	   RNAs,	  mainly	  miRNAs,	  were	   related	  with	   translational	   repression	   during	   RNA	  
transport.	   Long	   before	   miRNAs	   entered	   the	   game,	   another	   non-­‐coding	   RNA,	   BC1,	   was	   found	   in	   the	  
somatodendritic	   compartment	   in	   neurons	   (Tiedge	   et	   al.,	   1991).	   BC1	   was	   previously	   reported	   to	   be	  
involved	  in	  translational	  regulation,	  either	  by	  sequence-­‐specific	  binding	  of	  complementary	  regions	  in	  the	  
target	  mRNA	  via	  FMRP	  (Zalfa	  et	  al.,	  2003),	  or	  by	  a	  more	  general	  effect	  via	  interfering	  with	  the	  translation	  
initiation	  machinery	  (Wang	  et	  al.,	  2002).	  
miRNAs	   are	   a	   class	   of	   small	   (21	   nt)	   non-­‐coding	   RNAs	   that	   have	   been	   shown	   to	   be	   post-­‐
translational	   regulators.	   They	   bind	   to	   complementary	   sequences	   of	   mRNA	   transcripts	   and	   induce	   a	  
pathway	   that	   either	   leads	   to	   degradation	   of	   the	   mRNA	   or	   to	   reversible	   translational	   arrest.	   Many	  
miRNAs	  are	  especially	  enriched	  or	   tissue-­‐specifically	  expressed	   in	   the	  nervous	   system,	  having	   roles	   in	  
neural	  development,	  like	  neural	  patterning,	  cell	  specification,	  axonal	  pathfinding,	  or	  apoptosis,	  but	  also	  
in	   mature	   neurons.	   In	   mature	   neurons,	   they	   are	   thought	   to	   be	   involved	   in	   synaptic	   remodeling	  
(reviewed	  in	  Kosik,	  2006).	  A	  key	  Drosophila	  study	  by	  the	  Kunes	  lab	  supports	  this	  hypothesis:	  CaMKII	  is	  
directed	  to	  synaptic	  sites	  and	  rapidly	  translated	  upon	  synaptic	  activity.	  This	  process	  is	  regulated	  by	  the	  
RISC	  pathway,	  as	  Armitage	  is	  required	  for	  formation	  of	  long-­‐term	  memory.	  Armitage	  itself	  is	  controlled	  
by	  degradation	  by	  the	  proteasome	  (Ashraf	  et	  al.,	  2006).	  	  
Large-­‐scale	   studies	   aimed	   to	   investigate	   whether	   miRNAs	   are	   enriched	   in	   dendrites	   by	   laser	  
capture	  dissection	  or	  biochemical	  purification	  and	  identified	  a	  subset	  of	  dendritically	   localized	  miRNAs	  
(Konecna	  et	   al.,	   2009;	   Kye	   et	   al.,	   2007;	   Lugli	   et	   al.,	   2008).	   In	   neurons,	   only	   few	  examples	   for	   specific	  
miRNA-­‐mRNA	  pairs	  are	  known	  up	  to	  now.	  The	  first	  example	  that	  was	  shown	  in	  mammalian	  neurons	  was	  
dendritically	   localized	  LIMK1	  mRNA	  regulated	  by	  dendritically	   localized	  miR-­‐134.	  This	   repression	  could	  
be	   relieved	   upon	   release	   of	   BDNF	   (Schratt	   et	   al.,	   2006).	   The	   other	   neuronal	   miRNA	   that	   could	  
successfully	  be	  linked	  to	  its	  mRNA	  target	  is	  miR-­‐138	  regulating	  the	  depalmitoylation	  enzyme	  acyl	  protein	  
thioesterase	  1	  	  (APT1).	  Down-­‐regulation	  of	  APT1	  leads	  to	  an	  inhibition	  of	  dendritic	  spine	  growth	  (Siegel	  
et	  al.,	  2009).	  In	  general,	  identification	  of	  miRNA	  targets,	  or	  miRNAs	  targeting	  a	  specific	  mRNA,	  is	  based	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1.2.4 Protein	  components	  of	  RNPs	  
 
While	  the	  transported	  RNA	  represents	  the	  cargo,	  proteins	  have	  to	  assemble	  a	  functional	  vehicle	  
to	  enable	  transport	  and	  post-­‐transcriptional	  regulation	  of	  the	  RNA.	  RNA-­‐binding	  proteins	  are	  TAFs	  that	  
recognize	  their	  target	  RNAs	  via	  cis-­‐acting	  elements.	  Only	  a	   limited	  set	  of	  those	  TAFs	   is	  well	  studied	  to	  
date.	  Most	  of	  those	  that	  are	  now	  implicated	  with	  RNA	  localization	  in	  mammalian	  neurons,	  are	  homologs	  
of	  proteins	  initially	  identified	  in	  Drosophila	  studies	  of	  embryonic	  patterning.	  In	  a	  key	  study	  (Dubnau	  et	  
al.,	   2003),	   a	   microarray	   screen	   was	   performed	   to	   identify	   genes	   that	   are	   transcriptionally	   regulated	  
during	  memory	  formation	  in	  Drosophila.	  Of	  the	  genes	  identified,	  mutational	  analysis	  validated	  staufen,	  
pumilio,	   oskar,	   and	   eukaryotic	   translation	   initiation	   factor	   5C	   domain-­‐containing	   protein	   (eIF-­‐5C)	   as	  
those	   that	   reliably	   lead	   to	   defective	  memory.	  Mammalian	   homologs	   of	   some	  of	   those	   proteins	  were	  
identified	  then	   in	  mammalian	  neurons	  and	  now	  represent	  the	  most	  reliable	  set	  of	  TAFs.	  While	  mainly	  
ZBP1	  and	  hnRNP	  proteins	  are	  well	  known	  trans-­‐acting	  factors	   involved	  with	  neuronal	  RNA	  localization	  
(reviewed	  in	  (Palacios	  and	  St	  Johnston,	  2001)),	  here	  only	  Stau2	  and	  Pum2	  are	  introduced	  in	  more	  detail.	  	  	  	  
	  
Staufen2	  
Staufen	  was	  the	  first	  protein	  that	  was	  shown	  to	  have	  a	  role	  in	  RNA	  localization,	  in	  axis	  formation	  
in	  Drosophila.	  It	  consists	  of	  5	  double-­‐strand	  RNA-­‐binding	  domains	  (dsRBDs)	  of	  which	  different	  ones	  are	  
necessary	  for	  recognition	  of	  certain	  mRNAs	  (reviewed	  in	  St	  Johnston,	  2005).	  In	  mammals,	  two	  homologs	  
of	  Staufen,	  namely	  Stau1	  and	  Stau2,	  were	  identified	  (Marion	  et	  al.,	  1999;	  Wickham	  et	  al.,	  1999).	  They	  
were	  shown	  to	  be	   involved	   in	  RNA	  transport,	   localize	   to	  RNA-­‐protein	  granules	   in	   the	  somatodendritic	  
compartment	   and	   are	   in	   close	   vicinity	   to	   smooth	   endoplasmatic	   reticulum	   and	   microtubules	   near	  
synaptic	   contacts	   (Kiebler	   et	   al.,	   1999;	   Köhrmann	   et	   al.,	   1999b).	   While	   Stau1	   is	   expressed	   more	  
ubiquitously,	  expression	  of	  Stau2	  is	  enriched	  in	  neuronal	  tissues.	  Stau1	  and	  Stau2	  do	  not	  co-­‐localize	  in	  
cultured	   hippocampal	   neurons,	   but	   both	   are	   localized	   to	   granules	   and	   found	   in	   the	   P100	   fraction	   of	  
cytoplasmic	  extracts	  (Duchaine	  et	  al.,	  2002).	  In	  subsequent	  analyses	  of	  Stau2,	  a	  constructs	  lacking	  the	  C-­‐
terminal	  portion	  but	  still	  containing	  the	  dsRBDs	  was	  restricted	  to	  the	  cell	  body	  and	  proximal	  dendrites.	  
Furthermore,	  the	  amount	  of	  dendritic	  mRNA	  was	  decreased	  (Tang	  et	  al.,	  2001).	  Loss	  of	  Stau2	  in	  mature	  
neurons	   led	   to	   decreased	   numbers	   of	   dendritic	   spines	   and	   synaptic	   contacts,	   as	   well	   as	   reduced	  
miniature	   excitatory	   postsynaptic	   current	   (mEPSC)	   amplitudes	   and	   an	   altered	   dendritic	   actin	  
cytoskeleton	   (Goetze	   et	   al.,	   2006).	   The	   biological	   function	   of	  mammalian	   Stau2	   is	   still	   under	   debate.	  
Drosophila	  Staufen	  was	  shown	  to	  act	  on	  translational	  control	  of	  oskar	  mRNA	  (Micklem	  et	  al.,	  2000),	  and	  
mammalian	  Stau1	  exhibits	  translational	  control	  of	  target	  mRNAs	  recognized	  by	  5’-­‐UTR	  elements	  (Dugre-­‐
Brisson	  et	  al.,	  2005).	  For	  mammalian	  Stau2,	  however,	  no	  such	  a	  mechanism	  was	  shown	  so	  far.	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Pumilio2	  
Similar	  to	  Staufen,	  Drosophila	  Pumilio	  was	  identified	  in	  a	  screen	  for	  memory	  defects	  (Dubnau	  et	  
al.,	   2003).	   Pumilio	  was	   shown	   to	   be	   involved	   in	   synaptic	   growth	   and	   plasticity	   at	   the	   neuromuscular	  
junction	   (NMJ)	   in	  Drosophila.	   It	   acts	   as	   a	   translational	   repressor	   that	   selectively	   binds	   the	   3’-­‐UTR	   of	  
eIF4E	  (Menon	  et	  al.,	  2004)	  and	  is	  required	  for	  dendrite	  morphogenesis	  in	  peripheral	  neurons	  (Ye	  et	  al.,	  
2004).	   In	   mammals,	   two	   isoforms	   of	   Pumilio	   were	   identified:	   Pumilio1	   (Pum1)	   and	   Pumilio2	   (Pum2)	  
(Spassov	   and	   Jurecic,	   2002).	   In	   mammalian	   neurons,	   Pum2	   is	   recruited	   to	   somatodendritic	   stress	  
granules	   upon	  exposure	   to	   stress,	   but	   it	   is	   excluded	   from	  P-­‐bodies.	  Upon	   loss	   of	   Pum2,	   formation	  of	  
stress	  granules	   is	  hindered	   (Vessey	  et	  al.,	  2006).	  Recently,	   regulation	  of	  Pum2	  by	  a	  miRNA-­‐dependent	  
mechanism	   was	   shown.	   The	   miRNA	   cluster	   miR-­‐379-­‐410	   is	   transcriptionally	   regulated	   by	   neuronal	  
activity	  in	  a	  Mef2-­‐dependent	  manner,	  which	  is	  necessary	  for	  the	  elaboration	  of	  the	  dendritic	  tree.	  Pum2	  
itself	  was	  identified	  as	  a	  target	  of	  miR-­‐134,	  and	  as	  a	  mediator	  of	  a	  growth	  promoting	  effect	  on	  dendrites	  
of	   miR-­‐134	   (Fiore	   et	   al.,	   2009).	   Unlike	   Stau2,	   the	   physiological	   function	   of	   Pum2	   as	   translational	  
repressor	  is	  mostly	  accepted.	  However,	  the	  biological	  targets	  for	  Pum2	  in	  mammalian	  neurons	  are	  still	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1.3 Aims	  of	  this	  thesis	  
 
	  The	  aim	  for	  my	  work	  was	  to	  investigate	  the	  mechanisms	  of	  mRNA	  localization	  and	  translational	  
control	   in	  mammalian	  neurons.	   In	  chapters	  3.1	  and	  3.2,	   I	   studied	   two	  alternative	  pathways	   that	  have	  
been	  implicated	  in	  translational	  control	  of	  localizing	  mRNAs:	  the	  trans-­‐acting	  factor	  Pum2	  and	  miRNAs.	  
For	  Pum2,	  my	  aim	  was	  to	  investigate	  whether	  it	  controls	  the	  translation	  its	  putative	  target	  mRNA	  eIF4E.	  
Furthermore	  I	  wanted	  to	  observe	  whether	  this	  target	  also	  influences	  neuronal	  development	  as	  has	  been	  
shown	   for	   Pum2.	   Furthermore,	   I	   was	   interested	   whether	   specific,	   dendritically	   localized	   candidate	  
mRNAs	  would	  be	  under	  control	  of	  miRNAs	  that	  are	  predicted	  to	  bind	  in	  their	  3’-­‐UTRs.	  Another	  protein	  
that	   had	   been	   involved	   in	   RNA	   localization	   and	   translational	   control	   in	   Drosophila	   and	   mammals	   is	  
Staufen.	   In	   Chapter	   3.3,	   I	   investigated	   one	   of	   its	   two	   mammalian	   homologs,	   Stau2.	   My	   aim	   was	   to	  
unravel	   the	   physiological	   function	   of	   Stau2	   in	   neurons	   and	   to	   address	   whether	   it	   regulates	   the	  
localization,	  translation	  or	  stability	  of	  axonal	  or	  dendritic	  candidate	  mRNAs.	  Finally,	  I	  wanted	  to	  establish	  
a	  biochemical	  approach	  to	  identify	  novel	  TAFs	  in	  protein	  complexes	  that	  recognize	  specific,	  dendritically	  
localized	  mRNAs	  and	  transport	  them	  to	  their	  destination	  (Chapter	  3.4).	  	  















2 Materials	  and	  Methods	  
2.1 Buffers	  and	  media	  
 
Buffer	  for	  preparation	  of	  CaCl2-­‐competent	  E.	  coli	  cells	  
0.1	  M	  CaCl2	  
10	  mM	  Tris	  pH	  7.5	  
	  
2x	  tryptone-­‐yeast	  extract	  (2xTY)	  medium	  
16	  g/l	  Bacto-­‐tryptone	  
10	  g/l	  Bacto-­‐yeast	  extract	  
5	  g/l	  NaCl	  
H2O	  (Millipore)	  	  
Adjust	  pH	  to	  7.4,	  autoclave,	  store	  at	  4°C	  
	  
Luria-­‐Bertani	  broth	  (LB)	  medium	  
10	  g/l	  Bacto-­‐tryptone	  
5	  g/l	  Bacto-­‐yeast	  extract	  
10	  g/l	  NaCl	  
H2O	  (Millipore)	  	  
autoclave,	  store	  at	  4°C	  
	  
Bacterial	  growth	  plate	  
Add	  15	  g/l	  agar	  to	  LB	  or	  2xTY	  medium.	  Antibiotics	  were	  added	  from	  stocks	  in	  a	  dilution	  of	  1:1,000.	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Antibiotics	  stock	  solutions	  
All	  stock	  solutions	  are	  prepared	  in	  concentrations	  so	  that	  they	  can	  then	  be	  used	  in	  a	  dilution	  of	  1:1,000	  
in	  bacterial	  media.	  Antibiotics	  are	  dissolved	  in	  sterile	  ddH2O,	  filtered	  through	  a	  0.45	  um	  filter	  unit	  with	  a	  
syringe,	  aliquoted	  and	  frozen	  at	  -­‐20°C.	  	  
Stock	  solutions:	  100	  mg/ml	  Ampicillin	  (Amp);	  30	  mg/ml	  Kanamycin	  acid	  sulfate	  (Kan).	  
	  
Bromo-­‐chloro-­‐indolyl-­‐galactopyranoside	  (X-­‐gal)	  solution	  for	  blue-­‐white	  screening	  
15	  mg/ml	  X-­‐gal	   	   15	  μl	  of	  20	  mg/ml	  stock	  (stored	  at	  -­‐20°C)	  
25	  mM	  IPTG	   	   5	  μl	  of	  0.1	  M	  (1M	  stock	  stored	  at	  -­‐20°C)	  
20	  μl	  solution	  required	  per	  10-­‐cm	  plate	  
	  
Tris-­‐acetate-­‐EDTA	  (TAE)	  buffer	  for	  agarose	  gel	  electrophoreses	  (50x	  stock	  solution)	  
242	  g/l	  Tris	  base	  
57.1	  ml	  Acetic	  acid	  
50	  mM	  EDTA	  	  (dissolve	  in	  advance,	  adjust	  pH	  to	  8	  to	  get	  it	  dissolved)	  
Adjust	  pH	  to	  7.5	  –	  7.8	  
	  
Oligo	  annealing	  buffer	  	  
	  100	  mM	  NaCl	  
50	  mM	  HEPES	  (pH	  7.4)	  
	  
Brain	  extraction	  buffer	  
25	  mM	  HEPES	  (pH	  7.3)	  
150	  mM	  KCl	  
8	  %	  Glycerol	  
0.1	  %	  NP-­‐40	  
2	  μl/ml	  RNase	  inhibitor	  (40	  u/μl)	  
1	  mM	  DTT	  
1	  protease	  inhibitor	  tablet/10	  ml	  (Roche	  EDTA-­‐free)	  
	  
Lysis	  buffer	  for	  cultured	  mammalian	  cells	  
50	  mM	  Tris	  pH	  (7.5)	  
150	  mM	  NaCl	  
1	  mM	  EDTA	  
1	  %	  Triton-­‐X-­‐100	  
1	  protease	  inhibitor	  tablet/10	  ml	  (Roche	  EDTA-­‐free)	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Nuclear	  protein	  lysis	  buffer	  for	  cultured	  mammalian	  cells	  (according	  to	  M.	  Müller	  and	  J.	  Dangerfield,	  
University	  of	  Veterinary	  Medicine	  Vienna)	  
10	  mM	  HEPES	  (pH	  7.9)	  
400	  mM	  NaCl	  
1mM	  DTT	  
1	  protease	  inhibitor	  tablet/10	  ml	  (Roche	  EDTA-­‐free)	  
	  
SDS	  gel-­‐composition	  	  
Resolving	  gel	  (per	  5	  ml)	  (modified	  from	  (Sambrook	  and	  Russel,	  2001))	  
8%	   10%	   12%	  
2.3	  	   1.9	   1.6	   ml	  H2O	  
1.3	  	   1.7	   2.0	   ml	  30	  %	  acrylamide	  mix	  
1.3	  	   1.3	   1.3	   ml	  1M	  Tris	  (pH	  8.8)	  
50	  	   50	   50	   µl	  10	  %	  SDS	  
50	  	   50	   50	   µl	  10	  %	  ammonium	  persulfate	  
3	  	   2	   2	   µl	  TEMED	  
	  
Stacking	  gel	  (5%,	  per	  5	  ml)	  (modified	  from	  (Sambrook	  and	  Russel,	  2001))	  
3.4	  ml	  H2O	  
830	  µl	  30	  %	  acrylamide	  mix	  
630	  µl	  1M	  Tris	  (pH	  6.8)	  
50	  µl	  10	  %	  SDS	  
50	  µl	  10	  %	  ammonium	  persulfate	  
5	  µl	  TEMED	  
	  
SDS	  gel-­‐running	  buffer	  (10x)	  
250	  mM	  Tris	  
1.92	  M	  Glycine	  
1	  %	  SDS	  
	  
Western	  Blot	  transfer	  buffer	  (10x)	  
250	  mM	  Tris	  
1.92	  M	  Glycine	  
The	  1x	  dilution	  was	  supplemented	  with	  20	  %	  methanol.	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Tris-­‐buffered	  saline	  (TBS)	  	  
15	  mM	  Tris	  (pH	  7.5)	  
150	  mM	  NaCl	  
	  
Tris-­‐buffered	  saline	  tween	  20	  (TBS-­‐T)	  
TBS	  
0.1	  %	  Tween	  20	  
	  
SDS	  gel-­‐loading	  buffer	  (6x,	  from	  (Sambrook	  and	  Russel,	  2001))	  
300	  mM	  Tris-­‐HCl	  (pH	  6.8)	  
600	  mM	  DTT	  
12	  %	  SDS	  
0.6	  %	  bromophenol	  blue	  
60	  %	  glycerol	  
	  
In	  vitro	  transcription	  buffer	  (modified	  from	  (Sambrook	  and	  Russel,	  2001))	  
400	  mM	  Tris-­‐HCl	  (pH	  7.5)	  
120	  mM	  MgCl2	  
20	  mM	  spermidine	  
50	  mM	  NaCl	  
ddH2O	  (nuclease	  free)	  
	  
In	  vitro	  transcription	  buffer	  (as	  in	  Promega’s	  Ribomax	  kit)	  
400	  mM	  HEPES-­‐KOH	  (pH	  7.5)	  
120	  mM	  MgCl2	  	  
10	  mM	  spermidine	  	  
200	  mM	  DTT	  
ddH2O	  (nuclease	  free)	  	  
	  
In	  vitro	  transcription	  buffer	  (according	  to	  Suzanne	  McDermott,	  University	  of	  Edinburgh)	  
400	  mM	  Tris-­‐HCl	  (pH	  8.1)	  
10	  mM	  spermidine	  
0.01	  %	  Triton-­‐X-­‐100	  
ddH2O	  (nuclease	  free)	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RNA	  loading	  dye	  (2x)	  
95	  %	  formamide	  
0.025	  %	  bromophenol	  blue	  (w/v)	  
0.5	  mM	  EDTA	  
0.025	  %	  SDS	  
	  
StreptoTag	  Streptomycin	  Coupling	  buffer	  (CPB)	  
10	  mM	  NaOH	  (pH	  12)	  	  
	  
StreptoTag	  Low	  pH	  buffer	  (pH	  4.0)	  
100	  mM	  CH3COONa	  	  	  
500	  mM	  NaCl	  
	  
StreptoTag	  High	  pH	  buffer	  (pH	  8.3)	  
100	  mM	  NaHCO3	  
500	  mM	  NaCl	  
	  
StreptoTag	  Column	  buffer	  (CB,	  5x)	  
25	  mM	  MgCl2	  
250	  mM	  Tris-­‐HCl	  (pH	  7.6)	  
1.25	  M	  NaCl	  
	  
StreptoTag	  Column	  buffer	  (CB,	  5x)	  
25	  mM	  MgCl2	  
250	  mM	  Tris-­‐HCl	  (pH	  7.6)	  
1.25	  M	  NaCl	  
	  
StreptoTag	  Column	  buffer	  according	  to	  Eric	  Westhof	  (CNRS,	  Strassbourg)	  (5x)	  
10	  mM	  MgCl2	  
250	  mM	  Tris-­‐HCl	  (pH	  7.6)	  
750	  mM	  NaCl	  
	  
StreptoTag	  Column	  buffer	  according	  to	  Stefan	  Hüttelmaier	  (University	  of	  Halle)	  (5x)	  
2.5	  mM	  MgCl2	  
250	  mM	  Tris-­‐HCl	  (pH	  7.6)	  
750	  mM	  NaCl	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StreptoTag	  Column	  buffer	  according	  to	  Peter	  Lukavsky	  (LMB	  Cambridge)	  (5x)	  
50	  mM	  MgCl2	  
250	  mM	  Tris-­‐HCl	  (pH	  7.4)	  
600	  mM	  KCl	  
25	  %	  Sucrose	  
	  
Lysis	   buffer	   for	   production	   of	   T7	   RNA	   polymerase	   (according	   to	   Suzanne	  McDermott,	  University	   of	  
Edinburgh)	  
20	  mM	  Tris-­‐HCl	  (pH	  8.0)	  
10	  %	  glycerol	  
0.1	  %	  Tween	  20	  
200	  mM	  NaCl	  
1	  mM	  Imidazole	  
ddH2O	  
	  
Elution	  buffer	  for	  production	  of	  T7	  RNA	  polymerase	  (according	  to	  Suzanne	  McDermott,	  University	  of	  
Edinburgh)	  
20	  mM	  Tris-­‐HCl	  (pH	  8.0)	  
10	  %	  glycerol	  
0.1	  %	  Tween	  20	  
200	  mM	  NaCl	  
10	  mM	  Imidazole	  
ddH2O	  
	  
Extra-­‐elution	   buffer	   for	   production	   of	   T7	   RNA	   polymerase	   (according	   to	   Suzanne	   McDermott,	  
University	  of	  Edinburgh)	  
20	  mM	  Tris-­‐HCl	  (pH	  8.0)	  
10	  %	  glycerol	  
0.1	  %	  Tween	  20	  
200	  mM	  NaCl	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Storage	  buffer	  for	  T7	  RNA	  polymerase	  (according	  to	  Peter	  Lukavsky,	  LMB	  Cambridge)	  
20	  mM	  Potassium	  phosphate	  (pH	  7.5)	  
100	  mM	  NaCl	  
1	  mM	  EDTA	  
1	  mM	  DTT	  
50%	  Glycerol	  
100	  µg/ml	  BSA	  (optional)	  
	  
PCR	  buffer	  (for	  long	  products)	  (modified	  from	  Cheng	  et	  al.,	  1994)	  
425	  mM	  KOAc	  
125	  mM	  Tricine	  (pH	  8.7,	  adjusted	  with	  KOH)	  
40	  %	  glycerol	  
5	  %	  DMSO	  	  
	  
Phosphate-­‐buffered	  saline	  (PBS)	  (pH	  7.4)	  
137	  mM	  NaCl	  
10	  mM	  Phosphate	  
2.7	  mM	  KCl	  
	  
Hank’s	  balanced	  salt	  solution	  (HBSS)	  (pH	  7.3)	  	  
1.27	  mM	  CaCl2·∙2H2O	  
0.8	  mM	  MgSO4·∙7H2O	  
136	  mM	  NaCl	  
0.33	  mM	  Na2HPO4·∙2H2O	  
4.2	  mM	  NaHCO3	  
5.4	  mM	  KCl	  
0.44	  mM	  KH2PO4	  
5.6	  mM	  D(+)	  glucose	  
7	  mM	  HEPES	  (pH	  7.3)	  
ddH2O	  
	  
Blocking	  solution	  for	  immunostainings	  
2%	  fetal	  calf	  serum	  (FCS;	  PAA	  Laboratories,	  Pasching,	  Austria)	  
2%	  BSA	  (Sigma)	  
0.2%	  fish	  skin	  gelatine	  (Sigma)	  
PBS	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Firefly	  luciferase	  buffer	  (Gaunitz	  and	  Papke,	  1998)	  (pH	  7.8)	  
470	  μM	  D-­‐Luciferin	  
530	  μM	  ATP	  
270	  μM	  ATP	  
270	  μM	  Coenzyme	  A	  
33.3	  mM	  DTT	  
20	  mM	  Tricine	  
2.67	  mM	  MgSO4·∙7H2O	  
100	  μM	  EDTA	  
	  
Renilla	  luciferase	  buffer	  (Dyer	  et	  al.,	  2000)	  (pH	  5)	  
1.43	  μM	  Coelenterazine	  
2.2	  mM	  Na2EDTA	  
220	  mM	  KH2PO4	  
0.44	  mg/ml	  BSA	  
1.1	  M	  NaCl	  
1.3	  mM	  NaN3	  
	  
Dulbecco's	  Modified	  Eagle	  Medium	  with	  horse	  serum	  (DMEM-­‐HS)	  
1x	  D-­‐MEM	  containing	  4.5	  mg/l	  glucose	  and	  GlutaMAX-­‐I	  
10	  %	  horse	  serum	  
1	  mM	  sodium	  pyruvate	  
200	  mM	  L-­‐glutamine	  
ddH2O	  
	  
Neurobasal	  medium	  (NMEM)	  supplemented	  with	  B27	  (pH	  7.4)	  
	  1x	  MEM	  (modified	  Eagle’s	  medium)	  from	  a	  10x	  MEM	  stock	  
26	  mM	  NaHCO3	  
1	  mM	  sodium	  pyruvate	  
200	  mM	  L-­‐glutamine,	  stable	  
33	  mM	  D-­‐glucose	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Transfection	  medium	  (pH	  7.45)	  
1x	  MEM	  (modified	  Eagle's	  medium)	  from	  a	  10x	  MEM	  stock	  
15	  mM	  HEPES	  (4-­‐(2-­‐hydroxyethyl)-­‐1-­‐piperazineethanesulfonic	  acid)	  
1	  mM	  sodium	  pyruvate	  
2	  mM	  L-­‐glutamine,	  stable	  
33	  mM	  D-­‐glucose	  
1x	  B-­‐27	  supplement	  
ddH2O	  
	  
Transfection	  HBSS	  (pH	  7.3)	  
135	  mM	  NaCl2	  
20	  mM	  HEPES	  (4-­‐(2-­‐hydroxyethyl)-­‐1-­‐piperazineethanesulfonic	  acid)	  
1	  mM	  Na2HPO4	  
4	  mM	  KCl	  
2	  mM	  CaCl2	  
1	  mM	  MgCl2	  
10	  mM	  D-­‐glucose	  
ddH2O	  
	  
2x	  BBS	  buffer	  
50mM	  BES	  (N,N-­‐Bis(2-­‐hydroxyethyl)-­‐2-­‐aminoethanesulfonic	  acid)	  
1.5	  mM	  Na2HPO4	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2.2 Molecular	  biology	  
2.2.1 Cloning	  methods	  
2.2.1.1 PCR	  amplification	  of	  target	  sequences	  
Specific	   DNA	   sequences	   of	   target	   genes	   were	   amplified	   by	   polymerase	   chain	   reaction	   (PCR)	  
(Mullis	  et	  al.,	  1986;	  Saiki	  et	  al.,	  1985).	  As	   templates	  served	  either	  cDNA	  extracted	   from	  rat	   tissues	  or	  
plasmid	   DNA	   (if	   available).	   Primers	   were	   designed	   to	   be	   specific	   for	   target	   genes,	   to	   be	   19	   –	   21	  
nucleotides	   of	   length	   and	   to	   have	   an	   estimated	   melting	   temperature	   of	   60°C	   calculated	   with	   the	  
following	  formula:	  Tm	  (°C)	  =	  2(A+T)	  +	  4(G+C)	  (Suggs	  et	  al.,	  1981;	  Thein	  et	  al.,	  1986).	  The	  primers	  used	  
are	   listed	   in	   chapter	   2.6.	   Restriction	   enzyme	   target	   sites	   and	   an	   additional	   2	   nucleotides	   (nt)	   were	  
added	   at	   the	   end	   of	   the	   primer	   sequences	   as	   needed	   for	   further	   cloning	   steps.	   Amplification	   was	  
performed	  for	  35	   	  -­‐	  45	  cycles.	   In	  PCRs	  for	  cloning	  purposes,	  Phusion	  Pfu	  polymerase	  (Finnzymes)	  was	  
used,	   while	   for	   test	   PCRs	   and	   A-­‐tailing	   reactions	   (for	   TA-­‐cloning)	   Taq	   polymerase	   (Fermentas)	   was	  
used.	  	  	  	  	  
2.2.1.2 Restriction	  enzyme	  digests	  
Restriction	  enzyme	  digests	  for	  cloning	  purposes	  were	  assembled	  in	  50	  μl	  volume	  reactions,	  where	  
up	   to	  25	  μg	  of	  DNA	  were	  digested	  with	  1.5	  μl	   restriction	  endonuclease,	  under	  addition	  of	  5	  μl	  of	   the	  
corresponding	   10x	   buffer.	   Restriction	   enzyme	   digests	   for	   testing	   purposes	   were	   assembled	   in	   20	   μl	  
volume	   reactions,	   where	   up	   to	   10	   μg	   of	   DNA	   were	   digested	   with	   0.5	   μl	   restriction	   enzyme,	   under	  
addition	  of	  2	  μl	  of	  the	  corresponding	  10x	  buffer.	  Reactions	  were	  incubated	  at	  37°C	  for	  1	  -­‐	  3	  hours	  in	  a	  
water	   bath.	   Large	   scale	   digests	   for	   in	   vitro	   transcription	   were	   performed	   in	   300	   μl	   total	   volume,	  
digesting	  100	  μg	  DNA	  with	  8	  μl	  restriction	  enzyme.	  
Restriction	   enzymes	   were	   purchased	   from	   Fermentas	   and	   New	   England	   Biolabs.	  When	   double	  
digests	  were	  performed,	  optimal	  buffer	  conditions	  were	  used	  according	  to	  manufacturer’s	  instructions.	  
Either	   they	   were	   performed	   at	   the	   same	   time	   in	   a	   buffer	   that	   provided	   good	   conditions	   for	   both	  
enzymes,	  or	  after	  digest	  with	  the	  first	  enzyme,	  a	  clean	  up	  step	  was	  followed	  by	  the	  second	  digestion.	  	  
2.2.1.3 Agarose	  gel	  electrophoresis	  
DNA	   that	   was	   amplified	   in	   PCR	   reactions	   or	   plasmid	   DNA	   that	   was	   digested	   with	   restriction	  
enzymes	   was	   separated	   according	   to	   its	   size	   by	   agarose	   electrophoresis	   and	   subsequent	   ethidium	  
bromide	  staining	  (Sharp	  et	  al.,	  1973).	  Medium	  sized	  horizontal	  gels	  were	  used	  and	  run	  at	  const.	  100	  V	  
until	   the	   DNA	   bands	   were	   sufficiently	   separated.	   Agarose	   was	   heated	   and	   dissolved	   in	   TAE	   buffer,	  
which	  was	  also	  used	  as	  running	  buffer.	  Ethidium	  bromide	  was	  added	  in	  a	  concentration	  of	  0.05	  µg	  final	  
in	   the	   gel.	   Ethidium	  bromide-­‐stained	  DNA	  bands	  were	   visualized	  with	  UV-­‐light	   in	   a	  Gel-­‐Doc	   system	  
(PeqLab).	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2.2.1.4 Purification	  of	  DNA	  from	  PCRs,	  digestion	  reactions	  or	  agarose	  gels	  
DNA	  that	  had	  been	  isolated	  from	  agarose	  gels	  or	  treated	  with	  restriction	  enzymes	  was	  cleaned	  up	  
either	  using	   the	  Wizard	  SV	  Gel	  and	  PCR	  Clean-­‐Up	  System	  (Promega)	  or	  alternatively	   the	  QIAquick	  Gel	  
Extraction	   Kit	   (Qiagen)	   for	   DNA	   isolation	   from	   agarose	   gels	   and	   the	   QIAquick	   PCR	   Purification	   Kit	  
(Qiagen)	  for	  DNA	  from	  PCR	  reactions	  or	  digestion	  reactions.	  Procedures	  were	  carried	  out	  according	  to	  
the	  manufacturers’	  instructions.	  	  
2.2.1.5 Ligations	  
Ligation	   of	  DNA	   strands	  was	   performed	  with	   T4	  DNA	   ligase	   enzyme.	   Reactions	  were	   incubated	  
either	  at	  room	  temperature	  for	  15	  min	  -­‐	  3	  hrs,	  or	  at	  4°C	  overnight.	  The	  composition	  of	  the	  reaction	  mix	  
was	  assembled	  according	  to	  manufacturer’s	  instructions.	  	  
2.2.1.6 Transformation	  of	  chemically	  competent	  E.	  coli	  
Chemically	   competent	   E.	   coli	   were	   stored	   in	   100	   μl	   aliquots	   at	   -­‐80°C.	   For	   transformation,	   one	  
aliquot	   per	   transformation	   was	   thawed	   on	   ice.	   2	   -­‐	   4	   μl	   of	   the	   ligation	   mix	   or	   a	   vector	   for	   re-­‐
transformation	   was	   added	   and	   mixed	   gently	   with	   the	   cells	   by	   stirring	   softly	   with	   the	   pipet	   tip.	   The	  
transformation	  mix	  was	  then	  incubated	  on	  ice	  for	  30	  min.	  Heat	  shock	  for	  30	  sec	  at	  42°C	  was	  followed	  by	  
2	  min	  incubation	  on	  ice.	  Afterwards	  700	  μl	  LB	  medium	  without	  antibiotics	  were	  added	  and	  the	  reaction	  
was	   incubated	   at	   37°C,	   shaking	   at	   400	   rpm	   for	   1	   hr.	   Transformed	   cells	  were	   then	   plated	   on	   LB	   agar	  
plates	  containing	  the	  appropriate	  antibiotics.	  	  
2.2.1.7 Transformation	  of	  electro-­‐competent	  E.	  coli	  
Electro-­‐competent	  E.	  coli	  were	  stored	  in	  50	  μl	  aliquots	  at	  -­‐80°C.	  For	  transformation,	  one	  aliquot	  
per	   transformation	  was	   thawed	  on	   ice.	   2	  μl	  of	   the	   ligation	  mix	  or	   a	   vector	   for	   re-­‐transformation	  was	  
added	  and	  mixed	  gently	  with	  the	  cells	  by	  stirring	  softly	  with	  the	  pipet	  tip.	  The	  transformation	  mix	  was	  
then	   incubated	   on	   ice	   for	   2	   min.	   The	   E.	   coli	   pulser	   was	   set	   to	   1.80	   kV.	   DNA-­‐cell	   mixtures	   were	  
transferred	  to	  the	  bottom	  of	  pre-­‐cooled	  0.1	  cm	  cuvettes.	  Cells	  were	  then	  pulsed	  once.	  Afterwards,	  1	  ml	  
LB	   medium	   without	   antibiotics	   were	   added	   immediately	   and	   the	   reaction	   was	   incubated	   at	   37°C,	  
shaking	  at	  400	  rpm	  for	  30	  –	  60	  min.	  Transformed	  cells	  were	  then	  plated	  on	  LB	  agar	  plates	  containing	  the	  
appropriate	  antibiotics.	  
2.2.1.8 Colony	  screening	  
Colonies	  were	  screened	  either	  by	  colony-­‐PCR	  and/or	  test	  digests.	  For	  colony	  PCRs	  single	  colonies	  
were	  picked	  with	  pipet	  tips	  and	  added	  to	  25	  μl-­‐PCR	  reactions	  (Taq	  polymerase,	  Fermentas)	  containing	  
primers	  specific	  for	  the	  target	  insert	  or	  for	  the	  flanking	  plasmid	  sequences.	  PCR	  products	  were	  checked	  
on	   ethidium	   bromide	   agarose	   gels.	   For	   test	   digests,	   single	   colonies	   were	   used	   to	   inoculate	   5	   ml	   LB	  
medium.	   After	   8	   h	   to	   overnight	   growth,	   minipreps	   were	   performed	   and	   the	   extracted	   DNA	   was	  
restriction	  digested	  and	  checked	  on	  ethidium	  bromide	  agarose	  gels.	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2.2.1.9 Preparation	  of	  plasmid	  DNA	  from	  bacterial	  cultures	  
Mini-­‐	   and	   maxipreps	   of	   plasmid	   DNA	   from	   E.	   coli	   cultures	   were	   prepared	   according	   to	  
manufacturer’s	  instructions	  except	  for	  the	  procedures	  described	  below.	  For	  minipreps,	  5	  ml	  LB	  medium	  
were	   inoculated	   and	   incubated	   for	   8	   h	   to	   overnight;	   preparations	   were	   then	   performed	   with	   the	  
GenElute	   Plasmid	   Miniprep	   Kit	   (Sigma).	   For	   maxipreps,	   200	   ml	   LB	   medium	   were	   inoculated	   and	  
incubated	   overnight;	   preparations	  were	   done	   using	   the	   Endofree	   Plasmid	  Maxi	   Kit	   (Qiagen).	   Bacteria	  
were	  pelleted	  at	  6,000	  x	  g	  for	  15	  min	  at	  4°C	  (rotor	  JLA	  10.500).	  Centrifugation	  of	  the	  precipitated	  DNA	  
was	   done	   in	   either	   of	   two	   alternative	  ways.	   Previously,	   centrifugation	  has	   always	   been	  performed	   at	  
15,000	   for	   35	   min	   x	   g	   at	   4°C	   (rotor	   JA	   25.50).	   The	   centrifugation	   tubes	   had	   been	   cleaned	   with	  
isopropanol	  before.	  Afterwards,	  the	  DNA	  was	  transferred	  to	  1.5	  ml	  tubes	  and	  washed	  twice	  in	  500	  µl	  70	  
%	  ethanol	  (endotoxin	  free).	  Later,	  the	  protocol	  was	  adapted:	  Disposable	  50	  ml	  tubes	  were	  used	  and	  the	  
DNA	  was	  pelleted	  by	  centrifugation	  at	  4,000	  x	  g	  for	  60	  min	  at	  4°C.	  Then	  one	  washing	  step	  with	  5	  ml	  70	  %	  
ethanol	  (endotoxin	  free)	  followed,	  and	  samples	  were	  again	  centrifuged	  at	  4,000	  x	  g	  for	  60	  min	  and	  4°C.	  
The	  DNA	  was	  then	  transferred	  to	  1.5	  ml	  tubes	  and	  washed	  once	  with	  500	  µl	  70	  %	  ethanol	  (endotoxin	  
free).	  The	  second	  protocol	  yielded	  better	  DNA	  yields	  and	  higher	  purity	  of	  the	  samples.	  	  
2.2.1.10 Precipitation	  of	  DNA	  	  
To	  increase	  the	  concentration	  of	  DNA	  samples,	  DNA	  was	  precipitated	  by	  adding	  0.1	  volume	  of	  3M	  
NaOAc	  (pH	  5.2)	  and	  2	  volumes	  of	  95	  %	  ethanol.	  Samples	  were	  then	  mixed	  well	  and	  placed	  at	  -­‐80°C	  for	  at	  
least	  30	  min	  or	  at	  -­‐20°C	  overnight.	  DNA	  was	  retained	  by	  centrifugation	  at	  top	  speed	  for	  15	  min	  at	  4°C	  
(tabletop	  centrifuge).	  Ethanol	  was	  decanted	  off	  and	  the	  DNA	  pellet	  was	  washed	  once	  with	  1	  ml	  of	  70	  %	  
ethanol.	  After	  centrifugation	  at	  top	  speed	  for	  5	  min	  at	  4°C,	  the	  ethanol	  was	  decanted	  off	  again	  and	  the	  
pellet	  was	  air-­‐dried.	  DNA	  was	  then	  resuspended	  in	  TE	  buffer	  or	  H2O.	  DNA	  was	  stored	  at	  -­‐20°C.	  
 
2.2.2 Protein	  analysis	  
2.2.2.1 Preparation	  of	  brain	  lysates	  	  
Brain	   lysates	   were	   prepared	   from	   fresh	   and	   frozen	   (-­‐80°C)	   adult	   rat	   brains.	   The	   complete	  
procedure	  was	  carried	  out	  on	  ice,	  and	  all	  solutions	  and	  devices	  were	  pre-­‐cooled	  on	  ice.	  Solutions	  were	  
kept	  RNase-­‐free	  and	  devices	  were	   cleaned	  with	  RNase-­‐Zap	   (Ambion)	  and	  ethanol	  prior	   to	  use.	  Brains	  
were	   first	   washed	   with	   cold	   HBSS	   and	   then	   placed	   into	   a	   10	   cm-­‐dish	   with	   cold	   HBSS.	   Therein,	   the	  
hindbrain	  including	  cerebellum	  and	  pons	  as	  well	  as	  the	  meninges	  were	  removed.	  The	  remaining	  tissue	  
was	   then	   cut	   into	   small	   pieces	   and	   placed	   into	   an	   ice-­‐cooled	   glass	   vessel	   containing	   3	  ml	   cold	   brain	  
extraction	  buffer.	  For	  homogenization,	  a	  potter	  device	  was	  moved	  up	  and	  down	  slowly	  three	  times	  at	  
low	  speed,	  and	  then	  10	  times	  at	  1,000	  rpm.	  Subsequently,	  samples	  were	  transferred	  into	  1.5	  ml	  tubes	  
and	   centrifuged	   for	   10	  min	   at	   14,000	   rpm	  at	   4°C	   in	   a	   tabletop	   centrifuge.	   The	   supernatant	  was	   then	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transferred	  to	  new	  tubes,	  frozen	  in	  liquid	  nitrogen	  and	  stored	  at	  -­‐80°C.	  Concentration	  of	  those	  samples	  
was	  determined	  by	  Bradford	  assays	  (Bradford,	  1976)	  and	  was	  typically	  around	  10	  mg/ml	  protein.	  	  
2.2.2.2 Preparation	  of	  cell	  lysates	  	  
Lysates	   from	  adherent	   cells	   (primary	  neurons	  or	   cell	   lines)	  were	  prepared	  by	  washing	   the	   cells	  
once	  with	  warm	  PBS	  and	  then	  adding	  50	  µl	  2x	  Laemmli	  buffer	  that	  was	  pre-­‐heated	  to	  95°C	  directly	  onto	  
the	  cells.	  Cells	  were	  then	  scraped	  and	  transferred	  into	  1.5	  ml	  tubes.	  After	  incubation	  at	  95°C/400	  rpm	  
for	  10	  min,	  lysates	  were	  pre-­‐cleared	  for	  5	  min	  at	  top	  speed	  (table-­‐top	  centrifuge)	  and	  the	  supernatants	  
then	  used	  to	  load	  on	  SDS	  gels	  or	  stored	  at	  -­‐20°C.	  	  	  
2.2.2.3 Precipitation	  of	  proteins	  	  
Proteins	   were	   precipitated	   with	   two	   alternative	   methods.	   For	   precipitation	   with	   acetone,	   4	  
volumes	  of	  ice-­‐cold	  acetone	  were	  added	  to	  the	  samples	  and	  incubated	  at	  -­‐20°C	  overnight.	  Samples	  were	  
then	  centrifuged	  at	  27,000	  x	  g	   for	  45	  min	   (Rotor	   JA	  25.50)	  at	  4°C	  and	  the	  supernatant	  discarded.	  The	  
protein	  pellet	  was	  air-­‐dried	  and	  proteins	  dissolved	  in	  Laemmli	  sample	  buffer.	  Samples	  were	  then	  boiled	  
for	  10	  min	  at	  95°C	  and	  either	  frozen	  at	  -­‐20°C	  or	  used	  for	  SDS	  PAGE.	  
Alternatively,	   the	  TCA-­‐DOC	  method	  was	  used.	  Here,	  0.02	  %	  DOC	   (deoxycholate)	  were	  added	   to	  
the	  samples	  on	  ice.	  Samples	  were	  then	  vortexed	  and	  incubated	  on	  ice	  for	  5	  min.	  Afterwards,	  11	  %	  TCA	  
were	  added,	  samples	  vortexed	  again	  and	  then	  incubated	  on	  ice	  for	  at	  least	  30	  min.	  Protein	  was	  retained	  
by	   centrifugation	   at	   14,000	   rpm	   for	   20	   min	   at	   4°C	   in	   a	   table-­‐top	   centrifuge.	   After	   discarding	   the	  
supernatant,	  the	  pellet	  was	  washed	  once	  with	  500	  µl	  ice	  cold	  acetone	  and	  centrifuged	  again	  at	  14	  000	  
rpm	  for	  5	  min	  at	  4°C.	  Samples	  were	  air-­‐dried	  at	  room	  temperature	  and	  then	  resuspended	  in	  2x	  Laemmli	  
buffer	  supplemented	  with	  100	  mM	  Tris	  pH	  8.5.	  Samples	  were	  then	  boiled	  for	  10	  min	  at	  95°C	  and	  either	  
frozen	  at	  -­‐20°C	  or	  used	  for	  SDS	  polyacrylamide	  electrophoresis	  (SDS	  PAGE). 
2.2.2.4 Protein	  electrophoresis	  and	  detection	  
SDS	  polyacrylamide	  electrophoresis	  	  
To	   separate	   proteins	   according	   to	   their	  molecular	  weight,	   SDS	   PAGE	  was	   performed	   (Laemmli,	  
1970).	  For	  analysis	  of	  proteins	  with	  molecular	  weights	  of	  30	  -­‐	  130	  kDa,	  10-­‐%	  separation	  gels	  were	  used;	  
heavier	  proteins	  were	  separated	  on	  8	  %	  gels,	  while	   lighter	  ones	  were	  separated	  on	  12	  %	  gels.	  Before	  
electrophoresis,	   samples	   were	   mixed	   with	   Laemmli	   buffer	   and	   boiled	   for	   5	   -­‐	   10	   min	   at	   95°C.	  
Electrophoresis	  was	  performed	  for	  90	  –	  120	  min	  at	  const.	  100	  –	  120	  V.	  	  
Silver	  staining	  
Protein	   on	   acrylamide	   gels	   can	   be	   visualized	   by	   various	   methods.	   A	   very	   sensitive	   method	   to	  
detect	  protein	   in	  a	  non-­‐specific	  way	   is	  a	  silver	  stain	   (Merril	  et	  al.,	  1981).	  After	  SDS	  PAGE,	   the	  gel	  was	  
incubated	   for	   20	  min	   at	   room	   temperature	   in	   50	  %	  methanol	   supplemented	  with	  5	  %	  acetic	   acid	   for	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fixation.	  It	  was	  then	  washed	  once	  for	  10	  min	  in	  50	  %	  methanol	  and	  subsequently	  for	  2	  h	  with	  H2O,	  that	  
was	  changed	  every	  15	  min.	  A	  sensitization	  step	  with	  0.02	  %	  Na2S2O3	  was	  followed	  by	  two	  washes	  with	  
H2O	   for	   1	  min	   each.	   Silver	   staining	   itself	  was	   then	  performed	  by	   incubation	   for	   20	  min	   in	   cold	   0.1	  %	  
AgNO3.	  After	  2	  washes	  with	  H2O	  for	  1	  min	  each,	  the	  staining	  reaction	  was	  developed	  by	   incubation	   in	  
0.05	  %	  formalin	  supplemented	  with	  2	  %	  Na2CO3.	  Development	  was	  allowed	  until	   the	  staining	  had	  the	  
right	  intensity	  (2	  -­‐	  5	  min)	  and	  was	  stopped	  with	  addition	  5	  %	  acetic	  acid	  for	  10	  min.	  	  	   
Western	  blotting	  
After	   SDS-­‐PAGE,	   proteins	   are	   transferred	   onto	   a	   membrane,	   which	   can	   then	   be	   labeled	   with	  
antibodies,	   this	   method	   is	   termed	   Western	   Blotting	   (Towbin	   et	   al.,	   1979).	   Protein	   transfer	   was	  
performed	  in	  a	  tank	  blot	  system	  for	  90	  min	  at	  const.	  250	  mA	  (or	  overnight	  at	  const	  70	  V).	  Sponges,	  filter	  
paper,	  the	  SDS	  gel	  and	  the	  nitrocellulose	  membrane	  (0.2	  um	  pore	  size)	  were	  pre-­‐wetted	  in	  1x	  blotting	  
buffer	  and	  then	  assembled	  accordingly:	  cathode	  –	  sponge	  –	  3	  filter	  papers	  –	  SDS	  gel	  –	  membrane	  –	  2	  
filter	  papers	  –	  sponge	  –	  anode.	  Efficiency	  of	  blotting	  was	  probed	  afterwards	  by	  reversibly	  staining	  the	  
nitrocellulose	   membrane	   with	   Ponceau-­‐S	   solution.	   To	   avoid	   unspecific	   binding	   of	   antibodies,	   the	  
membrane	   was	   incubated	   with	   Detector	   Block	   (KPL)	   for more	   than	   30	   min	   at	   room	   temperature.	  
Primary	   and	   secondary	   antibodies	   were	   diluted	   in	   blocking	   Detector	   Block.	   The	   membrane	   was	  
incubated	  with	  the	  primary	  antibody	  for	  2	  h	  at	  room	  temperature	  or	  overnight	  at	  4°C.	  Three	  washing	  
steps	  of	  10	  min	  with	  TBS-­‐T	  then	  removed	  unspecifically	  bound	  antibody.	  Subsequently,	  the	  membrane	  
was	  incubated	  for	  one	  hour	  with	  the	  IRDye700	  or	  -­‐800	  conjugated	  secondary	  antibody.	  The	  membrane	  
was	   then	   washed	   three	   times	   with	   TBS-­‐T	   and	   afterwards	   scanned	   with	   the	   infrared-­‐based	   Odyssey	  
Imaging	   System.	   Quantification	   of	   Western	   Blot	   signals	   was	   done	   with	   ImageJ	  
(http://rsbweb.nih.gov/ij/index.html).	  	  
 
2.2.3 RNA	  isolation	  
RNA	  from	  cells	  or	   tissues	  was	   isolated	  with	  TriZol	   reagent	   (Invitrogen)	  or	  by	  using	  kits	   (SV	  Total	  
RNA	   Isolation	   System,	   Promega;	   mirVana	   miRNA	   Isolation	   Kit,	   Ambion),	   both	   according	   to	  
manufacturer’s	   instructions.	   RNA	   isolation	   from	   adherent	   cells	   in	   Petri	   dishes	  was	   performed	   after	   a	  
short	  wash	  with	  ice-­‐cold	  PBS.	  Cells	  were	  lysed	  by	  addition	  of	  TriZol	  or	  lysis	  reagent,	  then	  scraped	  with	  a	  
cell-­‐scraper	  and	  transferred	  into	  RNase-­‐free	  1.5-­‐ml	  tubes	  for	  further	  procedure.	  For	  RNA	  isolation	  from	  
tissues,	  tissue	  samples	  were	  first	  homogenized	  with	  a	  rotor-­‐homogenizer	   in	  TriZol	  or	   lysis	  reagent	  and	  
then	  processed	  according	  to	  manufacturer’s	  instructions.	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2.2.4 cDNA	  synthesis	  
Before	   cDNA	   synthesis,	   RNA	   was	   treated	   with	   DNase	   to	   remove	   contaminations.	   DNase	   (RQ1	  
RNase-­‐Free	  DNase,	  Promega)	  was	  used	  according	   to	  manufacturer’s	   instructions.	   Subsequently,	   cDNA	  
was	  synthesized	  using	   random	  hexamers	  or	  oligo-­‐dT	  primers	  according	   to	  manufacturer’s	   instructions	  
(First	  Strand	  cDNA	  Synthesis	  Kit,	  Fermentas;	  SuperScript	  III	  Reverse	  Transcriptase,	  Invitrogen).	  
2.2.5 Real	  time	  PCR	  
Quantitative	  real-­‐time	  PCR	  (qRT-­‐PCR)	  was	  performed	  to	  determine	  RNA	  levels	  of	  specific	  targets.	  
RNA	   was	   first	   DNase-­‐digested	   and	   then	   transcribed	   to	   cDNA.	   In	   qRT-­‐PCR,	   RNA	   levels	   are	   constantly	  
monitored	  via	  a	  fluorescent	  dye	  (here:	  SYBR	  Green),	  which	   is	   incorporated	   into	  double-­‐stranded	  DNA.	  
Routinely,	  an	  appropriate	  mastermix	  with	  iQ	  SYBR	  	  GRN	  Supermix	  (BioRad)	  was	  prepared	  for	  each	  set	  of	  
primers,	  while	  the	  template	  was	  added	   last	  and	  to	  the	  wells	  of	   the	  used	  96-­‐well	  plate	  only.	  Template	  
cDNA	  was	  diluted	  with	  nuclease-­‐free	  ddH2O.	  For	  non-­‐template	  controls	  (NTC),	  ddH2O	  was	  used	  instead	  
of	   template	  cDNA.	  Primers	  were	  used	   in	  a	   concentration	  of	  300	  nM,	  while	  MgCl2	  was	  used	  at	  3	  mM.	  
Each	  sample	  was	  measured	  in	  triplicates.	  The	  96-­‐well	  plates	  were	  sealed	  with	  flat	  cap	  strips.	  	  
All	   qRT-­‐PCR	   data	   were	   analyzed	   according	   to	   the	   comparative	   ΔΔCt	   method	   (Schmittgen	   and	  
Livak,	  2008).	   In	   this	  method,	   relative	  amounts	  of	  a	  specific	  RNA	  are	  determined	  by	  normalizing	   its	  Ct-­‐
value	   to	   an	   internal	   control	   and	   then	   comparing	   them	   between	   different	   samples	   (treatment	  
conditions).	  To	  avoid	  bias	  possibly	  introduced	  by	  a	  single	  reference	  gene,	  cross-­‐normalization	  to	  at	  least	  
two	  reference	  genes	  was	  used	  (Weidensdorfer	  et	  al.,	  2009).	  
2.2.6 Luciferase	  assay	  
DNA	  sequencing	  subjected	  to	  contain	  regulating	  elements	  were	  cloned	  downstream	  the	  synthetic	  
Renilla	   luciferase	   gene	   into	   the	   psiCHECK-­‐2	   vector	   (Promega)	   expressing	   both	   Renilla	   and	   Firefly	  
luciferase.	   As	   controls,	   the	   empty	   luciferase	   reporter	   plasmid	  was	   used.	   Rat	   primary	   cortical	   neurons	  
(E18)	  were	   transfected	  using	  Amaxa	  Nucleofection	   (Rat	  Neuron	  Nucleofector	   Kit,	   Lonza,	   program	  AK-­‐
009),	  alternatively	  cell	  lines	  were	  transfected	  with	  lipid-­‐based	  transfection	  reagents.	  Cells	  were	  lysed	  for	  
30	  min/shaking	   in	  Passive	  Lysis	  Buffer	  (Promega)	  after	  one	  (overexpression)	  to	  four	  (knockdown)	  days	  
after	   transfection.	  Luciferase	  assays	  were	  performed	  using	   the	  Dual-­‐Luciferase	  Reporter	  Assay	  System	  
(Promega)	   according	   to	   the	  manufacturer’s	   instructions	   in	   the	  GloMax	  device	   (Promega),	   except	   that	  
only	  50	  µl	  of	  each	  reagent	  were	  used	  per	  well.	  Tests	  and	  set-­‐up	  experiments	  were	  alternatively	  carried	  
out	  with	  self-­‐made	  luciferase	  buffers	  which	  are	  described	  in	  chapter	  2.1,	  and	  of	  which	  100	  µl	  each	  were	  
used	   per	   well.	   Raw	   ratios	   of	  Renilla/Firefly	   luciferase	   activity	   were	   calculated	   and	   normalized	   to	   the	  
mismatch	  or	  overexpression	  control.	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2.3 Cell	  biology	  
2.3.1 Cell	  culture	  
2.3.1.1 Primary	  hippocampal	  neuron	  culture	  
Cultures	  of	  primary	  hippocampal	  neurons	  were	  prepared	  from	  embryonic	  day	  17	  (E17)	  embryos	  
of	  timed	  pregnant	  rats	  as	  described	  previously	  (Dotti	  et	  al.,	  1988;	  Goetze	  et	  al.,	  2003;	  Zeitelhofer	  et	  al.,	  
2007).	  Hippocampal	  neuron	  culture	  was	  maintained	  by	  Sabine	  Thomas	  and	  Jacki	  Heraud.	  
2.3.1.2 Primary	  cortical	  neuron	  culture	  
Cultures	  of	  primary	  cortical	  neurons	  were	  prepared	  from	  the	  cortices	  remaining	  from	  preparation	  
of	  hippocampal	  neuron	  cultures	   from	  E17	  rat	  brains.	  Cortices	  were	  cut	   in	  HBSS	   into	  small	  pieces,	  and	  
then	  transferred	  to	  a	  15-­‐ml	  falcon	  tube.	  After	  centrifugation	  for	  4	  min	  at	  1,000	  rpm,	  HBSS	  was	  replaced	  
with	  5	  ml	  pre-­‐warmed	  trypsin.	  Incubation	  for	  10	  min	  at	  37°C	  allowed	  disruption	  of	  cell	  contacts.	  Trypsin	  
was	   inactivated	  by	  addition	  of	  DMEM-­‐HS	  medium	  and	  then	  removed	  after	  centrifugation	  for	  4	  min	  at	  
1,000	  rpm.	  6	  ml	  DMEM-­‐HS	  were	  added	  and	  cells	  dissociated	  by	  pipetting	  up	  and	  down	  the	  solution	  ten	  
times	  with	  a	  blue	  pipet	  tip	  on	  a	  1-­‐ml	  pipet,	  followed	  by	  triturating	  the	  solution	  approximately	  20	  times	  
with	  „fire-­‐polished“	  Pasteur	  pipettes.	  Afterwards,	  cells	  were	  filtered	  two	  times	  through	  a	  100	  µm	  cell-­‐
strainer,	   and	   two	   times	   through	   a	   70	   µm	   cell-­‐strainer,	   finally	   diluted	   to	   approximately	   25	   ml.	   Cell	  
numbers	  were	  determined	  with	  a	  counting	  chamber	  and	  then	  used	  for	  plating	  or	  nucleofection.	  
2.3.1.3 Cell	  lines	  
Cell	   lines	   that	   were	   used	   and	   maintained	   by	   Sabine	   Thomas	   were:	   HeLa	   (human	   cervix	  
adenocarcinoma	  epithelial	  cells)	  (Gey	  et	  al.,	  1952),	  B35	  (rat	  neuroblastoma	  cells)	  (Schubert	  et	  al.,	  1974)	  
and	  C6	  cells	  (rat	  fibroblast	  glioma	  cell)	  (Benda	  et	  al.,	  1968).	  	  
	  
2.3.2 Transfection	  methods	  
2.3.2.1 Transfection	  of	  neurons	  
CaPi-­‐precipitation	  
The	  method	  of	  choice	  for	  transfecting	  dissociated	  hippocampal	  neurons	  for	   imaging	  purposes	   is	  
CaPi-­‐precipitation	  as	  previously	  described	  (Köhrmann	  et	  al.,	  1999a).	  	  	  	  
Nucleofection	  
To	   obtain	   high	   transfection	   efficiencies	   in	   primary	   neuronal	   cultures,	   both	   hippocampal	   and	  
cortical	  neurons	  were	  nucleofected	  using	  the	  Amaxa	  device	   from	  Lonza	   (Rat	  Neuron	  Nucleofector	  Kit,	  
Amaxa).	  Procedures	  were	  carried	  out	  as	  previously	  described	  (Zeitelhofer	  et	  al.,	  2009;	  Zeitelhofer	  et	  al.,	  
2007).	  Cells	  were	  plated	  in	  a	  density	  of	  up	  to	  2	  million	  cells	  in	  6	  cm	  Petri	  dishes	  for	  biochemistry	  and	  up	  
to	  200,000	  cells	  per	  well	  in	  24-­‐well	  plates	  for	  luciferase	  assays.	  Typically	  30	  µg	  total	  DNA	  were	  used	  per	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nucleofection.	  The	  Amaxa	  device	  programs	   that	  were	  used	  were	  O-­‐003	   for	  hippocampal	  neurons	  and	  
AK-­‐009	  for	  cortical	  neurons.	  	  	  	  	  
Lipofection	  
Lipofection	  of	   primary	  neurons	  was	  only	   carried	  out	   in	   exceptional	   cases,	   because	   this	  method	  
significantly	   alters	   neuronal	   morphology.	   For	   luciferase	   assays	   to	   investigate	   the	   effect	   of	  
downregulation	  of	  a	  factor,	  those	  knockdown	  plasmids	  (effector	  plasmid)	  were	  transfected	  in	  a	  first	  step	  
by	  nucleofection	   as	   described	   above,	   and	   then	   transfected	  with	   the	   reporter	   plasmid	  24	  h	   later	  with	  
Lipofectamine	  2000.	  An	  alternative	  protocol	  to	  that	  suggested	  by	  the	  manufacturer	  was	  used.	  DNA	  and	  
Lipofectamine	   2000	   and	  MEM	  were	   allowed	   to	   warm	   to	   room	   temperature.	   Additionally,	  MEM	  was	  
warmed	   to	  37°C	  and	  NMEM	  supplemented	  with	  B27	  was	  pre-­‐equlibrated	   in	   a	  CO2	   incubator.	  DNA	   to	  
Lipofectamine	  2000	  were	  typically	  used	  in	  a	  ratio	  of	  1:3,	  where	  1	  µg	  DNA	  was	  used	  per	  well	  of	  a	  24-­‐well	  
plate.	  The	  DNA	  was	  prepared	  in	  a	  1.5	  ml	  tube,	  vortexed	  and	  spun	  down.	  In	  a	  second	  1.5	  ml	  tube	  per	  well	  
to	   be	   transfected	   100	  µl	   MEM	  were	   supplemented	   with	   3	  µl	   Lipofectamine	   2000.	   This	   mixture	   was	  
incubated	  for	  5	  min	  at	  room	  temperature.	  The	  mixture	  was	  then	  added	  to	  the	  prepared	  DNA,	  vortexed	  
and	  incubated	  at	  room	  temperature	  for	  at	  least	  20	  min.	  Meanwhile,	  the	  medium	  was	  removed	  from	  the	  
cells	  and	  washed	  once	  with	  pre-­‐warmed	  MEM	  (500	  µl/well).	  The	  transfection	  mix	  was	  diluted	  with	  400	  
µl	  pre-­‐warmed	  MEM.	  Afterwards	  it	  was	  used	  to	  replace	  the	  MEM	  on	  the	  cells.	  Cells	  were	  incubated	  with	  
the	  transfection	  mix	  for	  2	  h	  at	  37°C.	  The	  transfection	  was	  stopped	  after	  2	  h	  by	  washing	  the	  cells	  very	  
carefully	  twice	  with	  warm	  MEM	  which	  was	  then	  replaced	  with	  pre-­‐equilibrated	  NMEM+B27.	  24	  h	  later,	  
the	  luciferase	  assays	  were	  performed.	  	  	  	  	  	  	  	  	  	  
2.3.2.2 Transfection	  of	  cell	  lines	  
Cell	   lines	   were	   transfected	   with	   either	   Lipofectamine	   2000	   (Invitrogen)	   or	   Fugene	   HD	   (Roche)	  
mainly	  according	  to	  the	  manufacturer’s	   instructions.	  1	  µg	  DNA	  was	  used	  per	  well	   for	  transfection	   in	  a	  
24-­‐well	  plate.	  For	   luciferase	  assays,	   cells	  were	  either	  co-­‐transfected	  with	  900	  ng	  effector	  plasmid	  and	  
100	  ng	  reporter	  plasmids	  (overexpression	  of	  a	  factor),	  or	  with	  1	  µg	  plasmid	  each	  (single	  transfection	  of	  
first	  knockdown	  plasmid,	  and	  48	  hours	  later	  with	  the	  reporter	  plasmid.	  	  	  
2.3.3 Depolymerization	  treatments	  for	  neurons	  
 
To	  investigate	  the	  effects	  of	  depolymerization	  of	  the	  cytoskeleton	  on	  neurons,	  I	  used	  Colchicine	  to	  
destabilize	   microtubules,	   and	   Latrunculin	   A	   to	   depolymerize	   the	   actin	   cytoskeleton.	   Colchicine	   was	  
applied	   in	  a	   final	   concentration	  of	  15	  µM	  to	   the	  culture	  medium	  of	  neurons	  and	   incubated	   for	  3	  hrs.	  
Latrunculin	  A	  was	  directly	  added	  to	  the	  culture	  medium	  to	  a	  concentration	  of	  5	  µM	  final	  and	  incubated	  
for	  6	  hrs.	  Cells	  were	  then	  fixed	  and	  stained.	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2.3.4 Fixation	  and	  staining	  of	  cells	  	  
 
To	   visualize	   cells	   in	  microscopy	   they	   are	   fixed	   and	   can	   be	   stained	   via	   detection	   of	   proteins	   by	  
antibodies.	  Coverslips	  with	  cells	  were	  washed	  briefly	  in	  pre-­‐warmed	  HBSS	  and	  then	  fixed	  for	  15	  min	  at	  
room	  temperature	  in	  4%	  paraformaldehyde	  (PFA).	  They	  were	  then	  washed	  either	  3	  times	  for	  5	  min	  or	  5	  
times	  short	  with	  HBSS	  at	  room	  temperature.	  If	  antibody	  staining	  is	  desired,	  neurons	  on	  glass	  coverslips	  
were	  incubated	  in	  0.1%	  Triton-­‐X-­‐100	  in	  HBSS	  for	  5	  min	  at	  room	  temperature.	  After	  washing	  with	  HBSS	  
(as	  before)	  they	  were	  subsequently	  blocked	  with	  150	  µl	  Blocking	  Solution	  for	  at	   least	  30	  min	  at	  room	  
temperature.	  Incubation	  with	  the	  first	  antibody	  in	  a	  suitable	  dilution	  for	  2	  h	  at	  room	  temperature	  or	  at	  
4°C	   over	   night	   followed.	   After	  washing	  with	   HBSS	   the	   coverslips	  were	   incubated	  with	   the	   secondary	  
antibody	   for	   1	   h	   at	   room	   temperature	   in	   the	   dark.	   The	   coverslips	   were	   then	   washed	   again	   and	  
(optionally)	  stained	  with	  DAPI	  solution	  for	  3	  –	  5	  min	  at	  room	  temperature	  to	  visualize	  DNA.	  Coverslips	  
were	  washed	   again	   in	  HBSS,	   the	  wax	  dots	   from	  neuronal	   co-­‐cultures	  were	   removed	   and	   after	   briefly	  
dipping	  the	  coverslips	  into	  H2O,	  they	  were	  mounted	  onto	  slides	  with	  Moviol.	  	  	  
2.3.5 Sholl	  analysis	  of	  developing	  neurons	  
 
As	   a	   means	   to	   measure	   arborization	   of	   developing	   neurons,	   I	   used	   the	   Sholl	   approach	   (Sholl,	  
1953)	   to	   count	   outgrowing	   neurites.	   Cells	  were	   transfected	   on	   7	   days	   in	   vitro	   (DIV)	   and	   fixed	   3	   days	  
later.	   After	   taking	   images	   on	   the	  Axioplan	  microscope	   (40x	   objective),	   I	   used	   the	   software	   ImageJ	   to	  
draw	  concentric	  circles	  on	  the	  image	  of	  a	  neuron	  and	  counted	  line	  crosses	  for	  each	  circle.	  
2.3.6 Dendritic	  spine	  analysis	  of	  mature	  neurons	  
 
Development	  of	  dendritic	  spines	  counts	  as	  measurement	  of	  the	  excitability	  and	  functionality	  of	  a	  
neuron.	  Cells	  were	  transfected	  on	  15	  days	  in	  vitro	  (DIV)	  and	  fixed	  3	  days	  later.	  After	  taking	  Z-­‐stacks	  on	  
the	   Leica	   SP5	   confocal	   microscope	   (60x	   objective),	   I	   used	   the	   software	   ImageJ	   to	   measure	   50	   µm	  
stretches	  on	  dendrites	  and	  counted	  the	  extending	  spines.	  Additionally	   I	  measured	  the	   length	  of	   those	  
spines.	  	  
2.3.7 Measurement	  of	  fluorescence	  intensity	  in	  neurons	  
 
To	  compare	  the	  expression	  levels	  of	  different	  constructs,	  I	  measured	  fluorescence	  intensities	  with	  
either	  MetaMorph	  or	  ImageJ.	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2.4 Biochemistry	  
2.4.1 Basic	  protocol	  for	  StreptoTag	  affinitiy	  purification	  
The	   principle	   protocol	   described	   here	   is	   based	   on	   the	   procedures	   published	   (Windbichler	   and	  
Schroeder,	   2006)	   and	  was	   adapted	   for	   isolation	   of	   protein	   complexes	   from	   brain	   lysate	  with	   in	   vitro	  
transcribed,	   StreptoTagged	   RNAs.	   In	   frame	   of	   optimization	   experiments,	   the	   protocol	   was	   later	   on	  
modified	  in	  several	  steps	  of	  the	  procedure.	  These	  modifications	  of	  the	  protocol	  will	  be	  mentioned	  in	  the	  
results	  section	  for	  experiments	  where	  they	  were	  applied.	  	  
For	  preparation	  of	  the	  column	  material,	  5	  g	  Epoxy-­‐activated	  Sepharose	  was	  soaked	  in	  1	  l	  H2O	  for	  
1	   hr.	   Afterwards,	   it	   was	   filtered	   through	   a	   40-­‐100	   µm	   sintered	   glass	   filter	   and	   washed	   while	  
resuspending	  in	  the	  filter	  with	  50	  ml	  ethanol.	  This	  washing	  step	  was	  followed	  by	  4	  more	  washes	  of	  50	  ml	  
CPB	   each.	   Sepharose	   beads	   were	   then	   resuspended	   in	   10	   ml	   CPB,	   transferred	   to	   a	   50	   ml	   tube	   and	  
supplemented	  with	  15	  ml	  CPB	  containing	  0.06	  g	  Dihydrostreptomycin,	  yielding	  a	  final	  concentration	  of	  3	  
mM	  Dihydrostreptomycin.	  Beads	  were	   incubated	  for	  16	  h	  with	  gentle	  movement	  at	  37°C.	  Afterwards,	  
the	  CPB	  was	   removed	  by	   filtering	   through	   the	   sintered	  glass	   filter.	   The	   following	  washing	   steps	  were	  
subsequently	  performed:	  4	  times	  with	  50	  ml	  CPB	  each,	  3	  times	  alternating	  with	  50	  ml	  low	  pH	  buffer	  and	  
high	  pH	  buffer	  each,	  and	  finally	  4	  times	  with	  50	  ml	  H2O.	  The	  bead	  material	  was	  then	  stored	  in	  50	  ml	  H2O	  
containing	  0.05	  %	  NaN3	  in	  a	  50	  ml	  tube	  at	  4°C.	  	  	  	  
For	   the	   actual	   experiment,	   a	   column	   (Poly-­‐Prep	   Chromatography	   Columns,	   BioRad)	   was	   first	  
flushed	   with	   CB.	   3	   ml	   of	   coupled	   sepharose	   (containing	   2/3	   settled	   medium	   and	   1/3	   buffer)	   were	  
pipetted	   into	   the	   column,	   and	   washed	   4	   times	   with	   3	   ml	   CB	   each.	   Re-­‐used	   columns	   (regeneration	  
procedure	  see	  below)	  were	  also	  washed	  4	  times	  with	  3	  ml	  CB	  each.	  To	  block	  unspecific	  RNA	  binding,	  20	  
μg	   tRNA	   in	   1	  ml	   CB	  were	   loaded	   and	   the	   column	  washed	   once	  with	   1	  ml	   CB.	   100	   μg	   of	   the	   in	   vitro	  
transcribed,	  StreptoTagged	  RNA	  was	  pre-­‐treated	  in	  1	  ml	  CB	  supplemented	  with	  8	  μl	  RNase	  inhibitor:	  it	  
was	  incubated	  at	  65°C	  for	  5	  min,	  then	  the	  temperature	  of	  the	  heat	  block	  set	  to	  37°C	  (the	  sample	  was	  left	  
on	  the	  heat	  block),	  and	  when	  37°C	  were	  reached,	  the	  sample	  was	  incubated	  for	  another	  5	  min;	  finally	  it	  
was	   incubated	   at	   room	   temperature	   for	   5	   min.	   2	   mg	   protein	   (brain	   lysate	   was	   stored	   at	   -­‐80°C	   and	  
thawed	   only	   once	   on	   ice)	   was	   equilibrated	   with	   15	   μg	   tRNA	   in	   1.5	   ml	   CB	   for	   15	   min	   at	   room	  
temperature.	  The	  pre-­‐treated	  RNA	  was	   then	  added	  to	   the	  equilibrated	  brain	   lysate	  and	   incubated	   for	  
3.5	   h	   at	   room	   temperature	   shaking	   moderately.	   The	   RNA/protein	   mixture	   was	   then	   applied	   to	   the	  
column	  at	  4°C	   in	  0.5	  ml	  steps	  and	  allowed	  to	  bind	  for	  3	  min	  after	  each	   loading	  step.	  The	  column	  was	  
washed	  with	   2.5	  ml	   CB	   and	   the	   flow	   through	  was	   collected.	   Subsequently	   the	   column	  was	  washed	  5	  
times	   with	   5	   ml	   CB	   each;	   these	   fractions	   were	   collected.	   The	   experiment	   was	  moved	   back	   to	   room	  
temperature	   with	   the	   third	   washing	   step.	   Elution	   was	   performed	   subsequently	   with	   2	   ml	   1	   mM	  
Streptomycin	  in	  CB,	  1	  ml	  2	  M	  NaCl	  in	  CB	  and	  2	  ml	  1	  mM	  Streptomycin	  in	  CB.	  All	  elution	  fractions	  were	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collected	  and	  pooled.	  Afterwards,	  the	  column	  was	  washed	  with	  5	  ml	  CB,	  this	  fraction	  was	  collected	  as	  
well.	  Protein	  fractions	  were	  then	  precipitated	  and	  analyzed	  by	  SDS-­‐PAGE	  and	  silver	  stain	  of	  the	  gel.	  	  	  	  
Columns	  were	  re-­‐used	  several	  times.	  For	  regeneration,	  they	  were	  washed	  3	  times	  alternating	  with	  
2	  -­‐	  3	  bed	  volumes	  of	  high	  pH	  buffer	  and	  low	  pH	  buffer,	  and	  then	  re-­‐equilibrated	  with	  CB.	  	  
 
2.4.2 Protocol	  for	  StreptoTag	  affinitiy	  purification	  of	  in	  vivo	  expressed	  StreptoTagged	  RNA	  
 
HeLa	  were	  transfected	  in	  6	  cm	  Petri	  dishes	  with	  pCDNA3.1	  plasmids	  expressing	  SA1S	  or	  SL1S	  RNA	  
and	   incubated	   for	   3	   days.	   Cells	  were	  washed	  once	  with	  pre-­‐warmed	  PBS,	   trypsinized	   and	  pelleted	   at	  
1,400	  rpm	  for	  5	  min.	  PBS	  was	  then	  replaced	  with	  ice-­‐cold	  PBS	  and	  centrifuged	  again.	  After	  removal	  of	  
the	  supernatant,	  the	  cells	  were	  resuspended	  in	  10	  ml	  PBS.	  Formaldehyde	  to	  a	  final	  concentration	  of	  0.5	  
%	  (v/v)	  was	  added	  and	  incubated	  at	  room	  temperature	  for	  10	  min	  while	  shaking	  slowly.	  Glycine	  (pH	  7.0)	  
was	  then	  added	  to	  a	  final	  concentration	  of	  250	  mM	  and	  incubated	  at	  room	  temperature	  for	  5	  min.	  Cells	  
were	   harvested	   by	   centrifugation	   at	   3,000	   rpm	   for	   4	   min	   and	   washed	   twice	   with	   ice-­‐cold	   PBS.	   The	  
supernatant	  was	  removed	  and	  the	  cells	  lysed	  with	  750	  µl	  lysis	  buffer.	  After	  homogenization	  by	  pipetting	  
the	   sample	   was	   transferred	   to	   a	   1.5	  ml	   tube.	   To	   remove	   cell	   debris,	   the	   sample	   was	   centrifuged	   at	  
14,000	  rpm	  for	  5	  min	  at	  4°C.	  Sepharose	  (1	  ml	  columns	  per	  sample)	  was	  washed	  with	  CB,	  blocked	  with	  
BSA	  and	  afterwards	  washed	  twice	  with	  10	  ml	  CB.	  The	  crosslinked	  lysate	  was	  equilibrated	  with	  10	  ml	  CB	  
and	   20	  µl	   RNase	   inhibitor.	   After	   adding	   the	   lysate	   to	   the	   beads,	   overnight	   incubation	   at	   4°C	   rotating	  
head-­‐to-­‐tail	  followed.	  Columns	  were	  washed	  6	  times	  with	  3	  ml	  CB	  and	  elution	  was	  done	  in	  subsequent	  
steps	  of	  1	  ml	  1	  mM	  Streptomycin,	  1	  ml	  2	  M	  NaCl,	  and	  10	  mM	  Streptomycin.	  Beads	  were	  then	  washed	  
with	  3	  ml	  CB	  and	  stored	  in	  CB	  with	  NaN3.	  	  	  	  	  
 
2.4.3 Purification	  of	  T7-­‐RNA	  polymerase	  	  (according	  to	  Suzanne	  McDermott,	  University	  of	  
Edinburgh)	  
 
E.	   coli	   Rosetta	   transformed	   with	   pT7-­‐911	   were	   plated	   on	   an	   LB-­‐Amp	   agar	   plate	   and	   grown	  
overnight	  at	  37°C.	  The	  next	  day,	  several	  colonies	  were	  picked	  to	   inoculate	  100	  ml	  LB-­‐Amp	  and	  grown	  
overnight	  at	  30°C	  and	  200	  rpm.	  1	  L	  LB-­‐Amp	  was	  inoculated	  with	  50	  ml	  overnight	  culture	  and	  grown	  at	  
37°C	   in	  a	  shaking	   incubator.	  When	  OD600	  was	  at	  0.5	  –	  0.6,	   IPTG	  to	  a	   final	  concentration	  of	  1	  mM	  was	  
added	  and	  the	  culture	  grown	  for	  3	  more	  hours	  at	  37°C.	  Cells	  were	  then	  harvested	  at	  6,000	  xg	  at	  4°C	  for	  
20	  min.	   The	   pellet	  was	  washed	  once	  with	   PBS,	   and	   then	   frozen	   in	   50	  ml-­‐tubes	   at	   -­‐80°C	   until	   further	  
manipulation.	  Cells	  were	  then	  resuspended	  in	  20	  ml	   lysis	  buffer	  and	  sonicated	  (7	  x	  15	  sec	  with	  15	  sec	  
pauses,	   cycle	  0.9,	   amplitude	  80	  %).	   The	   lysate	  was	   centrifugated	  at	   15,000	   xg	   at	   4°C	   for	   30	  min.	   The	  
supernatant	  was	  taken	  off	  and	  frozen	  at	  -­‐80°C	  until	  further	  manipulation.	  5	  ml	  resin	  of	  Ni-­‐NTA	  per	  liter	  
Materials	  and	  Methods	  
	  
Lucia	  Schoderböck	   	   39	  	   	  
culture	  were	  prepared	  as	  column,	  and	  pre-­‐equilibrated	  with	  lysis	  buffer	  (1	  ml/min,	  2	  hrs).	  The	  lysate	  was	  
loaded	  on	   the	   column	  at	  0.2	  ml/min.	  The	  Ni-­‐NTA	  was	  afterwards	  washed	  with	  90	  ml	   lysis	  buffer	   (0.5	  
ml/min),	  and	  with	  30	  ml	  elution	  buffer	  (0.5	  ml/min).	  Protein	  was	  then	  eluted	  with	  a	  gradient	  of	  100	  –	  0	  
%	  elution	  buffer	  /	  0	  –	  100	  %	  extra-­‐elution	  buffer	  (0.5	  ml/min,	  3	  ml/fraction,	  270	  ml	  total).	  The	  protein	  
peak	  fractions	  were	  analyzed	  on	  a	  Coomassie-­‐stained	  SDS	  gel.	  Those	  fractions	  that	  appeared	  to	  be	  the	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2.5 Plasmids	  
Table	  2.	  Plasmids	  used	  for	  cloning.	  	  
Name	   Company	   Used	  for	  
pGEM-­‐T	   Promega	   TA-­‐Cloning	  of	  PCR	  products	  
pBlueskriptIIKS+	   Fermentas	  
In	  vitro	  transcription	  from	  T7	  promoter,	  
sub-­‐cloning	  
pcDNA3.1+	   Invitrogen	   Mammalian	  expression	  vector	  
pEGFP-­‐C2	   Clontech	  
EGFP	  expression	  vector	  with	  multiple	  
cloning	  site	  at	  C-­‐terminus	  of	  EGFP	  
pSuperior.neo+GFP	   OligoEngine	  
Co-­‐expression	  of	  short	  hairpins	  and	  GFP	  
as	  transfection	  marker	  
pSuper	   OligoEngine	   Expression	  of	  short	  hairpins	  
psiCHECK-­‐2	   Promega	   Luciferase	  plasmid	  
 
2.6 Primers	  and	  oligonucleotides	  
All	  standard	  PCR	  primers	  were	  purchased	  from	  Sigma	  Aldrich	  (0.025	  µmol).	  They	  were	  diluted	  to	  
100	  µM	  and	  stored	  at	  -­‐20°C.	  Oligos	  to	  be	  annealed	  for	  direct	  cloning	  were	  diluted	  to	  3	  µg/µl	  and	  stored	  
at	  -­‐20°C.	  	  	  
siRNA	   (small	   interfering	   RNA)	   oligos	  were	   ordered	   from	   Invitrogen	   (20	   nmol)	   and	   diluted	   upon	  
arrival	  in	  1	  ml	  DEPC	  H2O,	  which	  was	  delivered	  with	  the	  oligos.	  The	  20	  µM	  stock	  was	  stored	  at	  -­‐80°C.	  
miRNA	  duplexes	  were	  ordered	   from	  Sigma	  Aldrich	   (dry,	   10	  nmol)	   and	  2'-­‐O-­‐methyl	   inhibitors	  of	  
miRNAs	  were	  kindly	  provided	  by	  G.	  Meister	  (MPI	  of	  Biochemistry,	  Munich).	  	  
Table	  3.	  Primers	  used	  for	  cloning.	  	  
Name	   Sequence	   Used	  for	  
Pum_3UTR_for	   AACTCGAGGCAGAGTGAAATGGTTAAGG Cloning	  of	  Pum2	  3'-­‐UTR	  
Pum_3UTR_rev_Paolo	   AAGAGCTCTCTGATAGGTCTCCACTCAG Cloning	  of	  Pum2	  3'-­‐UTR	  
Pum_3UTR_rev_new	   AAGAGCTCGTTGGGSSSTGTACATAAGGC Cloning	  of	  Pum2	  3'-­‐UTR	  
Pum_3UTR_for_Jacki	   AACTCGAGCCAAATGGGATGCTGTAAGG Cloning	  of	  Pum2	  3'-­‐UTR	  
rno-­‐eIF4E3UTR-­‐forXhoI	   AACTCGAGGAAGACACCTTCTGAGTATC Cloning	  of	  eIF4E	  3'-­‐UTR	  
rno-­‐eIF4E3UTR-­‐revNotI	   AAGCGGCCGCGGATCTTTATCAAGTTACCAG Cloning	  of	  eIF4E	  3'-­‐UTR	  
sh_eIF4E_for1	  
GATCCCCGCTAATCCAGAGCACTATATTCAAGAGA
TATAGTGCTCTGGATTAGCTTTTTA Cloning	  of	  sh-­‐eIF4E	  
sh_eIF4E_rev1	  
AGCTTAAAAAGCTAATCCAGAGCACTATATCTCTT
GAATATAGTGCTCTGGATTAGCGGG Cloning	  of	  sh-­‐eIF4E	  
sh_eIF4E_for2	  
GATCCCCGGACGATGGCTAATTACATTTCAAGAGA
ATGTAATTAGCCATCGTCCTTTTTA Cloning	  of	  sh-­‐eIF4E	  
sh_eIF4E_rev2	  
AGCTTAAAAAGGACGATGGCTAATTACATTCTCTT
GAAATGTAATTAGCCATCGTCCGGG Cloning	  of	  sh-­‐eIF4E	  
sh_eIF4E_for3	  
GATCCCCGGGTATACAAGGAAAGGTTTTCAAGAGA
AACCTTTCCTTGTATACCCTTTTTA Cloning	  of	  sh-­‐eIF4E	  
sh_eIF4E_rev3	  
AGCTTAAAAAGGGTATACAAGGAAAGGTTTCTCTT
GAAAACCTTTCCTTGTATACCCGGG Cloning	  of	  sh-­‐eIF4E	  
Sept7-­‐3UTR-­‐for1	   AACTCGAGTAAACTCTATTGACCACCAGTT  Cloning	  of	  Sept7	  3'-­‐UTR	  
Sept7-­‐3UTR-­‐rev1	   AAGCGGCCGCTTACGTCACAACATTGTTTATTATG   Cloning	  of	  Sept7	  3'-­‐UTR	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Name	   Sequence	   Used	  for	  
psiMCSfor	  
TCGAGATCAGAGCTCGATCACTAGTCGTCGTCGAC
CGATGTTTAAACCTAAGC Cloning	  MCS	  in	  psiCHECK2	  
psiMCSrev	  
GGCCGCTTAGGTTTAAACATCGGTCGACGACGACT
AGTGATCGAGCTCTGATC Cloning	  MCS	  in	  psiCHECK2	  









Cloning	  of	  the	  myr	  site	  into	  
pEGFP-­‐C2	  
Lim	  1	  for	   AAGAGCTCTCCCTGACTGAGCCCAGTG Cloning	  of	  LIMK1	  3'-­‐UTR	  
Lim	  1	  rev	   AAAGATCTGCTCACTTCTAAAGCTGCC Cloning	  of	  LIMK1	  3'-­‐UTR	  
Lim	  2	  for	   AAGAGCTCTCCATGCAATGCCTGCAGC Cloning	  of	  LIMK1	  3'-­‐UTR	  
Lim	  2	  rev	   AAAGATCTGCCTCTGTGGTGTGGGCT Cloning	  of	  LIMK1	  3'-­‐UTR	  
Lim	  3	  for	   AAGAGCTCGGTACCAGTCCTCAGGATG Cloning	  of	  LIMK1	  3'-­‐UTR	  




















of	  the	  miR-­‐134	  bs	  
Lim369mut4for	   CTTTCTGTGTGATCTGGATCCTAAGAAGAGTTTG Site-­‐directecd	  mutagenesis	  
of	  the	  miR-­‐369	  bs	  
Lim369mut4rev	   CAAACTCTTCTTAGGATCCAGATCACACAGAAAG Site-­‐directecd	  mutagenesis	  
of	  the	  miR-­‐369	  bs	  
Lim369mut5for	   CTTTCTGTGTGATCTGTCGACTAAGAAGAGTTTG Site-­‐directecd	  mutagenesis	  







of	  the	  miR-­‐369	  bs	  
Arc	  1	  for	   AAGAGCTCCCCAGCCTGAATAGAGGGG Cloning	  of	  Arc	  3'-­‐UTR	  
Arc	  1	  rev	   AAGGATCCAGTAGAGGTTCCTTCGGCC Cloning	  of	  Arc	  3'-­‐UTR	  
Arc	  2	  for	   AAGAGCTCGTCCAGGGCCCTTTGGGT Cloning	  of	  Arc	  3'-­‐UTR	  
Arc	  2	  rev	   AAGGATCCCAGCTTGAGACCTGGTGTC Cloning	  of	  Arc	  3'-­‐UTR	  
Arc	  3	  for	   AAGAGCTCAGGCAGCAGCTGGAGTCTT Cloning	  of	  Arc	  3'-­‐UTR	  
Arc	  3	  rev	   AAGGATCCGTAAGGTCAGGCTGGGCTA Cloning	  of	  Arc	  3'-­‐UTR	  
Arc	  4	  for	   AAGAGCTCGAACCTTGCAGGAGCCTTA Cloning	  of	  Arc	  3'-­‐UTR	  
Arc	  4	  rev	   AAGGATCCGAAAATAGGGGATAGCCAC Cloning	  of	  Arc	  3'-­‐UTR	  
Arc1_for_Luc	   AACTCGAGCCCAGCCTGAATAGAGGGG Cloning	  of	  Arc	  3'-­‐UTR	  
Arc2_for_Luc	  	   AACTCGAGGTCCAGGGCCCTTTGGGT Cloning	  of	  Arc	  3'-­‐UTR	  
Arc3_for_Luc	  	   AACTCGAGAGGCAGCAGCTGGAGTCTT Cloning	  of	  Arc	  3'-­‐UTR	  
Arc4_for_Luc	  	   AACTCGAGGAACCTTGCAGGAGCCTTA Cloning	  of	  Arc	  3'-­‐UTR	  
Arc1_rev_Luc	   AAGAGCTCAGTAGAGGTTCCTTCGGCC Cloning	  of	  Arc	  3'-­‐UTR	  
Arc2_rev_Luc	  	   AAGAGCTCCAGCTTGAGACCTGGTGTC Cloning	  of	  Arc	  3'-­‐UTR	  
Arc3_rev_Luc	  	   AAGAGCTCGTAAGGTCAGGCTGGGCTA Cloning	  of	  Arc	  3'-­‐UTR	  
Arc4_rev_Luc	  	   AAGAGCTCGAAAATAGGGGATAGCCAC Cloning	  of	  Arc	  3'-­‐UTR	  
gDNA	  rno	  
pmir19a_BglII_for	  	  	  
AAAGATCTGCAAGCGTGTAGGGGTCTC  Cloning	  of	  miR-­‐19	  for	  
overexpression	  
gDNA	  rno	  
pmiR19a_HindIII_rev	  	  	  
AAAAGCTTCCAAGAGTCTACATCGACAC Cloning	  of	  miR-­‐19	  for	  
overexpression	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Name	   Sequence	   Used	  for	  
gDNA	  rno	  
pmiR134_BglII_for	  	  	  




AAAAGCTTCTGGAAAGTCTTCTTTAGTGG  Cloning	  of	  miR-­‐134	  for	  
overexpression	  
gDNA	  rno	  
pmiR326_BglII_for	  	  	  




AAAAGCTTGGTGTGCTGCTTTGCCTCG  Cloning	  of	  miR-­‐326	  for	  
overexpression	  
gDNA	  rno	  
pmiR328_BglII_for	  	  	  












AAAAGCTTGCAGCCTTTCCCTCCGTG Cloning	  of	  miR-­‐106b	  for	  
overexpression	  
scramble-­‐miR	  for	  pSup	  
GATCCCCGTGTAACACGTCTATACGCCCATTCAAG
AGATGGGCGTATAGACGTGTTACACTTTTTA 
Cloning	  scramble	  miR	  into	  
pSuperior	  
scramble-­‐miR	  rev	  pSup	  
AGCTTAAAAAGTGTAACACGTCTATACGCCCATCT
CTTGAATGGGCGTATAGACGTGTTACACGGG 
Cloning	  scramble	  miR	  into	  
pSuperior	  
	    	  
hB-­‐Actin	  cds	  for	  XhoI	   AACTCGAGTCACCATGGATGATGATATCG Cloning	  human	  b-­‐Actin	  
hB-­‐Actin	  3'	  UTR	  for	  
XhoI	  
AACTCGAGCAAATGCTTCTAGGCGGACT Cloning	  human	  b-­‐Actin	  
hB-­‐Actin	  zipcode	  rev	  
SacI	  
AAGACGCTCAATGTGCAATCAAAGTCCTCG Cloning	  human	  b-­‐Actin	  
hB-­‐Actin	  3'	  UTR	  rev	  
SacI	  	  
AAGAGCTCAAGGTGTGCACTTTTATTCAAC Cloning	  human	  b-­‐Actin	  
hB-­‐Actin_3UTR_rev_	  
SacI_new	  
AAGAGCTCGTCTCAAGTCAGTGTACAGG Cloning	  human	  b-­‐Actin	  
hs_bACT_cds_rev_NotI	   AAGCGGCCGCCTAGAAGCATTTGCGGTGGA Cloning	  human	  b-­‐Actin	  
rno-­‐b-­‐act-­‐5UTRfor_	  
XhoI	  
AACTCGAGCACTGTCGAGTCCGCGTC Cloning	  rat	  b-­‐Actin	  
rno-­‐b-­‐act-­‐
3UTRfor_XhoI	  
AACTCGAGGCGGACTGTTACTGAGCTG Cloning	  rat	  b-­‐Actin	  
rno-­‐b-­‐act-­‐
3UTRlongrev_NotI	  
AAGCGGCCGCTCTAGACGCAAGCTATGCAG Cloning	  rat	  b-­‐Actin	  
rno-­‐b-­‐act-­‐
3UTRshortrev_NotI	  
AAGCGGCCGCTGCGCAAGTTAGGTTTTGTCA Cloning	  rat	  b-­‐Actin	  
rn_bACT_cds_rev_NotI	   AAGCGGCCGCCTAGAAGCATTTGCGGTGCA Cloning	  rat	  b-­‐Actin	  
rn_bACT_3utrL_rev2_
NotI	  
AAGCGGCCGCGCTGAGGAAAGTAGGGTTGA Cloning	  rat	  b-­‐Actin	  
rn_bACT_cds_for_NotI	   AACTCGAGATGGATGACGATATCGCTGC Cloning	  rat	  b-­‐Actin	  
rn_bACT_cds_rev2_	  
XhoI	  
AAGCGGCCGCGCATTTGCGGTGCACGATG Cloning	  rat	  b-­‐Actin	  
Rno_bAct_5'UTRrev	   GCGGCCGCGGCGAACTGGTGGCGGGT Cloning	  rat	  b-­‐Actin	  
RhoA_cds_forSpeI	   ACTAGTATGGCTGCCATCAGGAAGA Cloning	  rat	  RhoA	  
RhoA_cds_revNotI	   GCGGCCGCTCACAAGATGAGGCACCCC Cloning	  rat	  RhoA	  
RhoA_5'UTR_forSpeI	   ACTAGTCTCCCACGGAGCTGCTC Cloning	  rat	  RhoA	  
RhoA_5'UTR_revNotI	   GCGGCCGCCAATACCTTATGAAGGTGCTG Cloning	  rat	  RhoA	  
RhoA_3'UTR_forSpeI	   ACTAGTAGCCTTGTGACACGCAGC Cloning	  rat	  RhoA	  
RhoA_3'UTR_revNotI	   GCGGCCGCCAGCTGGAGAGAGGAGACC Cloning	  rat	  RhoA	  
RhoA_cdsC2_forBglII	   AGATCTTGATGGCTGCCATCAGGAA Cloning	  rat	  RhoA	  
RhoA_cds_revSacII	   CCGCGGTCACAAGATGAGGCACCCC Cloning	  rat	  RhoA	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Name	   Sequence	   Used	  for	  
RhoA_3'UTR_revSacII	   CCGCGGCAGCTGGAGAGAGGAGACC Cloning	  rat	  RhoA	  
	    	  
Strepto	  rev	  
TCGACGGATCCGACCGTGGTGCCCGAAGGCAGAAG
TCCAAATG Cloning	  of	  the	  StreptoTag	  
Strepto	  for	  
AATTGATCCCTCTCTCGGATCGCATTTGGACTTCT
GCCTTCGGG Cloning	  of	  the	  StreptoTag	  
Lucy	  strepto	  II	  for	  
GATCCCTCTCTCGGATCGCATTTGGACTTCTGCCT
TCGGGCACCACGGTCGGATCCGAGCTCC Cloning	  of	  the	  StreptoTag	  




Cloning	  of	  the	  StreptoTag	  
StreptoEcoRIfor	   AAGAATTCATCCCTCTCTCGGATCGCA Cloning	  of	  the	  StreptoTag	  
StreptoXhoIrev	   AACTCGAGGGATCCGACCGTGGTGCC Cloning	  of	  the	  StreptoTag	  
StreptoXhoIfor	   AACTCGAGATCCCTCTCTCGGATCGCA Cloning	  of	  the	  StreptoTag	  
StreptoEcorRIrev	   AAGAATTCGGATCCGACCGTGGTGCC Cloning	  of	  the	  StreptoTag	  
	  
Table	  4.	  Primers	  used	  for	  sequencing	  and	  colony	  PCRs.	  	  
Name	   Sequence	   Used	  for	  
GFP-­‐951	  rev	   TTCGGGCATGGCGGACTTGA Sequencing	  primer	  pEGFP-­‐C2	  
GFP920for	   ACGACGGCAACTACAAGACC Sequencing	  primer	  pEGFP-­‐C2	  
GFP1384rev	   GGTACCGTCGACTGCAGAAT Sequencing	  primer	  pEGFP-­‐C2	  
pSuper2101f	   ACACAGGAAACAGCTATGAC Sequencing	  primer	  pSuperior	  
pSUPER-­‐2390rv	   GCGCCCTGGCAGGAAGATGG Sequencing	  primer	  pSuperior	  
psicheck	  seq	  fwd	   GGTAAGTACATCAAGAGCTTC Sequencing	  primer	  for	  psiCHECK-­‐2	  
psicheck	  fwd1	   CGTGCTGAAGAACGAGCAG Sequencing	  primer	  for	  psiCHECK-­‐2	  
psicheck	  rev1	   TCCGAAGACTCATTTAGATCC Sequencing	  primer	  for	  psiCHECK-­‐2	  
 
Table	  5.	  Primers	  used	  for	  qRT-­‐PCR	  and	  RT-­‐PCR.	  	  
Name	   Sequence	   Used	  for	  
FFL_for_qPCR	   GAGTCTATCCTGCTGCAGCAC To	  detect	  firefly	  luciferase	  in	  qRT-­‐PCR	  
FFL_rev_qPCR	   CTCGTCCACGAACACCACTC To	  detect	  firefly	  luciferase	  in	  qRT-­‐PCR	  
RNL_for_qPCR	   GTCCGGCAAGAGCGGGAATGG To	  detect	  renilla	  luciferase	  in	  qRT-­‐PCR	  
RNL_rev_qPCR	   ACGTCCACGACACTCTCAGCAT To	  detect	  renilla	  luciferase	  in	  qRT-­‐PCR	  
	  	     	  	  
Stau2-­‐F-­‐2	   GAACATCTCCTGCTGCTGAAG To	  detect	  Stau2	  in	  qRT-­‐PCR	  
Stau2-­‐R-­‐2	   ATCCTTGCTAAATATTCCAGTTGT To	  detect	  Stau2	  in	  qRT-­‐PCR	  
Actb	  short	  fwd	   GTCCACCTTCCAGCAGATGT To	  detect	  b-­‐Actin	  in	  qRT-­‐PCR	  
Actb	  short	  rev	   GAAAGGGTGTAAAACGCAGC To	  detect	  b-­‐Actin	  in	  qRT-­‐PCR	  
PPIA_qPCR_for	   GTCAACCCCACCGTGTTCTT To	  detect	  PPIA	  in	  qRT-­‐PCR	  
PPIA_qPCR_rev	   CTGCTGTCTTTGGAACTTTG To	  detect	  PPIA	  in	  qRT-­‐PCR	  
VCL_qPCR_for	   TCACAGTGGCAGAGGTAGTG To	  detect	  VCL	  in	  qRT-­‐PCR	  
VCL_qPCR_rev	   TGACAGTGTTCATTGAGTTC To	  detect	  VCL	  in	  qRT-­‐PCR	  
Tub-­‐F-­‐2	   TGTCTTCCATCACTGCTTCC To	  detect	  Tubulin	  in	  qRT-­‐PCR	  
Tub-­‐R-­‐2	   TGTTCATGGTAGGCTTTCTCAG To	  detect	  Tubulin	  in	  qRT-­‐PCR	  
Mov10A	  for	  (kosik)	  rat	   CAACCAACCGGATAGAGGAA To	  detect	  Mov10	  in	  qRT-­‐PCR	  
Mov10A	  rev	  (kosik)	  rat	   CCTTTGGGGACGTGAAGATA To	  detect	  Mov10	  in	  qRT-­‐PCR	  
RhoA-­‐Luci_for	   AAGGACCAGTTCCCAGAGGT To	  detect	  RhoA	  in	  qRT-­‐PCR	  
RhoA-­‐Luci_rev	   TGTCCAGCTGTGTCCCATAA To	  detect	  RhoA	  in	  qRT-­‐PCR	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rnoArc_cds_for_qPCR_2	   AGAATATTGGCTGTCCCAGAT To	  detect	  Arc	  in	  qRT-­‐PCR	  
rnoArc_cds_rev_qPCR_2	   CTGCAGAAACTCCTTCTTGAA To	  detect	  Arc	  in	  qRT-­‐PCR	  
rnoArc_3utr_for_qPCR_2	   AGAACGACACCAGGTCTCAA To	  detect	  Arc	  in	  qRT-­‐PCR	  
rnoArc_3utr_rev_qPCR_2	   CCTATTTTCTCTGCCTTGAAA To	  detect	  Arc	  in	  qRT-­‐PCR	  
rLimk1	  cds	  for	   TATGGACTTTGGCCTCAATGTAA To	  detect	  LIMK1	  in	  qRT-­‐PCR	  
rLimk1	  cds	  rev	   CCATTGTTCCAGCTTACAAAA To	  detect	  LIMK1	  in	  qRT-­‐PCR	  
	  	     	  	  
RREfor	   CCAGTGGGAATAGGAGCTT RT-­‐PCR	  primer	  to	  detect	  RRE	  
RRErev	   GATCCAGGAGCTGTTGTCC RT-­‐PCR	  primer	  to	  detect	  RRE	  
 
Table	  6.	  siRNA	  oligos	  targeting	  Stau2	  and	  controls.	  	  
Name	   Sequence	   Used	  for	  
siStau2-­‐2	   GATATGAACCAACCTTCAA Knockdown	  of	  Stau2	  
misStau2	   GATATGAAACCCCACTTAA Control	  of	  knockdown	  
siStau2	   CCGUCAGUUUUGAGGUUAU Knockdown	  of	  Stau2	  
non-­‐targeting	  siRNA	   UAAGGCUAUGAAGAGAUAC Control	  of	  knockdown	  
 
Table	  7.	  miRNA	  mimics	  (duplexes).	  	  
Name	   Sequence	  
scramble	  
  GUGUAACACGUCUAUACGCCCA 
AACACAUUGUGCAGAUAUGCGG 
rno-­‐miR-­‐19a	  
  UGUGCAAAUCUAUGCAAAACUGA 
AAACACGUUUAGAUACGUUUUGA 
rno-­‐miR-­‐19b	  
  UGUGCAAAUCCAUGCAAAACUGA 
AAACACGUUUAGGUACGUUUUGA 
rno-­‐miR-­‐369-­‐3p	  
  AAUAAUACAUGGUUGAUCUUU 
AAUUAUUAUGUACCAACUAGA 
rno-­‐miR-­‐326	  




Table	  8.	  Primary	  antibodies.	  	  





α-­‐Tubulin	   mouse	  monoclonal	   Sigma,	  clone	  B512	   1:5,000	   1:5,000	  
β-­‐Actin	   mouse	  monoclonal	   Sigma,	  A2228	   1:500	   1:1,000	  
c-­‐MYC	  	   mouse	  monoclonal	   Sigma,	  M4439	   -­‐	   1:300	  
eIF4E	  	   mouse	  monoclonal	   Santa	  Cruz	   1:500	   1:250	  
LIMKI	   mouse	  monoclonal	  
BD	  Transduction	  
Laboratories	  
1:100	   -­‐	  
MAP2	   mouse	  monoclonal	   Sigma,	  M4403	   1:2,000	   -­‐	  
Mov10	   rabbit	  polyclonal	   Bethyl,	  A301-­‐571A	   1:200	   1:200	  
Pumilio	  1	   goat	  polyclonal	   Bethyl,	  A300-­‐201A	   1:200	   1:200	  
Pumilio	  2	   rabbit	  polyclonal	   Bethyl,	  A300-­‐202A	   1:200	   1:200	  
RhoA	   mouse	  monoclonal	   Santa	  Cruz,	  sc-­‐418	   1:100	   1:200	  
Stau2	  FL	  H7	   rabbit	  polyclonal	  
self-­‐made	  (Karra,	  
unpublished)	  
1:500	   1:2,000	  
Tau	   mouse	  monoclonal	   Abcam	   1:1,000	   -­‐	  
Vinculin	   goat	  polyclonal	   Santa	  Cruz,	  sc-­‐7649	   1:100	   1:200	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Table	  9.	  Secondary	  antibodies.	  	  








Goat	   Donkey	   Cy3	   Jackson	  IR	   1:500	   -­‐	  
Mouse	   Donkey	   Alexa	  488	   Invitrogen,	  A21202	   1:500	   -­‐	  
Mouse	   Goat	   Alexa	  405	   Invitrogen,	  A31553	   1:50	   -­‐	  
Mouse	   Goat	   Alexa	  350	   Invitrogen	   1:50	   -­‐	  
Mouse	   Goat	   Cy5	   Dianova,	  115-­‐175-­‐003	   1:50	   -­‐	  
Mouse	   Goat	   Cy3	   Dianova	   1:500	   -­‐	  
Rabbit	   Donkey	   Alexa	  488	   Invitrogen,	  A21206	   1:500	   -­‐	  
Rabbit	   Goat	   Alexa	  488	   Mol.Probes	   1:500	   -­‐	  
Rabbit	   Goat	   Alexa	  405	   Invitrogen	   1:50	   -­‐	  
Rabbit	   Goat	   Alexa	  	  350	   Invitrogen,	  A11046	   1:50	   -­‐	  
Rabbit	   Goat	   Cy5	   Dianova,	  111-­‐175-­‐003	   1:50	   -­‐	  
Rabbit	   Goat	   Cy3	   Dianova	   1:500	   -­‐	  
	   	   	   	   	   	  
Mouse	   donkey	   IRDye680	   Licor	   -­‐	   1:5,000	  
Rabbit	   donkey	   IRDye700DX	   Rockland	   -­‐	   1:5,000	  
Rabbit	   donkey	   IRDye700DX	   Rockland	   -­‐	   1:5,000	  
Rabbit	   donkey	   IRDye800CW	   Licor	   -­‐	   1:5,000	  
	   	   	   	   	   	  
Phalloidin	   	  	   Alexa	  Fluor	  546	   Invitrogen	  VXA22283	   1:250	   -­‐	  




Table	  10.	  Software	  used	  for	  data	  analysis.	  	  
Software	   Use	  
analySIS	  B	  (Olympus)	   Image	  aquiring	  and	  processing	  with	  the	  Zeiss	  Axioplan	  
microscope.	  
Excel	  (Microsoft)	   Statistical	  calculations.	  Error	  bars	  are	  given	  as	  standard	  error	  of	  
the	  mean	  (SEM)	  and	  were	  calculated	  from	  data	  of	  biological	  
repeats.	  Statistical	  significance	  was	  calculated	  using	  t-­‐tests	  on	  
data	  from	  biological	  repeats	  compared	  to	  control	  conditions	  
and	  are	  indicated	  as	  *	  (p-­‐value	  <	  0.05),	  **	  (p-­‐value	  <	  0.01),	  and	  
***	  (p-­‐value	  <	  0.001).	  	  	  	  
ImageJ	  
(http://rsbweb.nih.gov/ij/index.html)	  
Analysis	  of	  images	  from	  microscopy:	  Sholl	  analysis	  using	  the	  
macro	  “concentric	  circles”,	  measurement	  of	  fluorescent	  
intensity,	  measurements	  of	  spine	  length.	  
Analysis	  of	  images	  from	  Western	  blots:	  Quantification	  of	  the	  
intensities	  of	  bands.	  	  
LAS	  AF	  (Leica	  Microsystems)	   Image	  aquiring	  and	  processing	  with	  the	  Leica	  TCS	  SP5	  
microscope.	  
MetaMorph	  (Molecular	  Devices)	   Analysis	  of	  images	  from	  microscopy:	  Measurement	  of	  
fluorescent	  intensity.	  
PicTar	  (http://pictar.mdc-­‐berlin.de/)	   Prediction	  of	  miRNA	  binding	  sites	  in	  candidate	  mRNAs.	  
TargetScan	  4.2	  
(http://www.targetscan.org/vert_42/)	  
Prediction	  of	  miRNA	  binding	  sites	  in	  candidate	  mRNAs.	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2.9 Equipment	  
 
Table	  11.	  Equipment	  used	  for	  experiments.	  	  
Category	   Description	  
Centrifuge	   Beckman	  Coulter	  Avanti	  J-­‐25	  
Centrifuge	   Heraeus	  Varifuge	  3.0R	  
Confocal	  microscope	   Leica	   TCS	   SP5	   with	   LEICA	   CTR6500	   and	   LAS	   AF	   software	   by	   Leica	  
Microsystems	  
Fluorescence	  Scanner	   LI-­‐COR	  Odyssey	  
Fluorospectrometer	   Nanodrop	  2000	  
Luminometer	   GloMax	  (Promega)	  
Microscope	   Zeiss	   Axioplan	   with	   F-­‐View	   Soft	   Imaging	   System,	   X-­‐Cite120	   Fluorescence	  
Illumination	   System,	   63x/1.4	   oil	   Plan-­‐APOCHROMAT	   or	   40x/1.3	   Oil	   Plan-­‐
NEOFLUAR	  objective,	  analySIS	  B	  imaging	  software	  (Olympus)	  
Nucleofection	  device	   Amaxa	  Nucleofector	  (Lonza)	  
 
2.10 	  Materials	  
 
Chemicals,	   reagents	   and	  kits	  were	  purchased	   from	   the	   companies	   as	  described	   in	   the	  methods	  
sections	   above,	   or	   were	   bought	   from	   Ambion,	   Fermentas,	   GE	   Healthcare,	   Invitrogen,	   New	   England	  
Biolabs,	  PJK,	  Promega,	  QIAGEN,	  Roche,	  Roth,	  or	  Sigma.	  Important	  components	  that	  had	  not	  been	  listed	  
previously	  are	  described	  in	  Table	  12.	  	  	  
Table	  12.	  Selected	  materials.	  	  
Description	   Company	   Catalogue	  number	  
GeneRuler	  Ladder	  Mix	   Fermentas	   SM0331	  
Page	  Ruler	  Plus,	  prestained	  Protein	  Ladder	   Fermentas	   SM1811	  
Random	  Hexamer	  Primer	   Fermentas	   S0142	  
Ribolock	  RNase	  inhibitor	   Fermentas	   EO0382	  
T4	  DNA	  Ligase	   NEB	   M0202S	  
Passive	  Lysis	  5X	  Buffer	   Promega	   E1941	  
Epoxy-­‐activated	  Sepharose	  6B	   GE	  Healthcare	   17-­‐0480-­‐01	  
Streptomycin	  sulfate	  salt	   Sigma	   S9137	  
Dihydrostreptomycin	  sesquisulfate	   Sigma	   D7253	  
Coelenterazin	   PJK	   102171	  
D-­‐Luciferin	   PJK	   102111	  
 
 











3.1 eIF4E	  is	  regulated	  by	  the	  translational	  repressor	  Pumilio2	  and	  is	  
involved	  in	  dendritic	  arborization	  and	  spine	  development	  
3.1.1 Background	  
 
On	   their	   journey	   to	   the	   final	   destination	   inside	   the	   cell,	   localized	   mRNAs	   are	   usually	   kept	  
translationally	   repressed.	   It	   has	   been	   suggested	   that	   two	   principle	   mechanisms	   could	   mediate	  
translational	  repression:	  i)	  TAFs	  interacting	  with	  their	  cognate	  RNA	  thereby	  regulating	  their	  translational	  
status,	  or	  ii)	  small	  non-­‐coding	  RNAs,	  e.g.	  miRNAs,	  preventing	  translation	  during	  transport.	  In	  both	  cases,	  
a	  stimulus	  at	  an	  activated	  synapse	  would	   initiate	  a	  signalling	  cascade,	  ultimately	   leading	   to	   release	  of	  
translational	  repression	  causing	  local	  protein	  synthesis	  at	  the	  place	  where	  it	  is	  needed.	  In	  this	  project,	  I	  
investigated	   the	   translational	   regulator	   Pum2	   and	   one	   of	   its	   target	   mRNAs,	   eukaryotic	   translation	  
initiation	  factor	  4E	  (eIF4E).	  	  	  
	  Pum2	   is	   one	   of	   the	   two	  mammalian	   homologs	   of	  Drosophila	   Pumilio,	   which	   is	   a	   well-­‐studied	  
translational	   regulator	   (Wickens	   et	   al.,	   2002).	   Previous	   work	   in	   the	   lab	   had	   shown	   that	   Pum2	   is	  
expressed	   in	   hippocampal	   neurons	   and	   is	   recruited	   to	   somatodendritic	   stress	   granules	   upon	   cellular	  
stress,	  but	  is	  excluded	  from	  P-­‐bodies.	  Domains	  within	  Pum2	  were	  identified	  to	  be	  responsible	  for	  stress	  
granule	  formation	  and	  knockdown	  of	  Pum2	  impeded	  formation	  of	  stress	  granules	  (Vessey	  et	  al.,	  2006).	  
Results	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This	   study	  gave	   first	   insight	   in	   the	   function	  of	  Pum2	   in	  mammalian	  neurons,	  but	   the	   targets	  of	  Pum2	  
remained	  elusive	  so	  far.	  My	  aim	  was	  to	   investigate	  the	  potential	   target	  of	  Pum2,	  eIF4E	  mRNA,	  and	  to	  
investigate	  its	  role	  in	  mature	  hippocampal	  neurons,	  especially	  as	  a	  colleague	  in	  the	  lab	  had	  shown	  that	  
Pum2	  influences	  dendritic	  arborization	  and	  spine	  development	  (Vessey	  et	  al.,	  2010),	  which	  could	  be	  an	  
indirect	  effect	  caused	  by	  misregulation	  of	  a	  target.	  Specifically,	  I	  wanted	  to	  know	  whether	  (i)	  Pum2	  is	  a	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3.1.2 Assessing	  the	  efficiency	  and	  specificity	  of	  Pumilio2	  up-­‐	  and	  downregulation	  	  	  
 
Plasmids	  for	  transient	  overexpression	  and	  knockdown	  of	  Pum2	  had	  been	  previously	  generated	  in	  
the	   lab	   (Vessey	   et	   al.,	   2006).	   For	   the	   current	   project,	   I	  was	   assessing	   their	   efficiency	   as	  well	   as	   their	  
specificity,	   especially	   to	   assure	   that	   observed	   effects	   are	   specific	   for	   Pum2,	   and	   that	   Pum1	   is	   not	  
affected.	   Pum1	   and	   Pum2	   are	   closely	   related	   sharing	   83%	   similarity	   (Spassov	   and	   Jurecic,	   2002).	   The	  
knockdown	  plasmid	  that	  I	  used	  (Vessey	  et	  al.,	  2006)	  was	  designed	  to	  target	  Pum2	  only,	  but	  there	  could	  
be	   crosstalk	   between	   the	   two	   mammalian	   Pumilios.	   I	   used	   nucleofection	   (Amaxa	   nucleofector)	   to	  
transfer	   plasmid	   DNA	   in	   an	   efficient	   way	   into	   rat	   E17	   cortical	   neurons.	   A	   significant	   experimental	  
problem	  in	  transfecting	  neurons	  for	  biochemical	  analysis	  is	  inefficient	  transfection,	  resulting	  in	  a	  mixed	  
population	   of	   transfected	   cells	   together	  with	  wild-­‐type	   neurons.	   After	   testing	   different	   nucleofection	  
conditions,	   I	  got	   the	  best	   transfection	  efficiencies	   for	  cortical	  neurons	  using	   the	  program	  AK009	   (data	  
not	  shown).	  This	  was	  then	  subsequently	  used	  in	  all	  further	  experiments	  to	  transfect	  cortical	  neurons	  in	  
parallel	  with	   control	   plasmids.	   For	   the	   experiments	   investigating	   Pum2	   function,	   I	   used	   the	   following	  
plasmids:	   knockdown	   short	   hairpin	   (sh)	   expressing	   plasmid	   (pSuperior	   sh-­‐Pum2),	   control	   mismatch	  
hairpin	   (mis)	   expressing	   plasmid	   (pSuperior	  mis-­‐Pum2)	   and	   control	   empty	   EYFP	   plasmid	   (pEYFP)	   and	  
overexpression	  plasmids	  (pEYFP-­‐Pum2	  and	  the	  sh-­‐resistant	  plasmid	  pPum2R-­‐cmyc).	  	  
Figure5A	   shows	   that	   transfection	   of	   the	   hippocampal	   neurons	   with	   sh-­‐Pum2	   led	   to	   efficient	  
knockdown	  of	  Pum2,	  while	  Pum1	  levels	  remained	  largely	  unaffected.	  Co-­‐transfection	  of	  sh-­‐Pum2	  with	  a	  
cleavage-­‐resistant,	  c-­‐myc-­‐tagged	  Pum2-­‐overexpression	  plasmid	  led	  to	  stable	  levels	  of	  Pum2.	  Expression	  
of	   Pum2-­‐EGFP	   yielded	  an	   additional	   band	  on	   the	  Western	  blot,	   at	   the	   corresponding	  height	  of	   Pum2	  
tagged	   with	   EGFP.	   The	   results	   from	   the	   Western	   blot	   were	   confirmed	   at	   the	   single-­‐cell	   level	   by	  
immunostainings,	  shown	  in	  panel	  B.	  While	  sh-­‐Pum2	  transfected	  cells	  (marked	  by	  co-­‐expression	  of	  EGFP)	  
showed	   reduced	   levels	   of	   Pum2	   staining	   intensity,	   Pum1	   immunostainings	   remained	   unaffected.	   The	  
cleavage-­‐resistant	  Pum2R	  and	  mis-­‐Pum2	  served	  as	  controls,	  where	  both	  Pum2	  and	  Pum1	  staining	  levels	  
were	  not	  altered.	  Figure5C	  shows	  an	  additional	  control:	  c-­‐myc-­‐tagged	  Pum2R	  was	  not	  reduced	  when	  co-­‐
expressed	  with	  sh-­‐Pum2,	  but	  endogenous	  Pum2	  levels	  were	  reduced.	  	  
Taken	   together,	   these	   controls	   provide	   evidence	   that	   the	   plasmids	   used	   for	   overexpression	   or	  
knockdown	   of	   Pum2	   act	   in	   a	   specific	   and	   efficient	   way,	   which	   confirms	   previous	   data	   and	   is	   a	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Figure	  5.	   (Right	   side).	  Controls	   for	  Pumilio2	  misregulation	  experiments.	   (A)	   Left	   side:	  Western	  blot	  experiment	  
using	  lysates	  from	  hippocampal	  neurons	  with	  transient	  knockdown	  or	  overexpression	  of	  Pum2.	  β-­‐Actin	  was	  used	  
as	  loading	  control.	  Pum2	  (predicted	  molecular	  weight	  (MW)	  of	  114	  kDa)	  is	  detected	  close	  below	  the	  130	  kDa	  band	  
of	   the	  molecular	  weight	  marker.	  Pum2-­‐EGFP	  causes	  a	  shift	  as	  expected	  by	  addition	  of	   the	  27	  kDa	  protein	  EGFP.	  
Pum1	  (predicted	  MW	  of	  126	  kDa)	  is	  detected	  close	  above	  the	  130	  kDa	  band	  of	  the	  molecular	  weight	  marker.	  Lane	  
1:	  extract	  from	  cells	  expressing	  a	  mismatch-­‐hairpin.	  Lane	  2:	  extract	  from	  cells	  expressing	  an	  sh-­‐RNA	  (expressed	  for	  
3	  days)	  directed	  against	  Pum2.	  Lane	  3:	  extract	  from	  cells	  expressing	  EYFP	  as	  a	  control	  for	  overexpression.	  Lane	  4:	  
extract	   from	  cells	   expressing	  EYFP-­‐Pum2.	   Lane	  5:	   extract	   from	  cells	   expressing	  both	  an	   sh-­‐RNA	  directed	  against	  
Pum2	  and	  the	  cleavage-­‐resistant	  c-­‐myc-­‐tagged	  Pum2R.	  Right	  side:	  quantification	  of	  the	  Western	  blot	  on	  the	   left	  
side.	   Quantification	   was	   performed	   with	   ImageJ	   and	   normalized	   to	   β	   -­‐Actin	   levels	   (to	   account	   for	   loading	  
inaccuracies)	  and	  the	  protein	  levels	  in	  the	  mismatch-­‐Pum2	  extract.	  (B)	  Cells	  transfected	  with	  sh-­‐Pum2	  or	  control	  
plasmids	  and	   immunostained	  with	  anti-­‐Pum2	  and	  anti-­‐Pum1	  antibodies.	  Transfected	  cells	  were	   identified	  by	  co-­‐
expression	   of	   EGFP.	   Asterisks	  mark	   transfected	   cells.	   (C)	   Left	   side:	  Western	   blot	   experiment	   containing	   lysates	  
from	  cortical	  neurons	  with	  transient	  knockdown	  of	  Pum2	  for	  3	  days.	  β-­‐Actin	  was	  used	  as	   loading	  control.	  Pum2	  
(predicted	  MW	  of	   114	   kDa)	   is	   detected	   close	   below	   the	   130	   kDa	   band	   of	   the	  molecular	  weight	  marker.	   Pum2	  
tagged	  with	  c-­‐myc	  is	  detected	  at	  the	  same	  height,	  the	  small	  tag	  does	  not	  cause	  a	  visible	  shift.	  Lane	  1:	  extract	  from	  
cells	  expressing	  both	  an	  sh-­‐RNA	  directed	  against	  Pum2	  and	  the	  cleavage-­‐resistant	  c-­‐myc-­‐tagged	  Pum2R.	  Lane	  2:	  
extract	  from	  cells	  expressing	  both	  a	  mismatch-­‐hairpin	  and	  the	  cleavage-­‐resistant	  c-­‐myc-­‐tagged	  Pum2R.	  Right	  side:	  
quantification	  of	  the	  Western	  blot	  on	  the	  left	  side.	  Quantification	  was	  performed	  with	  ImageJ	  and	  normalized	  to	  β	  















































Pum2 1.0 0.2 0.9 1.3 0.9 













































































Pum2 1.00 0.63 




















1             2             3             4             5
1                   2          
Results	  
	  

















































52	   	   Lucia	  Schoderböck	  
3.1.3 Pumilio2	  is	  a	  negative	  regulator	  of	  the	  translation	  of	  eIF4E	  	  
 
In	  Drosophila,	   Pumilio	   acts	   as	   a	   translational	   regulator	   of	   eIF4E	   and	   the	   voltage-­‐gated	   sodium	  
channel	  paralytic	  (para)	  mRNAs	  (Mee	  et	  al.,	  2004;	  Menon	  et	  al.,	  2009;	  Menon	  et	  al.,	  2004;	  Schweers	  et	  
al.,	  2002).	  The	  aim	  of	  these	  experiments	  was	  to	  investigate	  whether	  mammalian	  Pum2	  would	  also	  act	  as	  
translational	  repressor	  and	  whether	  also	  its	  targets	  would	  play	  a	  role	  in	  neuronal	  development.	  	  
Translational	  control	  was	  investigated	  by	  luciferase	  reporter	  assays.	  The	  reporter	  system	  of	  choice	  
was	  psiCHECK-­‐2	  (Promega),	  a	  plasmid	  that	  contains	  a	  synthetic	  version	  of	  Renilla	  luciferase	  (hRluc,	  SV40	  
promoter)	   as	   reporter	   gene,	   where	   the	   MCS	   is	   located	   3’	   of	   the	   translational	   stop.	   Additionally,	  
psiCHECK-­‐2	  contains	  a	  secondary	  synthetic	  firefly	  luciferase	  gene	  (HSV-­‐TK	  promoter),	  which	  enables	  for	  
intraplasmid	   transfection	   normalization.	   This	   is	   especially	   important	   for	   transfection	   into	   neurons,	  
where	   transfection	  of	  more	   than	  2	  plasmids	   is	  often	  problematic.	  By	   reducing	   the	   reporter	   system	  to	  
one	   plasmid,	   instead	   of	   the	   usual	   two	   for	   luciferase	   assays,	   co-­‐transfection	   with	   effector	   plasmids	  
(overexpression,	  knockdown	  etc)	  is	  possible.	  Luciferase	  reporter	  plasmids	  were	  generated	  by	  fusing	  the	  
3’-­‐UTR	  of	  eIF4E,	  which	  contains	  Pum2	  binding	   site	   consensus	   sequences,	   to	  Renilla	   luciferase.	  The	  3’-­‐
UTR	  was	  PCR	  amplified	  from	  rat	  brain	  cDNA,	  ligated	  into	  pGEM-­‐T	  and	  then	  sub-­‐cloned	  into	  psiCHECK-­‐2.	  
The	  cloning	  strategy	  is	  depicted	  in	  Figure	  6.	  	  	  	  
 
Figure	  6.	  Cloning	  strategy	  for	  the	  insertion	  of	  the	  3’-­‐UTR	  of	  eIF4E	  into	  the	  luciferase	  plasmid	  psiCHECK-­‐2.	  	  
 
The	   effects	   of	   misregulated	   Pum2	   on	   reporters	   containing	   candidate	   3’-­‐UTRs,	   which	   were	  
constructed	   analogous	   to	   that	   containing	   eIF4E	   3’-­‐UTR,	   were	   analyzed.	   As	   can	   be	   seen	   in	   Figure	   7,	  
luciferase	   activity	   of	   a	   reporter	   containing	   the	   3’-­‐UTR	   of	   eIF4E,	   the	   mammalian	   homolog	   of	   the	  
Drosophila	  Pum	  target,	  was	  negatively	  regulated	  by	  Pum2.	  Besides	  the	  sequence	  of	  eIF4E,	  also	  those	  of	  
Pum2	   itself	   contain	  potential	   Pum2	  binding	   sites.	   Therefore,	   also	   a	   reporter	   containing	   the	  3’-­‐UTR	  of	  
Pum2	  was	  included	  in	  the	  analysis.	  Knockdown	  of	  Pum2	  yields	  similar	  results	  as	  for	  eIF4E,	  showing	  an	  
upregulation	  of	  luciferase	  activity.	  A	  similar	  effect	  was	  also	  observed	  for	  Arc,	  LIMK1	  and	  PABPC1	  3’UTRs,	  























EYFP-Pum2 -2 -15 16 5 -14 9 










Lucia	  Schoderböck	   	   53	  	   	  
obvious	  Pum2	  binding	  sites,	  but	  still	   translation	  was	  regulated	   in	  a	  negative	  manner,	  which	  could	  also	  












































Figure	  7.	  Pum2	  is	  a	  negative	  translational	  regulator	  for	  eIF4E.	  (A)	  Luciferase	  assay	  performed	  on	  lysates	  of	  cortical	  
neurons	  co-­‐nucleofected	  with	  knockdown	  or	  overexpression	  plasmids	  of	  Pum2	  and	  Luciferase	  reporter	  plasmids	  
containing	  different	  3’-­‐UTRs.	  Overexpression	  was	  achieved	  overnight,	  knockdown	  experiments	  were	  incubated	  for	  
3	   days	   post	   transfection.	   Raw	   ratios	   were	   calculated	   by	   dividing	   Renilla	   luciferase	   activity	   by	   Firefly	   luciferase	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3.1.4 eIF4E	  levels	  influence	  dendritic	  arborization	  
 
To	  follow	  up	  whether	  the	  Pum2	  target	  eIF4E	  would	  also	  be	  involved	  in	  developmental	  processes	  –	  
as	   it	   has	   been	   shown	   for	   Pum2	   (Vessey	   et	   al.,	   2010)	   –	   misregulation	   experiments	   were	   performed	  
followed	  by	  Sholl	  analysis	  (Sholl,	  1953)	  to	  investigate	  whether	  dendritic	  arborization	  is	  affected	  or	  not.	  	  
In	  order	   to	  be	  able	   to	   investigate	   the	  effects	  of	  eIF4E	  misregulation	  on	  neuronal	  morphology,	   I	  
generated	  a	  plasmid	  to	  knockdown	  eIF4E.	  Potential	   target	  sequences	   for	  shRNAs	  were	   identified	  with	  
the	   online-­‐tool	   from	   BlockIT	   RNAi	   designer	   (Invitrogen).	   The	   two	   top-­‐ranked	   sequences	  were	   chosen	  
and	  ordered	  as	  oligos	  flanked	  by	  sequences	  to	  form	  short	  hairpins.	  The	  oligos	  were	  designed	  in	  a	  way,	  
that	  if	  annealed,	  the	  ends	  would	  form	  cohesive	  ends	  for	  ligation	  into	  the	  pSuperior	  vector	  digested	  with	  
BglII	   and	  HindIII.	   The	   cloning	   strategy	   is	  depicted	   in	  Figure	  8.	   The	  plasmid	  used	   for	  overexpression	  of	  
eIF4E	  was	  kindly	  provided	  by	  P.	  Macchi	  (University	  of	  Trento).	  	  
 
	  
Figure	  8.	  Cloning	  strategy	  for	  the	  insertion	  of	  the	  sh	  oligos	  targeting	  eIF4E	  into	  the	  pSuperior	  plasmid.	  	  
 
Efficiency	  of	  eIF4E	  knockdown	  and	  overexpression	  experiments	  are	  shown	   in	  Figure	  9.	  Western	  
blotting	   experiments	   (panel	   A)	   were	   performed	   after	   nucleofecting	   cortical	   neurons	   with	   control	  
(pSuperior	  and	  pEGFP-­‐C2),	  overexpression	  (pEGFP-­‐eIF4E)	  and	  knockdown	  plasmids	  (pSuperior	  sh-­‐eIF4E).	  
Those	  experiments	  proved	  that	  eIF4E	  levels	  were	  reduced	  to	  less	  than	  40	  %	  of	  the	  original	  levels	  in	  the	  
knockdown	  condition.	  Overexpression	  led	  to	  an	  additional	  band	  of	  50	  kDa,	  which	  would	  account	  for	  the	  
fusion	  of	  eIF4E	  (25	  kDa)	  with	  EGFP.	  Immunostaining	  experiments	  (panel	  B)	  at	  the	  single-­‐cell	  level	  using	  
an	   antibody	   directed	   against	   eIF4E	   proofed	   that	   both	   knockdown	   and	   overexpression	   work	   in	   an	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Figure	  9.	  Controls	  for	  eIF4E	  misregulation	  experiments.	  (A)	  Left	  side:	  Western	  blot	  experiment	  using	  lysates	  from	  
cortical	  neurons	  with	  transient	  knockdown	  or	  overexpression	  of	  eIF4E.	  β-­‐Actin	  was	  used	  as	  loading	  control.	  eIF4E	  
(predicted	  MW	  of	  25	  kDa)	  is	  detected	  close	  to	  the	  25	  kDa	  band	  of	  the	  molecular	  weight	  marker.	  EGFP-­‐eIF4E	  causes	  
a	   shift	   as	   expected	   by	   addition	   of	   EGFP	   and	   is	   detected	   close	   to	   the	   55	   kDa	   band.	   Lane	   1:	   extract	   from	   cells	  
expressing	  from	  the	  empty	  hairpin	  plasmid.	  Lane	  2:	  extract	  from	  cells	  expressing	  an	  sh-­‐RNA	  directed	  against	  eIF4E	  
(expression	  for	  3	  days).	  Lane	  3:	  extract	  from	  cells	  expressing	  EGFP	  as	  a	  control	  for	  overexpression.	  Lane	  4:	  extract	  
from	  cells	  expressing	  EGFP-­‐eIF4E.	  Right	  side:	  quantification	  of	  the	  Western	  blot	  on	  the	  left	  side.	  Quantification	  was	  
performed	   with	   ImageJ	   and	   normalized	   to	   β-­‐Actin	   levels	   (to	   account	   for	   loading	   inaccuracies)	   and	   the	   protein	  
levels	   in	   the	   sh-­‐control	   extract.	   Different	   scales	   were	   used	   for	   endogenous	   eIF4E	   levels	   (left	   scale)	   and	  
overexpressed	   EGFP-­‐eIF4E	   levels	   (right	   scale).	   (B)	   Cells	   transfected	  with	   sh-­‐eIF4E,	   EGFP-­‐eIF4E	  or	   control	   (empty	  
hairpin	  plasmid)	  plasmids	  and	  immunostained	  with	  an	  anti-­‐eIF4E	  antibody.	  Transfected	  cells	  were	  identified	  by	  co-­‐
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  Interestingly,	   Sholl	   analysis	   of	   neurons	   with	   misregulated	   eIF4E	   levels	   (Figure	   10)	   resulted	   in	  
similar	  effects	  to	  those	  observed	  upon	  Pum2	  misregulation	  (Vessey	  et	  al.,	  2010).	  The	  expectation	  that	  
downregulation	   of	   eIF4E	   compared	   to	   that	   of	   Pum2	   (being	   a	   negative	   regulator	   of	   eIF4E	   translation)	  
would	   yield	   opposite	   effects	   was	   not	   confirmed.	   Higher	   levels	   of	   eIF4E	   led	   to	   reduced	   dendritic	  
complexity,	   while	   reduced	   levels	   of	   eIF4E	   resulted	   in	   more	   complex	   arborization	   of	   the	   dendrites.	  
Considering	   that	   eIF4E	   is	   not	   the	   sole	   target	   of	   Pum2,	   and	   that	   also	   eIF4E	   itself	   has	  major	   regulative	  
functions,	  it	  is	  not	  surprising	  that	  more	  complex	  interaction	  underlying	  dendrite	  development	  led	  to	  an	  





































Figure	  10.	  eIF4E	  levels	  influence	  dendritic	  arborization.	  Sholl	  analysis	  of	  dendritic	  arbor	  complexity	  (Sholl,	  1953)	  
to	   investigate	   dendrite	   development.	   Compared	   to	   controls	   (diamonds),	   neurons	   with	   reduced	   levels	   of	   eIF4E	  
(triangles)	  showed	  significantly	  more	  line	  crossings	  between	  20	  and	  30	  mm	  and	  between	  60	  and	  100	  mm.	  Neurons	  
overexpressing	   EGFP-­‐eIF4E	   tended	   to	   show	   fewer	   line	   crossings	   at	   all	   distances,	   but	  without	   being	   significantly	  
different	  from	  controls.	  
Results	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3.1.5 eIF4E	  levels	  influence	  dendritic	  spine	  development	  and	  morphology	  
 
Being	  able	   to	  observe	  effects	  on	  dendrite	  development	  when	  eIF4E	   levels	  were	  misregulated,	   I	  
was	  wondering	  whether	  also	  processes	  occurring	  later	  in	  development	  of	  hippocampal	  neurons	  would	  
be	   affected.	   For	   this	   reason	   I	   investigated	   mature	   neurons	   transfected	   with	   knockdown	   and	  
overexpression	  plasmids	  at	   the	   stage	  of	  dendritic	   spine	  development.	   Significant	  differences	  on	   spine	  
density	   and	   spine	   length	   could	   be	   observed.	   Protrusions	   in	   misregulation	   conditions,	   both	  
overexpression	  and	  knockdown,	  were	  less	  dense	  and	  a	  higher	  proportion	  of	  protrusions	  was	  longer	  than	  
2	   µm	   when	   compared	   to	   control	   conditions	   (Figure	   11A	   and	   B).	   Representative	   pictures	   of	   mature	  
neurons	   under	   control	   and	  misregulation	   conditions	   are	   shown	   in	  Figure	   11C.	   As	   can	   clearly	   be	   seen	  
from	  the	  enlargements,	  spine	  heads	  in	  the	  control	  neuron	  show	  the	  typical	  mushroom-­‐like	  form,	  while	  
protrusions	  in	  neurons	  with	  misregulated	  eIF4E	  levels	  are	  more	  filopodia-­‐like	  long,	  thin	  structures.	  	  
 
3.1.6 Conclusions	  of	  the	  investigation	  of	  Pumilio2	  and	  eIF4E	  
 
My	  experiments	  yield	  major	  new	  insight	  in	  the	  role	  of	  mammalian	  Pum2	  in	  neurons.	  I	  show	  that	  
Pum2	  regulates	  the	  translation	  of	  eIF4E	  via	  the	  3’-­‐UTR	  of	  eIF4E.	  This	  confirms	  Pum2	  as	  a	  translational	  
repressor	  in	  mammals,	  and	  points	  towards	  an	  important	  role	  of	  the	  regulation	  of	  eIF4E,	  being	  conserved	  
from	  Drosophila	  to	  mammals.	  It	  is	  very	  likely	  that	  Pum2	  regulates	  also	  other	  transcripts,	  this	  will	  have	  to	  
be	  further	  investigated.	  	  
Misregulation	  of	  eIF4E	  itself	  also	  influences	  the	  neuronal	  development	  of	  hippocampal	  neurons	  in	  
culture:	   dendritic	   arborization	   was	   affected	   in	   a	   similar	   manner	   to	   that	   observed	   upon	   Pum2	  
misregulation.	   Also	   dendritic	   spine	   development	   was	   affected	   upon	   misregulation	   of	   eIF4E.	   Those	  
results	  give	  rise	  to	  the	  speculation	  that	  the	  effects	  observed	  upon	  Pum2	  misregulation	  might	  be	  indirect.	  
eIF4E	  might	  also	  be	  a	  part	  of	  the	  pathway	  regulating	  neuronal	  development	  which	  will	  need	  intensive	  
studies	  in	  future	  and	  will	  also	  address	  whether	  eIF4E	  mRNA	  is	  localized	  to	  synaptic	  sites.	  	  	  	  
	  
Protrusions
< 2 μm 
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Figure	   11.	   eIF4E	   levels	   influence	   dendritic	   spine	   development	   and	   morphology.	   Hippocampal	   neurons	   were	  
transfected	  at	  15	  DIV	  with	  control,	   knockdown	  and	  overexpression	  plasmids	   for	  eIF4E	  and	   then	   incubated	   for	  3	  
days	  for	  expression.	  (A)	  sh-­‐eIF4E	  treated	  neurons	  and	  neurons	  overexpressing	  eIF4E	  had	  a	  significant	  reduction	  of	  
protrusion	  density	  compared	  to	  control	  neurons.	  Numbers	  of	  protrusions/mm	  were	  determined	  by	  counting,	  and	  
length	   of	   protrusions	   (B)	   was	   measured	   using	   ImageJ.	   Neurons	   deficient	   for	   eIF4E	   or	   expressing	   elevated	  
exogenous	  levels	  of	  eIF4E	  showed	  significantly	  more	  protrusions	  longer	  than	  2	  µm	  compared	  to	  control	  neurons.	  
(C)	  Representative	  Z-­‐stacks	  of	  mature	  neurons	  with	  reduced,	  control	  and	  elevated	  eIF4E	  levels.	  Arrowheads	  mark	  
representative	  protrusion	  structures.	  
Results	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As	  already	  described	  earlier,	  miRNAs	  are	  seen	  as	  an	  alternative	  means	  of	  translational	  silencing	  of	  
mRNAs	  during	  their	  transport.	  miRNAs	  regulate	  the	  translation	  and/or	  stability	  of	  mRNAs	  by	  binding	  to	  
their	   complementary	   sequences	   and	   thereby	   recruiting	   the	   RISC	   machinery.	   miRNA-­‐dependent	  
translational	   silencing	   is	   thought	   to	  be	  a	  mechanism	  to	  keep	  mRNAs	  silent	  during	   their	   transport	   into	  
dendrites,	  where	  signals	  at	  synaptic	  sites	  then	  induce	  relieve	  of	  repression	  and	  lead	  to	  protein	  synthesis.	  
I	  was	  interested	  in	  potential	  miRNA	  binding	  sites	  in	  dendritically	  localized	  mRNAs,	  some	  of	  which	  have	  
been	  identified	  by	  bioinformatic	  sequence	  analysis.	  
Up	   to	   now,	   only	   very	   few	   dendritically	   localized	   mRNAs	   were	   shown	   to	   be	   under	   control	   of	  
miRNAs.	  The	  key	  finding	  was	  published	  by	  Sam	  Kunes’	  group	  (Ashraf	  et	  al.,	  2006),	  who	  could	  show	  that	  
synaptic	  protein	  synthesis	  is	  regulated	  by	  the	  RISC	  pathway	  in	  Drosophila.	  Although	  they	  did	  not	  identify	  
a	   specific	   miRNA	   regulating	   CaMKII	   mRNA	   in	   their	   study,	   they	   provide	   clear	   evidence	   for	   a	   role	   of	  
miRNAs	   in	   regulation	  of	  synaptic	  protein	  synthesis.	   In	  mammalian	  cells,	  only	   few	  examples	  of	  miRNA-­‐
regulated,	  localized	  mRNAs	  are	  known	  so	  far.	  First,	  a	  regulator	  of	  actin	  filament	  dynamics,	  LIMK1,	  was	  
found	   to	  be	   regulated	  by	  miR-­‐134,	  which	  was	   shown	   to	  be	   localized	  close	   to	   synapses	   (Schratt	  et	  al.,	  
2006).	  Recently,	  the	  brain-­‐specific	  miR-­‐138	  was	  found	  to	  regulate	  APT1,	  which	  encodes	  for	  an	  enzyme	  
that	   catalyzes	   the	   removal	   of	   palmitate	   modifications	   (Siegel	   et	   al.,	   2009).	   In	   a	   more	   generalized	  
approach	  to	  identify	  miRNAs	  localized	  in	  dendrites,	  miR-­‐26a	  was	  found	  to	  regulate	  the	  dendritic	  mRNA	  
coding	  for	  the	  microtubule-­‐associated	  protein	  2	  (MAP2)	  (Kye	  et	  al.,	  2007).	  
The	  aim	  of	  this	  project	  was	  to	  develop	  and	  adapt	  assays,	  which	  could	  then	  be	  used	  to	  investigate	  
miRNA-­‐dependent	  regulation	  of	  dendritically	  localized	  mRNAs.	  In	  this	  project,	  I	  initially	  chose	  LIMK1	  and	  
Arc	  mRNA	  as	  first	  candidates	  to	  establish	  assays,	  which	  would	  then	  allow	  me	  to	  study	  other	  interesting	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3.2.2 Bioinformatic	  analysis	  of	  dendritic	  mRNAs	  for	  potential	  miRNA	  binding	  sites	  
 
To	  identify	  potential	  miRNA	  binding	  sites	  in	  selected	  candidates	  of	  dendritically	  localized	  mRNAs,	  
those	  mRNAs	  were	   analyzed	  with	   two	  web-­‐based	   tools:	   i)	   PicTar	   (http://pictar.mdc-­‐berlin.de/)	   (Chen	  
and	   Rajewsky,	   2006;	   Krek	   et	   al.,	   2005;	   Rajewsky	   lab	   (Center	   for	   Comparative	   Functional	   Genomics,	  
2007),	  and	   ii)	  TargetScan	  4.2	   (http://www.targetscan.org/vert_42/)	   (Grimson	  et	  al.,	  2007;	  Lewis	  et	  al.,	  
2005;	  Whitehead	  Institute	  for	  Biomedical	  Research,	  2008).	  These	  bioinformatic	  analyses	  rely	  mainly	  on	  
complementarity	   of	   a	  miRNA	   to	   a	   target	   sequence	   and	   conservation	  of	   the	   target	   sequence.	  Usually,	  
only	   3’-­‐UTRs	   are	   taken	   into	   account	   for	   these	   analyses.	   The	  miRNAs	   predicted	   to	   bind	  my	   candidate	  
mRNAs	  are	  listed	  in	  Table	  13.	  As	  most	  localized	  mRNAs	  carry	  relatively	  long	  3’-­‐UTRs,	  it	  is	  not	  surprising	  
that	  often	  a	  large	  number	  of	  miRNA-­‐binding	  sites	  are	  predicted.	  Interestingly,	  for	  Arc	  3’-­‐UTR	  (1.4	  kb)	  an	  
unusually	   low	   number	   of	   potential	   binding	   sites	   was	   predicted.	   Figure	   12	   shows	   an	   overview	   on	  
predicted	   miRNA-­‐binding	   sites	   on	   LIMK1	   and	   Arc	   3’-­‐UTR,	   the	   two	   candidates	   that	   were	   chosen	   to	  
establish	  the	  assays.	  
A	  summer	  student	   in	  the	   lab,	  Diego	  Barcena,	  extended	  the	  bioinformatic	  analysis	   for	  Arc	  mRNA	  
and	  used	   the	  RNAup	   software	   (http://www.tbi.univie.ac.at/~ulim/RNAup/)	   (Muckstein	  et	   al.,	   2006)	   to	  
investigate	  the	  miR-­‐19a-­‐binding	  site	  predicted	  by	  PicTar	  and	  TargetScan	  in	  Arc	  3’-­‐UTR.	  RNAup	  is	  a	  tool	  to	  
calculate	   thermodynamics	  of	  RNA-­‐RNA	   interaction,	   and	   thereby	   considers	   site	   accessibility	   for	  miRNA	  
binding.	   This	   analysis	   predicted	   a	   high	   likelihood	   that	   miR-­‐19a	   would	   bind	   and	   regulate	   Arc	   mRNA	  
(Barcena,	   unpublished;	   Gruber	   et	   al.,	   2008;	   Kertesz	   et	   al.,	   2007;	   Muckstein	   et	   al.,	   2006;	   Tafer	   and	  
Hofacker,	  2008).	  	  
For	  Arc	  mRNA,	  all	  predicted	  miRNAs	  were	  included	  in	  the	  analysis,	  while	  for	  LIMK1	  only	  few	  were	  
chosen:	   i)	   miR-­‐134	   is	   not	   predicted	   to	   bind	   to	   the	   LIMK1	   3’-­‐UTR,	   although	   it	   has	   been	   shown	  
experimentally.	  Therefore,	   it	  was	   included	  as	  positive	  control	  (Schratt	  et	  al.,	  2006).	   ii)	  miR-­‐369-­‐3p	  was	  
considered	  to	  be	  especially	  interesting,	  as	  it	  was	  shown	  to	  be	  able	  to	  reverse	  the	  mode	  of	  miRNA	  action	  
and	  upregulate	   its	  target	   in	  cell	  cycle-­‐arrested	  cells	   (Vasudevan	  et	  al.,	  2007).	  As	  cultured	  hippocampal	  
neurons	  are	  postmitotic	  cells,	  this	  mode	  of	  action	  could	  apply	  here	  as	  well.	   iii)	  miR-­‐106b	  was	  included	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Table	  13.	  Bioinformatic	  analysis	  of	  dendritically	  localized	  mRNAs.	  The	  web-­‐based	  tool	  PicTar	  was	  used	  to	  predict	  
potential	  miRNA-­‐regulators	  of	  dendritically	  localized	  mRNAs.	  This	  information	  was	  supplemented	  with	  expression	  
patterns	  in	  hippocampus	  (Landgraf	  et	  al.,	  2007).	  In	  the	  very	  right	  column,	  miRNAs	  of	  special	  interest,	  which	  were	  

















LIMK1	   NM_002314	   hsa-­‐miR-­‐328	   +	   +	   -­‐	   9	   	  
	  	   	  	   hsa-­‐miR-­‐138	   +	   +	   -­‐	   8	   	  
	  	   	  	   hsa-­‐miR-­‐369-­‐3p	   -­‐	   +	   -­‐	   3	   yes	  
	  	   	  	   hsa-­‐miR-­‐106b	   +	   -­‐	   +	   3	   yes	  
	  	   	  	   hsa-­‐miR-­‐20b	   -­‐	   -­‐	   -­‐	   1	   	  
	  	   	  	   hsa-­‐miR-­‐93	   +	   +	   +	   2	   	  
	  	   	  	   hsa-­‐miR-­‐20a	   +	   -­‐	   +	   2	   	  
	  	   	  	   hsa-­‐miR-­‐17-­‐5p	   +	   +	   ?	   1	   	  
	  	   	  	   hsa-­‐miR-­‐27b	   +	   +	   +	   1	   	  
	  	   	  	   hsa-­‐miR-­‐128b	   +	   +	   -­‐	   2	   	  
	  	   	  	   hsa-­‐miR-­‐128a	   +	   +	   -­‐	   2	   	  
	  	   	  	   hsa-­‐miR-­‐27a	   +	   +	   +	   1	   	  
	  	   	  	   hsa-­‐miR-­‐372	   ?	   -­‐	   -­‐	   1	   	  
	  	   	  	   hsa-­‐miR-­‐143	   +	   +	   -­‐	   2	   	  
	  	   	  	   hsa-­‐miR-­‐134	   +	   -­‐	   -­‐	   1	   yes	  
Arc	   NM_015193	   hsa-­‐miR-­‐326	   +	   +	   -­‐	   9	   yes	  
	  	   	  	   hsa-­‐miR-­‐19a	   -­‐	   -­‐	   +	   2	   yes	  
	  	   	  	   hsa-­‐miR-­‐19b	   +	   +	   +	   1	   yes	  
CaMKIIα 	   NM_015981	   hsa-­‐miR-­‐331	   ?	   ?	   ?	   15	   	  
	  	   	  	   hsa-­‐miR-­‐338	   +	   +	   ?	   4	   	  
	  	   	  	   hsa-­‐miR-­‐27b	   +	   +	   +	   6	   	  
	  	   	  	   hsa-­‐miR-­‐198	   ?	   ?	   -­‐	   8	   	  
	  	   	  	   hsa-­‐miR-­‐27a	   +	   +	   +	   4	   	  
	  	   	  	   hsa-­‐miR-­‐26b	   -­‐	   -­‐	   +	   3	   	  
	  	   	  	   hsa-­‐miR-­‐26a	   +	   +	   +	   3	   	  
	  	   	  	   hsa-­‐miR-­‐106b	   +	   -­‐	   +	   3	   	  
	  	   	  	   hsa-­‐miR-­‐130a	   +	   +	   -­‐	   2	   	  
	  	   	  	   hsa-­‐miR-­‐186	   +	   +	   +	   4	   	  
	  	   	  	   hsa-­‐miR-­‐142-­‐5p	   +	   +	   +	   4	   	  
	  	   	  	   hsa-­‐miR-­‐152	   -­‐	   -­‐	   -­‐	   2	   	  
	  	   	  	   hsa-­‐miR-­‐148a	   ?	   ?	   -­‐	   2	   	  
	  	   	  	   hsa-­‐miR-­‐148b	   -­‐	   -­‐	   +	   1	   	  
	  	   	  	   hsa-­‐miR-­‐130b	   +	   +	   +	   1	   	  
	  	   	  	   hsa-­‐miR-­‐301	   ?	   ?	   ?	   1	   	  
MAP2	   NM_002374	   hsa-­‐miR-­‐369-­‐3p	   -­‐	   +	   -­‐	   10	   	  
	  	   	  	   hsa-­‐miR-­‐200c	   ?	   ?	   +	   2	   	  
	  	   	  	   hsa-­‐miR-­‐200b	   ?	   ?	   -­‐	   2	   	  
	  	   	  	   hsa-­‐miR-­‐141	   -­‐	   -­‐	   +	   1	   	  
	  	   	  	   hsa-­‐miR-­‐139	   ?	   ?	   ?	   1	   	  
	  	   	  	   hsa-­‐miR-­‐335	   -­‐	   -­‐	   +	   1	   	  
	  	   	  	   hsa-­‐miR-­‐26b	   -­‐	   -­‐	   +	   1	   	  
	  	   	  	   hsa-­‐miR-­‐26a	   +	   +	   +	   1	   	  
	  	   	  	   hsa-­‐miR-­‐194	   -­‐	   -­‐	   +	   1	   	  
	  	   	  	   hsa-­‐miR-­‐136	   +	   +	   -­‐	   1	   	  
	  	   	  	   hsa-­‐miR-­‐302b-­‐star	   ?	   ?	   ?	   1	   	  
	  	   	  	   hsa-­‐miR-­‐186	   +	   +	   +	   1	   	  
β-­‐Actin	   NM_001101	   hsa-­‐miR-­‐124a	   ?	   ?	   ?	   1	   	  
	  	   	  	   hsa-­‐miR-­‐145	   -­‐	   -­‐	   -­‐	   1	   	  
	  	   	  	   hsa-­‐miR-­‐205	   -­‐	   -­‐	   -­‐	   1	   	  
	  	   	  	   hsa-­‐miR-­‐18b	   -­‐	   -­‐	   +	   1	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Figure	  12.	  Overview	  on	  predicted	  miRNA-­‐binding	  sites	  and	  constructs	  designed	  for	  LIMK1	  and	  Arc.	  (A)	  Potential	  
miRNA-­‐binding	  sites	  in	  LIMK1	  3’-­‐UTR	  (A)	  and	  Arc	  3’-­‐UTR	  (B),	  predicted	  by	  PicTar	  and/or	  TargetScan	  4.2,	  are	  marked	  
relative	  to	  their	  position.	  Cloned	  constructs	  refer	  to	  the	  fragments	  that	  were	  initially	  designed	  for	  the	  StreptoTag	  
method.	   Dendritic	   target	   elements	   (DTEs)	   were	   suggested	   to	   be	   sufficient	   and	   necessary	   for	   the	   mRNA	   to	   be	  
localized	  to	  distal	  dendrites	  (Kobayashi	  et	  al.,	  2005).	  A	  site	  complementary	  to	  the	  small	  non-­‐coding	  RNA	  BC1	  (Zalfa	  
et	  al.,	  2003)	  and	  an	  AU-­‐rich	  site	  (Tenenbaum	  et	  al.,	  2000)	  have	  been	  identified	  previously.	  
Results	  
	  
Lucia	  Schoderböck	   	   63	  	   	  
3.2.3 Effects	  of	  overexpressed	  miRNAs	  on	  endogenous,	  dendritically	  localized	  mRNAs	  
 
First,	  effects	  of	  overexpressed	  miRNAs	  on	  the	  endogenous	  mRNA	   levels	  of	  Arc	  and	  LIMK1	  were	  
investigated.	  Endogenous	  miRNA	   levels	  might	  not	  be	  high	  enough	   to	   result	   in	  a	  measurable	  effect	  on	  
(overexpressed)	   reporters.	   Therefore,	  plasmids	  were	  generated	   to	  overexpress	  miRNAs.	   Sequences	  of	  
pri-­‐miRNAs	  (length	  between	  130	  –	  200	  bp)	  were	  PCR-­‐amplified	  from	  genomic	  DNA	  and	  then	  cloned	  into	  
pSuperior,	   pSuper	   (both	   polymerase	   III	   H1	   promoters)	   and	   pcDNA3.1	   (polymerase	   II	   CMV	   promoter)	  
vectors.	   The	   cloning	   strategy	   is	   shown	   in	   Figure	   13,	   and	   the	   generated	   plasmids	   are	   summarized	   in	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Table	  16.	  Overview	  on	  the	  pcDNA3.1	  plasmids	  overexpressing	  the	  miRNAs	  of	  interest.	  
 
 
Figure	  14A	   shows	   the	   change	  of	  Arc	  mRNA	   levels	  upon	  overexpression	  of	  miRNA	  candidates	   in	  
cortical	  neurons.	  Arc	  levels	  were	  reduced	  upon	  overexpression	  of	  miR-­‐19a	  as	  would	  be	  expected	  if	  the	  
miRNA	   is	   regulating	   Arc	   mRNA.	   Arc	   mRNA	   levels	   were	   also	   reduced	   in	   untreated	   cells	   and	   in	   cells	  
transfected	  with	  empty	  pSuperior	  (not	  expressing	  a	  miRNA)	  when	  normalized	  to	  the	  not-­‐predicted	  miR-­‐
134.	  This	  must	  lead	  to	  the	  assumption,	  that	  the	  effects	  of	  miR-­‐19a	  and	  miR-­‐326	  may	  be	  questionable.	  	  
Effects	   on	   LIMK1	  mRNA	   levels	   (Figure	   14B)	   were	   only	   significant	   for	   treatment	  with	   pSuperior	  
plasmids	  not	  expressing	  a	  miRNA,	  when	  normalized	  to	  the	  not-­‐predicted	  miR-­‐19a.	  Neither	  the	  published	  
miR-­‐134	  nor	  the	  predicted	  miR-­‐369	  significantly	  downregulated	  LIMK1	  mRNA	  levels.	  	  
As	   visible	   in	   both	   graphs,	   GAPDH	   and	   α-­‐Tubulin	   mRNA	   levels,	   which	   were	   used	   for	   cross-­‐
normalization,	   were	   not	   stable	   themselves	   and	   should	   be	   replaced	   by	   better	   controls	   in	   future	  








UT pSuperior miR-19a miR-134 miR-326 miR-369 
Arc -73 -44 -63 0 -38 -14 
GAPDH -11 -25 -21 0 -23 -18 



































UT pSuperior miR19-a miR-134 miR-326 miR-369 
LIMK1 -25 -50 0 20 0 -31 
GAPDH 25 -9 0 32 29 43 








































































Figure	  14.	  Response	  of	  endogenous	  mRNA	  levels	  to	  elevated	  miRNA	  levels	  in	  cortical	  neurons.	  (A)	  Change	  of	  Arc	  
mRNA	  levels	  determined	  by	  qRT-­‐PCR	  upon	  transient	  transfection	  of	  miRNAs	  expressed	  from	  pSuperior	  for	  3	  days.	  
Data	   were	   cross-­‐normalized	   to	   glyceraldehyde-­‐3-­‐phosphate	   dehydrogenase	   (GAPDH)	   and	   α-­‐Tubulin	   and	   then	  
normalized	   to	   the	   response	   to	  miR-­‐134,	  which	   is	   not	   predicted	   to	   bind	  Arc	  mRNA.	   (B)	   Change	   of	   LIMK1	  mRNA	  
levels	  determined	  by	  qRT-­‐PCR	  upon	  transient	  transfection	  of	  miRNAs	  expressed	  from	  pSuperior	   for	  3	  days.	  Data	  
were	   cross-­‐normalized	   to	  GAPDH	  and	  α-­‐Tubulin	   and	   then	  normalized	   to	   the	   response	   to	  miR-­‐19a,	  which	   is	   not	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3.2.4 Effects	  of	  miRNAs	  on	  luciferase	  reporters	  containing	  3’-­‐UTRs	  of	  dendritically	  localized	  
mRNAs	  
 
To	  test	  and	  quantify	  effects	  of	  candidate	  miRNAs	  on	  luciferase	  reporters	  fused	  to	  Arc	  or	  LIMK1	  3’-­‐
UTR,	   miRNAs	   were	   misregulated	   first	   in	   HeLa	   cells	   and	   then	   cortical	   neurons	   and	   their	   effects	   on	  
translation	  investigated.	  Here,	  the	  3’-­‐UTRs	  of	  Limk1	  and	  Arc	  were	  cloned	  into	  to	  the	  3’-­‐end	  of	  hRluc	   in	  
psiCHECK-­‐2	  by	  PCR-­‐amplification,	  restriction	  enzyme	  digest	  and	  ligation	  (Figure	  15).	  As	  controls	  that	  the	  
suggested	  miRNAs	   actually	   bind	   at	   the	   predicted	   sites,	   those	   binding	   sites	  were	  mutated	   (Table	   19).	  
Mutations	  within	   the	   seed	   sequence	  were	   introduced	  by	  modifying	   the	  plasmids	  with	   the	   Stratagene	  
Site-­‐Directed	  Mutagenesis	  Kit.	  For	  screening	  of	  colonies,	  a	  new	  restriction	  enzyme	  site	  was	  generated	  
through	  the	  mutated	  site.	  	  
All	  luciferase	  reporter	  plasmids	  generated	  for	  quantification	  of	  miRNA	  effects	  are	  summarized	  in	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Table	  19.	  Overview	  on	  the	  mutations	  that	  were	  introduced	  in	  the	  3’-­‐UTRs	  of	  LIMK1	  and	  Arc	   to	  destroy	  the	  seed	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Figure	  16	  shows	  the	  results	  of	  the	  luciferase	  assays	  in	  HeLa	  cells.	  In	  panel	  A,	  the	  control	  reporter	  
psiCHECK-­‐2	  without	  a	  3’-­‐UTR	  is	  shown	  to	  be	  unaffected	  by	  overexpression	  of	  various	  miRNAs.	  In	  panel	  
B,	  effects	  on	  a	   reporter	  under	   the	  control	  of	  Arc	  3’-­‐UTR	  are	  shown:	  compared	   to	  a	  scrambled	  miRNA	  
(normalized	  to	  0	  %	  change),	  especially	  transfection	  of	  duplex	  miRNAs,	  e.g.	  miR-­‐19a,	  miR-­‐19b,	  miR-­‐326,	  
and	  miR-­‐369,	   led	   to	  elevated	   luciferase	  activity	   levels.	  However,	   these	   results	  are	  opposite	   to	  what	   is	  
predicted,	  since	  overexpression	  of	  an	  interacting	  miRNA	  should	  lead	  to	  reduction	  of	  luciferase	  activity.	  
Panel	  C	  depicts	  the	  effects	  of	  overexpressed	  miRNAs	  on	  a	  LIMK1	  3’-­‐UTR	  containing	  luciferase	  reporter.	  
Here,	  effects	  were	  very	  subtle.	  While	  miR-­‐134	  again	  did	  not	  cause	  a	  significant	  effect,	  elevated	  miR-­‐369	  
levels	   led	   to	  a	  small,	  but	  significant	   increase	   in	   luciferase	   levels.	  Again,	   the	  directionality	  of	   the	  effect	  
was	  opposite	  of	  what	  is	  expected.	  	  
 
Figure	  17	  displays	  similar	  experiments	  as	  Figure	  16,	  but	  carried	  out	  in	  cortical	  neurons.	  While	  in	  
panel	  A	   the	  Arc	   3’-­‐UTR	   luciferase	   reporter	  was	  negatively	   affected	  by	  elevated	  miR-­‐19a	  and	  miR-­‐326	  
levels	  when	  compared	  to	  a	  scrambled	  miRNA	  (normalized	  to	  0	  %	  change),	  also	  transfection	  of	  the	  empty	  
pSuperior	  plasmid	   led	   to	  a	   similar	  effect.	   In	  panel	  B,	   cortical	  neurons	  were	   transfected	  with	  2’-­‐O-­‐Me-­‐
oligos	   to	   inhibit	   the	   action	   of	   their	   complementary	   miRNA.	   The	   LIMK1	   3’-­‐UTR	   containing	   luciferase	  
reporter	  was	  only	  affected	  to	  a	  non-­‐significant	  extend	  by	  inhibition	  of	  miR-­‐369,	  but	  not	  of	  miR-­‐134.	  The	  
Arc	   3’-­‐UTR	   luciferase	   reporter	   was	   positively	   affected,	   albeit	   also	   in	   a	   non-­‐significant	   manner,	   by	  






























































































B psiCHECK-2 Arc 3’-UTR reporter in HeLa cells
C psiCHECK-2 LIMK1 3’-UTR reporter in HeLa cells






















































































































Figure	   16.	   Response	   of	   Arc	   and	   LIMK1	   3’-­‐UTR	   luciferase	   reporters	   to	   elevated	   miRNA	   levels	   in	   HeLa	   cells.	  
Elevation	  of	  miRNA	  levels	  was	  either	  achieved	  by	  transfection	  of	  miRNA-­‐expressing	  pSuperior	  or	  pcDNA3.1	  vectors	  
or	   alternatively	   via	   transfection	   of	   duplex	   miRNAs.	   Data	   are	   expressed	   as	   change	   of	   activity	   levels	   of	   Renilla	  
luciferase	  relative	  to	  Firefly	   luciferase,	  which	  were	  normalized	  to	  expression	  of	  a	  non-­‐targeting	  scramble	  miRNA,	  
both	  expressed	   from	  pSuperior	   and	   transfected	   as	  duplex.	   (A)	  Activity	   levels	   of	   the	   control	   plasmid	  psiCHECK-­‐2	  
were	  not	  significantly	  affected	  by	  elevated	  miRNA	  levels.	  (B)	  Activity	  of	  luciferase	  under	  the	  control	  of	  the	  Arc	  3’-­‐
UTR	  was	  positively	  affected	  by	  addition	  of	  duplex	  miRNAs.	  (C)	  Effects	  on	  luciferase	  reporters	  under	  the	  control	  of	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A psiCHECK-2 Arc 3’-UTR reporter in cortical neurons











































Figure	  17.	  Response	  of	  Arc	  and	  LIMK1	  3’-­‐UTR	  luciferase	  reporters	  to	  elevated	  or	  reduced	  miRNA	  levels	  in	  cortical	  
neurons.	  (A)	  Elevation	  of	  miRNA	  levels	  was	  either	  achieved	  by	  transfection	  of	  miRNA-­‐expressing	  pSuperior	  vector	  
or	  via	  transfection	  of	  duplex	  miRNAs.	  Data	  are	  expressed	  as	  change	  of	  activity	  levels	  of	  Renilla	  luciferase	  relative	  to	  
Firefly	   luciferase,	  which	  were	  normalized	  to	  expression	  of	  a	  non-­‐targeting	  scramble	  miRNA,	  both	  expressed	  from	  
pSuperior	   and	   transfected	   as	   duplex.	   Activity	   of	   luciferase	   under	   the	   control	   of	   the	  Arc	   3’-­‐UTR	   was	   negatively	  
affected	  by	  addition	  of	  miRNAs.	  (B)	  Reduction	  of	  miRNA	  levels	  was	  achieved	  by	  transient	  transfection	  of	  2’-­‐O-­‐Me	  
oligos.	  Data	  are	  expressed	  as	  change	  of	  activity	  levels	  of	  Renilla	  luciferase	  relative	  to	  Firefly	  luciferase,	  which	  were	  
normalized	  to	  a	  control	  reporter	  (psiCHECK-­‐2	  without	  3’-­‐UTR)	  and	  a	  control	  effector	  (non-­‐targeting	  scramble	  2’-­‐O-­‐
Me	  oligos).	  The	  luciferase	  reporters	  under	  the	  control	  of	  LIMK1	  3’-­‐UTR	  were	  only	  affected	  by	  inhibition	  of	  miR-­‐369,	  
while	  those	  under	  the	  control	  of	  Arc	  3’-­‐UTR	  were	  only	  affected	  by	  inhibition	  of	  miR-­‐19a.	  EV:	  empty	  vector.	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3.2.5 Generation	  of	  a	  GFP-­‐reporter	  system	  for	  monitoring	  translational	  effects	  
 
My	  interest	  in	  miRNAs	  mainly	  derived	  from	  their	  potential	  role	  in	  regulation	  during	  transport	  and	  
local	  relieve	  of	  repression.	  Therefore,	  I	  did	  not	  only	  want	  to	  quantify	  effects	  of	  miRNAs	  on	  mRNAs	  in	  a	  
whole-­‐cell	  approach,	  but	  I	  wanted	  to	  visualize	  these	  effects	  in	  subcellular	  compartments.	  To	  achieve	  this	  
goal,	   I	  adapted	  a	  GFP	  reporter	  system	  (Aakalu,	  2001;	  Meister	  et	  al.,	  2004;	  Schratt	  et	  al.,	  2006),	  where	  
expression	  of	  EGFP	  is	  under	  control	  of	  either	  isolated	  miRNA-­‐binding	  sites	  or	  alternatively,	  a	  complete	  
3’-­‐UTR	  containing	  miRNA-­‐binding	  sites.	  Generation	  of	  the	  GFP	  reporter	  system	  was	  done	  in	  subsequent	  
cloning	  steps	  (Figure	  18).	  First,	  I	  fused	  a	  myristoylation	  site	  to	  the	  N-­‐terminus	  of	  the	  EGFP	  sequence	  in	  
the	  Clontech	  pEGFP-­‐C2	  vector	  by	  ligating	  annealed	  oligos	  carrying	  the	  myristoylation	  site	  into	  a	  pEGFP-­‐
C2	  plasmid.	  This	  post-­‐translational	  modification	  tags	  the	  protein	  to	  the	  cell	  membrane,	  as	  can	  be	  seen	  in	  
the	  inset	  in	  the	  left	  upper	  corner	  in	  Figure	  19.	  The	  resulting	  plasmid	  pmyrEGFP-­‐C2	  was	  already	  used	  for	  
cloning	  3’-­‐UTRs	  to	  the	  EGFP	  gene	  by	  sub-­‐cloning	  the	  insert	  from	  pGEM-­‐T	  carrying	  the	  desired	  insert	  of	  
Limk1	  or	  Arc	  3’-­‐UTR	  (Figure	  20).	  
For	   future	   experiments,	   I	   generated	   plasmids	   where	   I	   replaced	   the	   C-­‐terminus	   of	   the	   EGFP	  
sequence	  in	  the	  pmyrEGFP-­‐C2	  with	  a	  sequence	  from	  a	  destabilized	  form	  of	  EGFP	  (Figure	  18).	  I	  used	  two	  
different	  forms	  of	  the	  destabilized	  EGFP,	  one	  termed	  d1EGFP,	  which	  has	  a	  half-­‐live	  of	  1	  hour,	  and	  one	  
termed	   d2EGFP,	   which	   has	   a	   half-­‐live	   of	   2	   hours.	   The	   pmyrEGFP-­‐C2	   vector	   was	  modified	   to	   express	  
myrd1EGFP	  by	  first	  changing	  the	  multiple	  cloning	  site	  (MCS)	  of	  the	  plasmid	  to	  carry	  also	  a	  NotI	  site.	  This	  
site	  was	  then	  used	  to	  replace	  EGFP	  with	  d1EGFP	  or	  d2EGFP.	  The	  resulting	  pmyrd1EGFP-­‐C2	  was	  the	  final	  
vector	   used	   as	   reporter	   with	   3’-­‐UTRs	   of	   LIMK1	   and	   Arc (Figure	   20).	   The	   efficiency	   of	   these	  
destabilization	   elements	   can	   be	   seen	   in	   Figure	   19	   in	   the	   left	   column.	   Compared	   to	   red	   fluoresecent	  
protein	   (RFP)	   levels,	  which	   served	  as	   transfection	   control	   and	   can	  be	   seen	   in	   the	   center	   column,	  GFP	  
levels	  were	  drastically	  reduced	  in	  the	  d1	  and	  d2	  forms.	  	  	  
Mutations	   in	   the	   miRNA-­‐binding	   sites	   were	   introduced	   as	   described	   above	   for	   the	   luciferase	  
reporter	  plasmids	  (Table	  19).	  All	  constructs	  that	  were	  generated	  to	  be	  used	  as	  GFP	  reporters	  for	  miRNA	  
action	  are	  summarized	  in	  Tables	  20	  to	  23.	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Figure	   19.	   Expression	   of	   destabilized	   EGFP	   in	   hippocampal	   neurons.	  The	   original	   plasmid	   pEGFP-­‐C2	   (Clontech)	  
was	   modified	   by	   the	   insertion	   of	   a	   myristoylation	   site	   (N-­‐terminal)	   to	   attach	   the	   expressed	   EGFP	   to	   the	   cell	  
membrane.	   In	   a	   second	   cloning	   step,	   the	   C-­‐terminus	   of	   EGFP	  was	  modified	   to	   obtain	   destabilized	  myrd1-­‐	   and	  
myrd2-­‐EGFP.	  The	   two	   forms	  have	  different	  half-­‐lives	  of	  1	  hr	   (d1)	  or	  2	  hrs	   (d2)	   in	   the	  cell.	  Hippocampal	  neurons	  
were	  transiently	  transfected	  and	  incubated	  for	  expression	  overnight.	  An	  RFP	  plasmid	  was	  co-­‐transfected	  and	  RFP	  
expression	  used	  as	  transfection	  control.	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Figure	  20.	  Cloning	  strategy	  for	  the	  generation	  of	  the	  pmyrEGFP	  and	  pmyrd1EGFP-­‐C2	  plasmids	  containing	  LIMK1	  or	  
Arc	  3’-­‐UTR.	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3.2.6 Effects	  of	  endogenous	  miRNAs	  on	  GFP	  reporters	  containing	  3’-­‐UTRs	  of	  dendritically	  
localized	  mRNAs	  
 
I	  first	  used	  the	  EGFP	  reporters	  to	  test	  the	  effects	  of	  endogenous	  miRNAs	  on	  myrEGFP	  LIMK1	  3’-­‐
UTR	  reporters.	   I	   therefore	  generated	  different	  mutations	  of	   the	  predicted	  miRNA-­‐binding	  sites.	  Those	  
mutated	   constructs	   used	   for	   these	   experiments	   are	   summarized	   in	   Figure	   21A.	   Panel	   B	   shows	  
representative	  images	  of	  HeLa	  cells	  transfected	  with	  the	  myrEGFP-­‐containing	  plasmids	  with	  and	  without	  
LIMK1	  3’-­‐UTR,	  and	  LIMK1	  3’-­‐UTR	  carrying	  mutations.	  In	  panel	  C,	  the	  fluorescence	  intensities	  as	  shown	  in	  
panel	  B,	  were	  quantified.	  All	  effects	  observed	  were	  rather	  subtle.	  When	  miR-­‐134	  interaction	  with	  LIMK1	  
3’-­‐UTR	  is	  interrupted	  by	  mutation1	  (Schratt	  et	  al.,	  2006),	  fluorescence	  intensity	  was	  elevated,	  which	  was	  
not	   the	   case	   for	   mutation2.	   Mutation	   of	   the	   miR-­‐369-­‐binding	   site	   in	   the	   LIMK1	   3’-­‐UTR	   also	   led	   to	  
elevated	  fluorescence	  levels,	  indicating	  relieve	  of	  repression.	  	  
Representative	  images	  for	  the	  same	  type	  of	  experiment	  but	  performed	  in	  cultured	  hippocampal	  
neurons	  are	  shown	  in	  Figure	  22.	  LIMK1	  3’-­‐UTR	  carrying	  mutation1	  in	  the	  miR-­‐134-­‐binding	  site	  seemed	  
to	  show	  elevated	  fluorescence	  levels,	  but	  differences	  were	  not	  significant	  (data	  not	  shown).	  	  
 
3.2.7 Effects	  of	  overexpressed	  miRNAs	  on	  endogenous	  protein	  levels	  of	  potential	  targets	  
and	  on	  GFP	  reporters	  containing	  3’-­‐UTRs	  of	  dendritically	  localized	  mRNAs	  
 
Since	   overexpression	   of	   EGFP-­‐reporters	   produce	   high	   amounts	   of	   potential	   targets	   for	  
endogenous	  miRNAs,	  I	  also	  tested	  whether	  overexpression	  of	  miR-­‐134	  would	  affect	  the	  EGFP	  reporters	  
in	  cultured	  hippocampal	  neurons.	  Figure	  23A	  shows	  representative	  images	  of	  cells	  co-­‐transfected	  with	  
EGFP	  LIMK1	  3’-­‐UTR	  reporter	  and	  miR-­‐134	  overexpressed	  from	  the	  pSuper	  plasmid.	  These	  images	  have	  
not	   been	   quantified,	   but	   show	   a	   slight	   reduction	   in	   EGFP	   levels	   upon	   overexpression	   of	  miR-­‐134.	   In	  
panel	  B,	  a	  representative	  image	  of	  a	  neuron	  co-­‐transfected	  with	  pSuper	  expressing	  miR-­‐134	  and	  RFP	  as	  
transfection	   control	   is	   shown.	   Fluorescence	   levels	   from	   LIMK1	   immunostaining	   were	   equal	   in	   the	  
transfected	  cell	  (marked	  with	  an	  asterisk)	  and	  the	  untransfected	  cell	  directly	  below	  it.	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Figure	  21.	  Effects	  of	  endogenous	  miRNAs	  on	  the	  expression	  levels	  of	  myrEGFP	  in	  HeLa	  cells.	  (A)	  Overview	  on	  the	  
mutations	  on	  miRNA-­‐binding	  sites	  used	  in	  the	  experiment.	  (B)	  Representative	  images	  of	  HeLa	  cells	  expressing	  the	  
pmyrEGFP	  reporters	  (upper	  row)	  together	  with	  a	  transfection	  control	  (RFP,	  second	  row).	  (C)	  Quantification	  of	  the	  
fluorescence	  of	  HeLa	  cells	  transfected	  with	  the	  pmyrEGFP	  constructs	  under	  the	  control	  of	  LIMK1	  3’-­‐UTR	  with	  and	  
without	  mutations	  in	  predicted	  miRNA-­‐binding	  sites.	  	  













































































































Figure	  22.	  Effects	  of	  endogenous	  miRNAs	  on	  the	  expression	  levels	  of	  myrEGFP	  in	  hippocampal	  neurons.	  
Representative	  images	  of	  hippocampal	  neurons	  expressing	  the	  pmyrEGFP	  reporters	  (left	  column)	  together	  with	  a	  


































































































Figure	   23.	   Effects	   of	   overexpressed	  miR-­‐134	   on	   the	   levels	   of	   endogenous	   LIMK1	   and	   on	  myrEGFP	   under	   the	  
control	  of	  LIMK1	  3’-­‐UTR	  in	  hippocampal	  neurons.	  (A)	  Representative	  images	  of	  hippocampal	  neurons	  expressing	  
the	   pmyrEGFP	   reporters	   (left	   column)	   together	   with	   a	   transfection	   control	   (RFP,	   right	   column).	   The	   cell	   in	   the	  
second	   row	   was	   co-­‐transfected	   with	   pSuper	   expressing	   miR-­‐134.	   (B)	   Representative	   images	   of	   hippocampal	  
neurons	   transfected	  with	  pSuper	  expressing	  miR-­‐134	  and	   immunostained	   for	  LIMK1	   (left	   side).	  RFP	  was	  used	  as	  
transfection	  control	  (right	  side).	  
Results	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3.2.8 Conclusions	  from	  observed	  effects	  of	  candidate	  miRNAs	  on	  dendritically	  localized	  
mRNAs	  	  
 
Table	  24	  summarizes	  the	  results	  of	  the	  experiments,	  which	  were	  performed	  to	  establish	  assays	  to	  
test	  for	  miRNA	  regulation	  of	  dendritically	  localized	  mRNAs.	  Experiments	  were	  performed	  for	  candidate	  
miRNAs	  potentially	  interacting	  with	  Arc	  and	  LIMK1	  mRNAs.	  While	  my	  results	  could	  not	  consistently	  re-­‐
confirm	   miR-­‐134	   as	   a	   regulator	   of	   LIMK1	   3’-­‐UTR,	   based	   on	   the	   fluorescence	   levels	   observed	   after	  
mutation	  of	  the	  binding	  site,	  miR-­‐369-­‐3p	  could	  serve	  as	  a	  regulator	  of	  LIMK1	  3’-­‐UTR.	  However,	  the	  most	  
likely	  candidate	  of	  the	  investigated	  miRNAs	  to	  be	  a	  regulator	  of	  LIMK1	  or	  Arc	  mRNAs	  is	  miR-­‐19a,	  which	  
showed	   effects	   both	   on	   endogenous	  mRNA	   levels,	   and	   in	   luciferae	   assays	   in	   cortical	   neurons.	   These	  
results	  will	  have	  to	  be	  strengthened	  by	  future	  experiments.	  	  
 
Table	  24.	   Summary	  of	   the	   results	  obtained	   for	  miRNA-­‐dependent	   regulation	  of	   the	  dendritically	   localized	  Arc	  
and	  LIMK1	  mRNAs.	  N.s.,	  not	  significant.	  OE,	  overexpression.	  Where	  no	  result	  is	  mentioned,	  experiments	  have	  not	  
been	  carried	  out	  so	  far.	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The	  double-­‐stranded	  RNA-­‐binding	  protein	  Staufen	  (Stau)	  has	  a	  crucial	  role	  in	  localizing	  RNAs,	  e.g.	  
bicoid,	   oskar	   and	   prospero,	   in	   Drosophila	   (reviewed	   in	   St	   Johnston,	   2005).	   This	   has	   dramatic	  
consequences	   for	   establishing	   the	   antero-­‐posterior	   body	   axis.	   In	   mammalian	   cells,	   two	   isoforms	   are	  
expressed,	   of	   which	   Stau1	   is	   expressed	   in	   most	   cell	   types,	   while	   Stau2	   is	   highly	   enriched	   in	   brain	  
(Wickham,	  1999;	  Duchaine	  et	  al.,	  2002).	  Previous	  data	  from	  our	  lab	  showed	  that	  Stau2	  localizes	  within	  
RNPs	   in	   the	   somatodendritic	   compartment	   in	   cultured	   hippocampal	   neurons	   (Goetze	   et	   al.,	   2006).	  
Additionally,	  they	  observed	  that	  upon	  Stau2	  knockdown	  in	  mature	  neurons,	  the	  actin	  cytoskeleton	  was	  
significantly	  affected,	  and	  that	  β-­‐actin	  mRNA	  levels	  were	  reduced.	  Besides	  that,	  no	  mRNA-­‐interactors	  of	  
Stau2	  had	  been	   identified	   in	  mammalian	  cells.	  However,	  microarray	   lists	  of	  potential	  target	  mRNAs	  of	  
Stau2	  have	  been	  recently	  published	  (Maher-­‐Laporte	  and	  DesGroseillers,	  2010).	   In	  parallel,	  our	   lab	  has	  
performed	  microarrays	   as	  well	   as	   deep-­‐sequencing	   experiments	   from	  Stau2	   immunoprecipitation	   (IP)	  
samples,	  to	  identify	  mRNA	  interactors	  of	  Stau2	  (Konecna,	  Karra,	  unpublished	  data).	  These	  are	  currently	  
being	  validated	  (Heraud,	  Doyle,	  unpublished	  data).	  Furthermore	  our	  lab	  is	  intensively	  investigating	  the	  
protein	   composition	   of	   Stau2-­‐containing	   particles	   by	   isolating	   them	   via	   IP	   and	   analysis	   with	   mass	  
spectrometry	  (Härtel,	  Karra,	  unpublished).	  Preliminary	  data	  in	  the	  lab	  have	  shown	  that	  Stau2	  leads	  to	  an	  
axon	   outgrowth	   defect	   and	   also	   affects	   β-­‐actin	   mRNA	   stability	   in	   developing	   neurons	   (Xie,	   Lenek,	  
unpublished	  data).	   It	  was,	  however,	  not	  clear	  whether:	   i)	   this	   is	  a	  direct	  effect	  of	  Stau2	  protein	  on	  β-­‐
actin	  mRNA	  or	  other	  unknown	  Stau2	  targets	  and	  ii)	  whether	  this	  effect	  only	  occurs	  on	  the	  mRNA	  level	  or	  
whether	   there	   are	   additional	   Stau2-­‐mediated	   translational	   effects.	   Also	   no	   clear	   link	   between	   the	  β-­‐
actin	   mRNA	   stability	   effect	   and	   the	   axon	   outgrowth	   defect	   has	   been	   shown	   so	   far,	   although	   it	   is	  
tempting	  to	  speculate	  that	  it	  might	  exist.	  	  
This	  project	  pursued	  several	  goals.	  I	  first	  wanted	  to	  investigate	  the	  expression	  and	  localization	  of	  
Stau2	  during	  development	  of	  cultured	  hippocampal	  neurons.	  Second,	  I	  wanted	  to	  observe	  the	  effects	  of	  
disassembly	  of	  cytoskeleton	  elements	  on	  Stau2	   localization	  as	  well	  as	  effects	  of	  Stau2	  on	  cytoskeletal	  
components.	   The	   third	   and	   most	   important	   aim	   was	   to	   investigate	   potential	   translational	   effects	   of	  
Stau2	  on	  candidate	  target	  mRNAs.	  The	  target	  candidates	  were	  on	  one	  side β-­‐actin	  mRNA	  and	  one	  of	  the	  
identified	  targets	  from	  the	  microarray	  experiments,	  RhoA	  mRNA.	   I	  was	   interested	  to	  validate	  whether	  
the	  observed	  effects	  on	   the	  actin	   cytoskeleton	  previously	  observed	   in	  mature	  neurons	   (Goetze	  et	  al.,	  
































































Figure	  24.	  Stau2	  expression	  and	  localization	  during	  neuronal	  development.	  Stau2	  is	  expressed	  at	  all	  5	  stages	  of	  
development	   of	   cultured	   hippocampal	   neurons	   (Dotti	   et	   al.,	   1988).	   Left	   images	   show	   a	   merge	   of	   Stau2-­‐
immunostaining	   (green),	   Tubulin-­‐immunostaining	   (blue),	   and	   Phallodin-­‐staining	   of	   F-­‐actin	   (red).	   Images	   on	   the	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3.3.2 Staufen2	  expression	  and	  localization	  in	  the	  5	  stages	  of	  neuronal	  development	  
 
While	  Stau1	  is	  expressed	  in	  most	  cell	  types,	  Stau2	  is	  enriched	  in	  neuronal	  cells.	  Figure	  24	  shows	  
that	  Stau2	  is	  expressed	  at	  all	  stages	  of	  neuronal	  development,	  from	  young,	  still	  round	  cells	  at	  stage	  1	  to	  
mature	  neurons	  with	  dendritic	  spines	  and	  synaptic	  contacts	  at	  stage	  5.	  Co-­‐immunostaining	  of	  Stau2	  with	  
anti	  α-­‐Tubulin	  and	  Phallodin	  staining	  for	  filamentous	  actin	  (F-­‐actin)	  indicated	  that	  Stau2	  localizes	  to	  all	  
neurites	   in	  developing	  neurons.	  Here,	   it	  was	  even	  detected	   in	  growth	  cones	   (Xie	  and	  Schoderböck,	   in	  
preparation).	  Representative	  images	  of	  cultured	  hippocampal	  neurons	  at	  stage	  3	  (Figure	  25)	  indicate	  that	  





































Figure	  25.	  Stau2	  is	  expressed	  in	  axons	  and	  dendrites	  of	  hippocampal	  neurons.	  (A)	  Stau2	  immunostaining	  (green)	  
overlaps	  with	  the	  dendritic	  marker	  MAP2	  (red)	  in	  the	  merged,	  upper	  image.	  In	  the	  image	  below,	  an	  inversed	  Stau2	  
immunostaining	  is	  shown.	  (B)	  Stau2	  immunostaining	  (green)	  also	  overlaps	  with	  the	  axon	  marker	  Tau	  (red)	  in	  the	  
merged,	  upper	  image.	  In	  the	  image	  below,	  an	  inversed	  Stau2	  immunostaining	  is	  shown.	  
Results	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3.3.3 Staufen2	  localization	  depends	  on	  an	  intact	  cytoskeleton	  
 
Stau2	  is	  expressed	  in	  all	  developmental	  stages	  of	  cultured	  hippocampal	  neurons	  and	  localized	  to	  
growth	   cones.	   I	   was	   interested	   whether	   this	   localization	   pattern	   would	   change	   upon	   disruption	   of	  
certain	   cytoskeleton	   components.	  Neurons	   that	  were	   treated	  with	   Latrunculin	  A	   to	  depolymerize	   the	  
actin	  cytoskeleton	  (Figure	  26)	  were	  still	  Stau2-­‐positive	  in	  all	  neurites	  without	  obvious	  alterations	  in	  the	  
staining	   pattern,	   but	   growth	   cones	   were	   missing	   as	   expected.	   Depolymerization	   of	   the	   microtubule	  
cytoskeleton	  with	  Colchicine	  (Figure	  26)	  on	  the	  other	  hand	  led	  to	  large	  Stau2	  aggregates	  approximately	  
in	   the	  middle	  of	   the	  outgrowing	  neurites.	  These	   results	   show	   that	   the	  correct	   localization	  of	  Stau2	   in	  































































































































Figure	   26.	   Stau2	   localization	   depends	   on	   an	   intact	   cytoskeleton.	   Stau2	   localization	   relative	   to	   cytoskeleton	  
components	  after	  depolymerization	  of	  either	  the	  actin	  cytoskeleton	  (Latrunculin	  A	  treatment)	  or	  the	  microtubule	  
cytoskeleton	   (Colchicine	   treatment).	   Left	   images	   show	   a	   merge	   of	   Stau2-­‐immunostaining	   (green),	   Tubulin-­‐
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3.3.4 Staufen2	  knockdown	  influences	  cytoskeleton	  components	  	  
 
Our	  lab	  has	  previously	  shown	  that	  knockdown	  of	  Stau2	  leads	  to	  reduced	  β-­‐actin	  mRNA	  levels	   in	  
developing	   and	   mature	   neurons,	   as	   well	   as	   altered	   F-­‐Actin	   patterns	   (Goetze	   et	   al.,	   2006)(Xie,	  
unpublished	  data).	   In	  Figure	  28,	  developing	  hippocampal	  neurons,	  which	  were	   transiently	   transfected	  
with	  sh-­‐Stau2	  plasmids	  were	  Phalloidin-­‐stained	  for	  F-­‐Actin	  and	  immunostained	  for	  RhoA.	  While	  F-­‐Actin	  
was	   significantly	   affected,	   and	   Stau2-­‐depleted	   neurons	   showed	   strongly	   reduced	   Phalloidin-­‐staining,	  
effects	  on	  RhoA	   immunostaining	  were	  very	  mild.	   Endogenous	  RhoA	  protein	  was	   reduced	   in	   some	  sh-­‐
treated	   cells,	   but	   this	   result	   was	   not	   significant.	   The	   antibody	   staining	   was	   weak,	   as	   the	   available	  
antibody	  did	  not	  yield	  strong	  signal	  in	  rat	  neurons.	  To	  still	  be	  able	  to	  image	  effects	  of	  Stau2	  knockdown	  
on	   RhoA	   in	   neurons,	   I	   generated	   a	   plasmid	   overexpressing	   EGFP-­‐RhoA	   (Figure	   27).	   Therefore	   I	   PCR-­‐
amplified	  the	  coding	  sequence	  of	  rat	  RhoA	  coding	  sequence	  and	  ligated	  it	   into	  pGEM-­‐T,	  from	  where	  it	  
was	  sub-­‐cloned	  into	  pEGFP-­‐C2	  by	  digestion	  with	  BglII	  and	  SacII.	  	  	  
	  
 
Figure	  27.	  Cloning	  strategy	  for	  the	  generation	  of	  pEGFP-­‐RhoA.	  
 
	  	  	  
 
 
EGFP-­‐RhoA	  was	   co-­‐transfected	  with	   a	   plasmid	   expressing	   sh-­‐Stau2	   in	  mature	   neurons.	   In	   contrast	   to	  
other	  experiments	  in	  this	  thesis,	  where	  pSuperior+GFP	  was	  used,	  here	  pSuper	  without	  the	  GFP	  ORF	  was	  
used	  to	  be	  able	  to	  observe	  effects	  on	  the	  EGFP-­‐RhoA	  fusion	  protein.	  EGFP-­‐RhoA	  was	  highly	  increased	  in	  
cells	  with	  reduced	  Stau2	  levels	  (Figure	  29).	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Figure	  28. Stau2	  knockdown	  affects	  the	  cytoskeleton.	  Representative	  images	  of	  cells	  transfected	  with	  pSuperior	  
expressing	   either	   mis-­‐Stau2	   or	   sh-­‐Stau2	   were	   marked	   by	   expression	   of	   GFP	   (green,	   left	   column).	   F-­‐Actin	   (red,	  
center	  column)	  was	  stained	  via	  Phalloidin,	  and	  RhoA	  (white,	  right	  column)	  was	  immunostained	  with	  an	  anti-­‐RhoA	  
antibody.	  Asterisks	  mark	  transfected	  cells.	  (A)	  In	  the	  control	  condition,	  cells	  expressing	  mis-­‐Stau2	  were	  not	  distinct	  
from	   untransfected	   cells	   in	   the	   pattern	   and	   intensity	   of	   F-­‐actin	   and	   in	   RhoA	   immunostainings.	   (B)	   In	   Stau2	  
knockdown,	   cells	   expressing	   sh-­‐Stau2	   showed	   reduced	   Phalloidin	   staining	   while	   the	   intensity	   of	   RhoA	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Stau2-HA 0.30 0.18 
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Figure	  29. Stau2	  negatively	  regulates	  overexpression	  of	  RhoA.	  (A)	  Representative	  images	  of	  cells	  co-­‐transfected	  
with	  pSuper	  expressing	  either	  mis-­‐Stau2	  or	  sh-­‐Stau2	  and	  EGFP-­‐RhoA.	   Images	  show	  EGFP-­‐RhoA	   fluorescence.	   (B)	  
Preliminary	  quantification	  (1	  experiment)	  of	  EGFP-­‐RhoA	  fluorescence	  after	  overexpression	  or	  knockdown	  of	  Stau2.	  
Stau2-­‐HA	  overexpression	  led	  to	  reduced	  EGFP-­‐RhoA	  fluorescence,	  while	  knockdown	  of	  Stau2	  resulted	  in	  elevated	  
levels	  of	  EGFP-­‐RhoA	  fluorescence	  (quantification	  with	  ImageJ).	  
Results	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To	  be	  able	  to	  visualize	  effects	  on	  the	  actin	  cytoskeleton	  on	  a	  broader	  level,	  I	  utilized	  EGFP	  fused	  to	  
mouse	   talin,	   which	   is	   a	   well-­‐studied	   interactor	   of	   the	   actin	   cytoskeleton.	   It	   binds	   to	   the	   actin-­‐
cytoskeleton	   without	   interfering	   with	   the	   function	   of	   actin	   (Kost,	   1998).	   To	   generate	   the	   plasmid	  
expressing	  EGFP-­‐talin,	  I	  cut	  the	  coding	  sequence	  of	  mouse	  talin	  by	  restriction	  digest	  from	  a	  plasmid	  that	  
had	  been	  previously	  used	   in	   the	   lab.	   I	   subcloned	   it	  via	  pBSIIKS+	   into	  pEGFP-­‐C2	   (in	   frame),	   the	  cloning	  
strategy	  is	  depicted	  in	  Figure	  30.	  	  	  	  
	  
 




In	   my	   experiment	   I	   co-­‐transfected	   EGFP-­‐talin	   with	   the	   above	   mentioned	   pSuper	   plasmid	  
expressing	  sh-­‐Stau2.	  In	  mature	  hippocampal	  neurons,	  EGFP-­‐talin	  was	  not	  significantly	  affected	  by	  Stau2	  














































Figure	   31. Stau2	   has	   no	   effect	   on	   EGFP-­‐talin	   expression.	   Representative	   images	   of	   cells	   co-­‐transfected	   with	  




Lucia	  Schoderböck	   	   91	  	   	  
3.3.5 Staufen2	  knockdown	  reduces	  the	  levels	  of	  different	  protein	  factors	  in	  developing	  
neurons	  
 
Besides	   imaging	   the	   effects	   of	   Stau2	   on	   cytoskeletal	   components,	   I	   investigated	   the	   effects	   of	  
Stau2	  knockdown	  on	  the	  endogenous	  protein	  levels	  of	  β-­‐Actin,	  RhoA	  and	  the	  RISC	  component	  Moloney	  
leukemia	  virus	  10	  homolog	   (Mov10),	  an	  RNA	  helicase	   that	  plays	  an	   important	   role	   in	  synaptic	  protein	  
translation	   in	   Drosophila	   (Kunes	   paper	   2006).	   Cortical	   neurons	   were	   nucleofected	   with	   plasmids	  
expressing	  either	  a	  mismatch	  hairpin	  or	  a	  short	  hairpin	  targeting	  Stau2	  and	  then	  incubated	  for	  3	  days.	  
Western	   blotting	   and	   decoration	   with	   specific	   antibodies	   revealed	   the	   interesting	   fact	   that	   all	   three	  
proteins	  were	  significantly	  reduced	  in	  Stau2	  deficient	  neurons	  (Figure	  32).	  While	  the	  antibodies	  against	  
Stau2	  and	  β-­‐Actin	  work	  very	  well	  for	  Western	  blots,	  those	  used	  for	  decoration	  of	  RhoA	  and	  Mov10	  are	  
on	   the	  border	  of	  detection	   limits.	  The	  experiment	  had	  already	  been	  optimized	  but	  would	   still	  benefit	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Figure	  32.	  Stau2	  knockdown	  results	  in	  reduced	  levels	  of	  endogenous	  β-­‐Actin,	  RhoA	  and	  Mov10	  protein.	  Western	  
blot	   experiment	   showing	   lysates	   from	   cortical	   neurons	   that	   are	   deficient	   for	   Stau2.	   Vinculin	   (Vnc)	   -­‐	   a	   loading	  
control	  -­‐	  is	  detected	  close	  to	  the	  130	  kDa	  band	  of	  the	  molecular	  weight	  marker,	  Mov10	  close	  to	  the	  100	  kDa	  band,	  
Stau2	  isoforms	  between	  the	  50	  and	  70	  kDa	  bands,	  β-­‐Actin	  close	  to	  the	  40	  kDa	  band,	  and	  RhoA	  close	  to	  the	  25	  kDa	  
band.	  (A)	  Detection	  of	  Vnc,	  Mov10,	  Stau2	  and	  β-­‐Actin	  on	  a	  Western	  blot	  membrane	  from	  an	  8	  %	  SDS	  gel.	  Lane	  1:	  
extract	  from	  cells	  expressing	  an	  sh-­‐RNA	  directed	  against	  Stau2.	  Lane	  2:	  extract	  from	  cells	  expressing	  a	  mismatch-­‐
hairpin.	  (B)	  Detection	  of	  Vnc,	  Stau2,	  	  β-­‐Actin	  and	  RhoA	  on	  a	  Western	  blot	  membrane	  from	  a	  15	  %	  SDS	  gel.	  Lane	  1:	  
extract	  from	  cells	  expressing	  an	  sh-­‐RNA	  directed	  against	  Stau2.	  Lane	  2:	  extract	  from	  cells	  expressing	  a	  mismatch-­‐
hairpin.	   (C)	   Quantification	   of	  Western	   blots	   from	   Stau2	   knockdown	  with	   sh-­‐expressing	   plasmids.	  Quantification	  
was	   performed	  with	   ImageJ	   and	  normalized	   to	  Vnc	   levels	   (to	   account	   for	   loading	   inaccuracies)	   and	   the	  protein	  
levels	  in	  the	  mismatch-­‐control	  extract. 
Results	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3.3.6 Staufen2	  regulates	  β-­‐actin	  stability	  but	  not	  translation	  
 
Preliminary	  data	  from	  our	  lab	  indicate	  that	  Stau2	  may	  regulate	  the	  stability	  of	  β-­‐actin	  mRNA	  (Xie,	  
Lenek,	   Schoderböck,	   unpublished	   data).	   I	  was	   therefore	   interested	  whether	   Stau2	  would	   also	   have	   a	  
function	   in	   translational	   control	   of	   β-­‐actin.	   I	   employed	   luciferase	   assays	   to	   explore	   this	   question.	   I	  
generated	   luciferase	   reporters	  with	   different	  β-­‐Actin	   constructs	   fused	   to	   the	   3’-­‐UTR	   of	   the	   luciferase	  
gene,	   an	  overview	   is	   given	   in	  Figures	   33	   and	  34.	   The	  β-­‐actin	   constructs	  were	  PCR-­‐amplified	   from	   rat	  
brain	   or	   HeLa	   cell	   cDNA,	   respectively,	   ligated	   into	   pGEM-­‐T	   and	   then	   sub-­‐cloned	   into	   psiCHECK-­‐2	   as	  
shown	  in	  Figure	  35.	  
	  
 
Figure	  33.	  Overview	  on	  the	  constructs	  that	  were	  cloned	  for	  the	  investigation	  of	  human	  β-­‐actin	  mRNA	  in	  luciferase	  






Figure	   34.	  Overview	  on	   the	   constructs	   that	  were	   cloned	   for	   the	   investigation	   of	   rat	  β-­‐actin	  mRNA	   in	   luciferase	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Figure	  35.	  Cloning	  strategy	  for	  the	  generation	  of	  luciferase	  reporter	  plasmids	  containing	  β-­‐actin	  constructs.	  	  	  
 
 
In	  Stau2	  knockdown	  and	  overexpression	  experiments,	  I	  was	  able	  to	  show	  that	  luciferase	  reporters	  
that	   were	   mainly	   under	   the	   control	   of	   the	   coding	   sequence	   of	   β-­‐actin	   were	   affected	   by	   Stau2	  
misregulation	  (Figure	  36A	  and	  B).	  As	  this	  effect	  occured	  on	  the	  protein	  level,	  but	  underlying	  RNA	  effects	  
could	   not	   be	   excluded,	   I	   co-­‐transfected	   Stau2	   overexpression	   or	   knockdown	  plasmids	  with	   a	  β-­‐actin-­‐
coding	   sequence	   reporter	   into	   cortical	   neurons.	   After	   3	   days	   of	   expression,	   I	   isolated	   the	   RNA	   and	  
performed	   qRT-­‐PCR	   with	   primers	   against	   the	   Firefly	   and	   Renilla	   luciferase	  mRNA.	   As	   can	   be	   seen	   in	  
Figure	  36C,	  the	  coding-­‐sequence	  element	  was	  already	  sufficient	  to	  obtain	  effects	  on	  the	  RNA	  level.	  This	  














Figure	  36.	  (right	  side)	  Stau2	  appears	  to	  affect	  translation	  of	  β-­‐actin.	  (A	  and	  B)	  Data	  are	  expressed	  as	  change	  of	  
activity	  levels	  of	  Renilla	  luciferase	  relative	  to	  Firefly	  luciferase,	  all	  normalized	  to	  effects	  on	  the	  empty	  psiCHECK-­‐2	  
plasmid	  as	  control	  reporter.	  (A)	  Knockdown	  of	  Stau2	  was	  achieved	  by	  nucleofection	  of	  cortical	  neurons	  with	  an	  sh-­‐
Stau2	  expressing	  plasmid.	  As	  control,	  a	  mismatch-­‐expressing	  plasmid	  was	  used.	  After	  48	  hrs	  of	  expression	  of	  the	  
sh-­‐plasmids,	   luciferase	   reporters	   were	   transfected.	   24	   hrs	   later,	   luciferase	   assays	   were	   performed.	   Effects	   on	  
luciferase	   reporters	   under	   the	   control	   of	   human	   and	   rat	   β-­‐Actin	   sequences	   were	   determined.	   Data	   were	  
normalized	  to	  expression	  of	  a	  mismatch	  sh-­‐RNA.	  (B)	  Overexpression	  of	  Stau2	  was	  achieved	  by	  co-­‐nucleofection	  of	  
cortical	  neurons	  with	  an	  EGFP-­‐Stau2	  expressing	  plasmid	  and	   luciferase	   reporters,	  as	   control	  an	  EGFP	  expressing	  
plasmid	  was	  used.	  After	   24	  hrs	   of	   expression,	   luciferase	   assays	  were	  performed.	   Effects	   on	   luciferase	   reporters	  
under	   the	   control	   of	   rat	  β-­‐Actin	   sequences	  were	  determined.	  Data	  were	  normalized	   to	   expression	  of	   EGFP.	   (C)	  
Effects	   of	   Stau2	  overexpression	  or	   knockdown	  on	  RNA	   levels	   of	   the	   rat	  β-­‐actin	   coding	   sequence	   (cds)	   reporter.	  
Cortical	   neurons	   were	   co-­‐nucleofected	   with	   the	   effector	   (EGFP-­‐Stau2,	   sh-­‐Stau2,	   or	   mis-­‐Stau)	   plasmid	   and	   the	  
reporter	  plasmid	  (psiCHECK-­‐2	  rat	  β-­‐Actin	  cds).	  RNA	  was	  isolated	  after	  3	  days	  of	  expression,	  transcribed	  into	  cDNA	  
and	  quantified	  in	  qRT-­‐PCR.	  Renilla	  luciferase	  mRNA	  levels	  were	  normalized	  to	  Firefly	  luciferase	  mRNA	  levels	  and	  to	  
the	  effects	  of	  the	  mismatch	  plasmid. 
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In	  parallel,	  also	  the	  different	  isoforms	  of	  Stau2	  were	  tested	  to	  observe	  whether	  they	  show	  distinct	  
effects	  on	  luciferase	  reporters	  containing	  b-­‐Actin	  sequences.	  No	  significant	  differences	  between	  the	  62	  
kDa	   and	   the	   59	   kDa	   isoform	   were	   observed	   when	   they	   were	   overexpressed	   (data	   not	   shown).	   Also	  
constructs	   bearing	  mutations	   in	   Stau2	   (AMA,	   DRBD1,	   DRBD5DTBD,	   AMA-­‐IV	  mut	   NLS)	   (Macchi	   et	   al.,	  
2004)	  were	   tested	   for	   their	  effects	   in	   luciferase	  assays.	  All	  effects	  observed	  here	  were	   ranging	   from	  -­‐
20%	  to	  +20%	  without	  being	  significantly	  different	  (data	  not	  shown).	  However,	  those	  experiments	  with	  
the	  different	  isoforms	  and	  mutation	  constructs	  were	  only	  carried	  out	  for	  the	  human	  3’-­‐UTR	  reporter	  of	  
β-­‐Actin.	  Potentially	  effects	  could	  be	  seen	  on	  other	  reporters.	  	  	  
3.3.7 Staufen2	  regulation	  of	  β-­‐actin	  could	  be	  indirect	  via	  RhoA	  
 
Stau2	   is	   a	   double-­‐strand	   RNA	   binding	   protein	   that	   most	   likely	   interacts	   with	   more	   than	   one	  
mRNA.	  In	  Drosophila,	  at	  least	  three	  distinct	  mRNAs	  are	  being	  recognized,	  e.g.	  bicoid,	  oskar	  and	  prospero	  
RNAs.	  Besides	  β-­‐aenctin,	  I	  also	  wanted	  to	  test	  translational	  effects	  on	  RhoA.	  RhoA	  mRNA	  was	  identified	  
in	  microarray	   experiments	   as	   enriched	   in	   Stau2	   IPs	   (Heraud,	   Doyle,	   unpublished	   data).	   As	   RhoA	   is	   a	  
known	  regulator	  of	   the	  actin	  cytoskeleton	   (reviewed	   in	   (Van	  Aelst	  and	  D'Souza-­‐Schorey,	  1997)),	   I	  was	  
interested	  whether	  RhoA	  mRNA	  could	  be	  the	  functional	  link	  between	  Stau2	  and	  β-­‐Actin.	  	  
Since	   it	   became	   clear	   from	   in	   situ	   hybridization	   (ISH)	   experiments,	   that	   Septin7	   mRNA	   is	   not	  
changed	   upon	   Stau2	  misregulation	   (Mikl,	   Vendra,	   unpublished),	   I	   wanted	   to	   test	   this	  mRNA	   as	   well.	  
Again,	  the	  constructs	  were	  PCR-­‐amplified	  from	  rat	  brain	  cDNA,	  ligated	  into	  pGEM-­‐T	  and	  then	  subcloned	  
into	  psiCHECK-­‐2.	  Overview	  on	  the	  reporters	  generated	  are	  given	   in	  Figure	  37	  and	  38,	  and	  the	  cloning	  
strategy	  is	  depicted	  in	  Figure	  39.	  
	  
 
Figure	   37.	  Overview	   on	   the	   constructs	   that	   were	   cloned	   for	   the	   investigation	   of	   rat	   RhoA	   mRNA	   in	   luciferase	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Figure	  38.	  Overview	  on	   the	   constructs	   that	  were	   cloned	   for	   the	   investigation	  of	   rat	  Septin7	  mRNA	   in	   luciferase	  





Figure	  39.	  Cloning	  strategy	  for	  the	  generation	  of	  luciferase	  reporter	  plasmids	  containing	  RhoA	  constructs.	  	  	  
 
 
In	  Stau2	  knockdowns	  in	  cortical	  neurons,	  RhoA	  mRNA	  levels	  were	  greatly	  elevated,	  while	  β-­‐Actin	  
and	  Mov10	  mRNA	  levels	  were	  not	  affected	  (Figure	  40A).	   I	  also	  explored	  a	  potential	  effect	  of	  Stau2	  on	  
luciferase	  reporters	  under	  the	  control	  of	  RhoA	  sequence	  elements.	  Overexpression	  of	  Stau2	  in	  cortical	  
neurons	  led	  to	  small,	  but	  significant	  effect	  on	  reporters	  under	  control	  of	  RhoA	  5’-­‐	  or	  3’-­‐UTR,	  although	  in	  
opposite	  directions	  (Figure	  40B).	  	  
Knockdown	  of	   Stau2	   (Figure	   40C)	   perfomed	  by	   nucleofection	   of	   si-­‐RNA	  oligos	   yielded	   a	   similar	  
result	   as	   the	   overexpression	   on	   the	   5’-­‐UTR	   reporter	   while	   the	   3’-­‐UTR	   reporter	   was	   not	   significantly	  
affected.	   Interestingly,	   in	  Stau2-­‐deficient	  cells,	  the	  activity	  of	  the	  coding	  sequence	  reporter	  was	  highly	  
upregulated.	   Summing	   up,	   misregulation	   of	   Stau2	   in	   neurons	   grossly	   affects	   RhoA	   mRNA	   levels,	   an	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Figure	  40.	  (right	  side)	  Stau2	  possibly	  affects	  translation	  of	  RhoA.	  (A)	  Effects	  of	  Stau2	  knockdown	  on	  RNA	  levels	  of	  
endogenous	   Stau2,	   b-­‐Actin,	   Mov10	   and	   RhoA.	   Cortical	   neurons	   were	   nucleofected	   with	   sh-­‐Stau2	   or	   mis-­‐Stau	  
expressing.	  RNA	  was	   isolated	  after	  3	  days	  of	  expression,	   transcribed	   into	  cDNA	  and	  quantified	  by	  qRT-­‐PCR.	  RNA	  
levels	  were	  cross-­‐normalized	  to	  PPIA,	  Vinculin,	  and	  a-­‐Tubulin.	  Data	  are	  expressed	  as	  change	  in	  RNA	  levels	  relative	  
to	  the	  mis-­‐Stau2	  expressing	  plasmid.	  (B	  and	  C)	  Data	  are	  expressed	  as	  change	  of	  activity	  levels	  of	  Renilla	  luciferase	  
relative	   to	   Firefly	   luciferase,	   all	   cross-­‐normalized	   to	   effects	   on	   the	   empty	   psiCHECK-­‐2	   plasmid	   and	   psiCHECK-­‐2	  
Sept7	   3’-­‐UTR	   as	   control	   reporters.	   	   (B)	  Overexpression	   of	   Stau2	   was	   achieved	   by	   co-­‐nucleofection	   of	   cortical	  
neurons	  with	  an	  EGFP-­‐Stau2	  expressing	  plasmid	  and	   luciferase	  reporters,	  as	  control	  an	  EGFP	  expressing	  plasmid	  
was	  used.	  After	  24	  hrs	  of	  expression,	  luciferase	  assays	  were	  performed.	  Effects	  on	  luciferase	  reporters	  under	  the	  
control	  of	  rat	  RhoA	  sequences	  were	  determined.	  Data	  were	  normalized	  to	  expression	  of	  EGFP.	  (C)	  Knockdown	  of	  
Stau2	  was	  achieved	  by	  nucleofection	  of	  cortical	  neurons	  with	  si-­‐Stau2	  oligos	  (Invitrogen),	  as	  control	  non-­‐targeting	  
oligos	  were	  used.	  48	  hrs	  after	  nucleofection	  of	  the	  indicated	  sh-­‐plasmids,	  luciferase	  reporters	  were	  transfected.	  24	  
hrs	   later,	   luciferase	   assays	   were	   performed.	   Effects	   on	   luciferase	   reporters	   under	   the	   control	   of	   rat	   RhoA	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3.3.8 Conclusions	  of	  the	  investigation	  of	  Stau2	  in	  developing	  neurons	  
 
Stau2	  is	  expressed	  in	  all	  stages	  of	  neuronal	  development	  and	  localizes	  throughout	  development	  in	  
distal	  neurites:	  both	  axons	  and	  dendrites.	  Its	  localization	  pattern	  is	  altered	  upon	  depolymerization	  of	  the	  
tubulin	   cytoskeleton	   by	   drug	   treatment.	   Loss	   of	   Stau2	   on	   the	   other	   side	   influences	   the	   actin	  
cytoskeleton	  and	  seems	  to	  induce	  strong	  rearrangements	  within	  it.	  	  
The	   effects	   observed	   on	  β-­‐actin	   levels	   (Xie,	   Lenek,	   unpublished)	  were	   confirmed	   to	   arise	   from	  
stability	   control,	   rather	   than	   translational	   control.	   The	  most	   important	   finding	   in	  my	   investigation	   of	  
Stau2	   in	   developing	   neurons	   was	   the	   strong	   effect	   that	   Stau2	   carries	   out	   on	   RhoA	   mRNA.	   Upon	  
knockdown	  of	  Stau2,	  RhoA	  is	  greatly	  upregulated.	  A	  connection	  between	  the	  effect	  on	  RhoA	  mRNA	  and	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3.4 Investigating	  the	  protein	  composition	  of	  transport	  RNPs	  	  
3.4.1 Background	  
 
Transport	  RNPs	  are	  defined	  as	  particles	  consisting	  of	  both	  RNA	  and	  proteins	  that	  transport	  RNA	  to	  
specified	  locations	  within	  a	  cell.	  Currently,	  there	  is	  a	  major	  effort	  in	  the	  lab	  to	  identify	  the	  protein	  and	  
RNA	   components	   of	   transport	   RNPs	   also	   in	   our	   lab	   (Härtel,	   Karra,	   unpublished	   data	   and	   Konecna,	  
Heraud,	  Doyle,	  unpublished	  data).	  In	  my	  thesis,	  I	  chose	  an	  alternative	  experimental	  approach:	  Starting	  
with	  selected	  dendritically	  localized	  mRNAs,	  my	  aim	  was	  to	  identify	  the	  proteins,	  which	  recognize	  them	  
and	  mediate	  their	  localization	  in	  the	  cell.	  	  
There	  have	  been	  several	  attempts	  over	  the	  years	  to	  establish	  a	  reliably	  working	  method	  for	  this	  
question.	   As	   described	   in	   the	   introduction,	  most	   of	   the	  methods	   used	   similar	   strategies:	   the	   RNA	   of	  
interest	  is	  tagged	  with	  some	  various	  structure-­‐based	  RNA	  aptamers,	  which	  would	  then	  couple	  the	  RNA	  
to	  different	   columns	  by	   interaction	  of	   the	  RNA	  aptamer	  with	   the	   column	  material.	   The	  RNA	   is	   either	  
expressed	  in	  cultured	  cells	  or	  in	  vitro	  transcribed	  and	  then	  incubated	  with	  protein	  extracts.	  The	  method	  
that	  I	  chose	  was	  published	  initially	  in	  1999	  by	  the	  Schroeder	  lab	  (Bachler	  et	  al.,	  1999;	  Windbichler	  and	  
Schroeder,	  2006).	  	  
3.4.2 Principle	  of	  the	  method	  
 
The	  method	  of	   choice	  utilizes	   an	  RNA	  aptamer	   called	   StreptoTag,	  which	  binds	   to	   the	   antibiotic	  
streptomycin	  that	  can	  be	  coupled	  to	  sepharose	  beads.	  On	  overview	  on	  the	  underlying	  principle	  is	  given	  
in	  Figure	  41A.	  Aptamer-­‐tagged	  RNA	  is	  generated	  by	  in	  vitro	  transcription	  with	  T7	  RNA	  polymerase	  from	  
purified,	  linearized	  plasmid	  DNA.	  A	  critical	  step	  of	  the	  procedure	  is	  to	  allow	  optimal	  folding	  of	  the	  RNA	  
so	  that	  the	  aptamer	  can	  form	  correctly,	  which	  is	  essential	  for	  binding	  to	  the	  column	  material.	  As	  I	  will	  
describe	   later,	   several	   optimization	   steps	   were	   taken	   to	   improve	   RNA	   binding	   to	   the	   streptomycin-­‐
beads.	  Brain	  lysate	  is	  then	  applied	  on	  the	  column	  to	  allow	  interacting	  proteins	  to	  bind	  the	  coupled	  RNA.	  
After	  application	  of	  brain	   lysate,	   several	  wash	  steps	   follow.	  Since	  unspecific	  binding	  of	  protein	   turned	  
out	   to	   be	   another	   major	   drawback	   of	   this	   method,	   optimization	   experiments	   on	   i)	   blocking	   of	   the	  
column	  material	  before	  application	  of	  brain	  lysate,	  ii)	  use	  of	  different	  column	  buffers,	  and	  iii)	  different	  
washing	  conditions	  were	  performed.	  Elution	  is	  finally	  performed	  by	  addition	  of	  free	  streptomycin,	  which	  
competes	  for	  the	  tagged	  RNA	  with	  the	  column	  material.	  Afterwards,	  the	  resulting	  fractions	  arising	  from	  
the	  procedure	  can	  be	  analyzed.	  Routinely,	  I	  used	  SDS	  gels	  and	  silver	  staining	  to	  detect	  the	  total	  protein,	  
but	  also	  experiments	  performing	  Western	  blotting	  were	  done.	  
Results	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To	   establish	   the	   method	   in	   the	   lab,	   I	   used	   an	   already	   established	   RNA-­‐protein	   pair	   from	   our	  
collaborators	   J.	   Dangerfield	   and	  M.	  Müllner	   (Müllner,	   2006):	   the	   HIV	   protein	   Rev	   binding	   to	   an	   REM	  
responsive	   element	   (RRE).	   Plasmids	   for	   overexpression	   of	   Rev	   protein	   in	   HeLa	   cells	   and	   in	   vitro	  
transcription	   of	   double-­‐StreptoTagged	  RRE	   (SRS)	   RNA	  were	   kindly	   provided	   by	   our	   collaborators.	   The	  
experiments	  were	   carried	  out	   according	   to	   the	  procedures	  described	   in	   (Müllner,	   2006).	  As	   shown	   in	  
Figure	   41B	   and	   C,	   I	   was	   able	   to	   set	   up	   the	   method	   in	   our	   lab	   successfully.	   Panel	   B	   shows,	   in	   an	  
experiment	  without	  loading	  protein,	  that	  SRS	  RNA	  efficiently	  bound	  to	  the	  column	  material:	  no	  RNA	  was	  
lost	  in	  the	  flow-­‐through	  or	  wash	  fractions.	  Most	  importantly,	  the	  RNA	  could	  be	  detected	  on	  the	  beads	  
before	  elution,	  and	  most	  of	   the	  RNA	  was	  eluted	  with	  excess	  streptomycin.	  Furthermore,	  not	  only	   the	  
RNA	  was	  successfully	  coupled	  to	  the	  column,	  but	  also	  Rev	  protein	  was	  specifically	  retained	  via	  the	  RNA	  
(Figure	  41C).	  While	  no	  Rev	  protein	  was	  lost	  during	  washing,	  Rev	  protein	  in	  its	  monomeric	  and	  its	  dimeric	  
form	  was	  eluted	  with	  excess	  streptomycin.	  These	  first	  experiments	  can	  be	  seen	  as	  a	  proof	  of	  principle	  














Figure	  41.	  (right	  side)	  Principle	  of	  the	  StreptoTag	  method.	  (A)	  Schematic	  overview	  on	  the	  subsequent	  steps	  of	  the	  
protocol.	   In	   step	  1,	   in	   vitro	   transcribed	  and	  pre-­‐folded	  RNA	   is	   loaded	  onto	  a	   sepharose	  column	  which	  has	  been	  
coupled	  to	  streptomycin.	  In	  step	  2a,	  adult	  rat	  brain	  is	  homogenized	  and	  loaded	  onto	  the	  RNA-­‐bound	  column	  (step	  
2b).	  After	  incubation	  of	  the	  brain	  lysate	  with	  the	  beads,	  the	  column	  is	  washed	  several	  times	  to	  remove	  unspecific	  
binders	  (step	  3).	  Finally,	  RNA-­‐protein	  complexes	  are	  eluted	  from	  the	  column	  by	  competition	  of	  the	  column-­‐bound	  
streptomycin	   with	   free	   streptomycin	   (step	   4).	   The	   composition	   of	   the	   eluted	   complexes	   can	   then	   be	   further	  
analyzed	   (step	   5).	   (B)	   Proof	   that	   SRS	   RNA	   efficiently	   bound	   to	   the	   column.	   Lane	   1:	   loading	   control	   (in	   vitro	  
transcribed	  RNA,	  50	  ug).	  Lane	  2:	   sample	   from	  beads	  before	   loading	  of	  RNA.	  Lane	  3:	   flow	  through	  after	  blocking	  
with	  tRNA	  and	  loading	  of	  RNA.	  Only	  tRNA	  is	  detected.	  Lanes	  4	  and	  5:	  wash	  steps,	  no	  RNA	  is	  lost.	  Lane	  6:	  sample	  
from	  beads	  before	  elution.	   SRS	  RNA	   is	  detected.	   Lane	  7:	   eluted	  RNA.	  Both	  SRS	  and	   tRNA	  are	  detected.	   Lane	  8:	  
wash	   step	   after	   elution,	   no	  RNA	   is	   detected	   any	  more.	   Lane	  8:	   sample	   from	  beads	   after	   elution,	   no	  detectable	  
amount	  of	  RNA	  is	  left	  on	  beads.	  (C)	  Proof	  of	  principle	  that	  the	  method	  was	  working.	  Rev	  protein	  (overexpressed	  in	  
HeLa	   cells)	   was	   pulled	   down	   from	   a	   column	   that	   had	   SRS	   RNA	   bound.	   Lane	   1:	   flow-­‐through	   of	   loaded	   protein	  
extract.	  Lanes	  2	  and	  3:	  no	  protein	  was	  lost	  during	  the	  wash	  steps.	  Lane	  4:	  Rev	  protein	  was	  eluted	  in	  its	  monomeric	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3.4.3 	  Generation	  of	  plasmids	  for	  the	  StreptoTag	  method	  
 
The	  isolation	  of	  RNPs	  using	  the	  StreptoTag	  method	  is	  based	  on	  coupling	  in	  vitro	  transcribed	  mRNA	  
to	  Sepharose	  beads	  (Bachler	  et	  al.,	  1999;	  Windbichler	  and	  Schroeder,	  2006).	  For	   in	  vitro	   transcription,	  
the	   sequence	  of	   the	   StreptoTag	   itself,	   as	  well	   as	   the	   sequence	  of	   the	   target	  mRNA	  had	   to	  be	   cloned	  
adjacent	   to	   an	   RNA	   polymerase	   promoter.	   I	   decided	   to	   generate	   plasmids	   containing	   the	   mRNA	  
sequences	   attached	   to	   one	   or	   two	   StreptoTags,	   the	   latter	   as	   a	   possibility	   to	   increase	   binding	   to	   the	  
column.	   The	   first	   candidates	   were	   the	   dendritically	   localized	   mRNAs	   LIMK1	   and	   Arc.	   Many	   protein	  
binding	  sites	  are	  thought	  to	  be	  located	  in	  the	  3’-­‐UTR	  of	  especially	  localized	  mRNAs,	  therefore	  we	  used	  
the	  3’-­‐UTR	  (untranslated	  region)	  in	  our	  approach.	  Since	  there	  were	  indications	  by	  previous	  users	  of	  this	  
method,	  that	  only	  sequences	  with	  a	  length	  up	  to	  500	  bp	  could	  efficiently	  fold	  and	  bind	  to	  the	  column,	  
three	   (Limk1,	  1.1	  kb)	  and	   four	   (Arc,	  1.5	  kb)	  overlapping	  constructs	  of	   the	  3’-­‐UTRs	  were	  PCR	  amplified	  
and	   used	   for	   subsequent	   cloning.	   Later,	   also	   full-­‐length	   constructs	   of	   LIMK1	   and	   Arc	   3’-­‐UTR	   were	  
amplified	   and	   cloned.	   The	   plasmid	   of	   choice	   here	   was	   pBluescript	   II	   KS+	   (pBSIIKS+),	   which	   has	   a	   T7	  
promoter	   site	   upstream	   of	   the	   multiple-­‐cloning	   site.	   The	   cloning	   strategy	   consisted	   of	   several	  
subsequent	  steps,	  as	  shown	  in	  Figure	  42:	  First,	  the	  StreptoTag	  sequence	  was	  inserted	  at	  two	  alternative	  
sites	  into	  pBSIIKS+	  by	  annealing	  complementary	  oligos	  containing	  the	  StreptoTag	  sequence	  and	  forming	  
cohesive	   ends	   for	   ligation	   (pBS	   Strepto1	   and	   pBS	   Strepto2).	   In	   a	   next	   step,	   PCR	   amplified	   mRNA	  
sequences,	  which	  had	  been	   subcloned	   into	   the	  pGEM-­‐T	   vector	   and	   cut	   out	  with	   restriction	   enzymes,	  
were	   inserted	   into	   pBS	   Strepto1.	   From	   those	   plasmids,	   the	   StreptoTag	   sequence	   and	   the	   mRNA	  
sequence	   were	   cut	   with	   restriction	   enzymes	   and	   ligated	   into	   pBS	   Strepto2,	   resulting	   in	   plasmids	  
containing	   the	  mRNA	   sequence	   attached	   to	   a	   StreptoTag	   on	   either	   side	   of	   the	   construct	   (pBS	   SnS,	   n	  
standing	  for	  the	  corresponding	  Limk1	  or	  Arc	  construct).	  The	  cloned	  constructs	  are	  summarized	  in	  Figure	  
44.	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Figure	  42.	  Cloning	  strategy	  for	  the	  generation	  of	  plasmids	  carrying	  Arc	  or	  LIMK1	  3’-­‐UTR	  constructs	  fused	  to	  two	  




As	  pBSIIKS+	  only	  enables	  in	  vitro	  transcription	  and	  the	  StreptoTagged	  constructs	  were	  also	  to	  be	  
expressed	   in	  mammalian	   cells,	   the	   constructs	   had	   to	   be	   cloned	   into	   a	  mammalian	   expression	   vector.	  
Therefore,	  the	  sequences	  including	  the	  StreptoTags,	  were	  PCR	  amplified,	  using	  the	  pBS	  SxS	  plasmids	  as	  




Figure	  43.	  Cloning	  strategy	  for	  the	  generation	  of	  pcDNA3.1	  plasmids	  carrying	  Arc	  or	  LIMK1	  3’-­‐UTR	  constructs	  fused	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Figure	  44.	  Overview	  on	  the	  constructs	  availabe	  for	  in	  vitro	  transcription	  of	  StreptoTagged	  RNAs.	  	  
 
3.4.4 Adaption	  of	  the	  method	  for	  our	  purposes	  
 
The	  StreptoTag	  method	  was	  originally	  designed	  to	  purify	  high	  affinity	  protein	  interactors	  of	  short	  
RNA	   fragments	   (Bachler	   et	   al.,	   1999).	   I	   was,	   however,	   interested	   in	   identifying	   unknown	   protein	  
interactors	  of	  dendritically	  localized	  mRNAs.	  Those	  interactions	  are	  not	  necessarily	  of	  high	  affinity,	  but	  
might	  rather	  bind	  weakly	  or	  indirectly	  to	  its	  cognate	  RNA.	  I	  chose	  to	  use	  the	  3’-­‐UTRs	  of	  two	  candidates	  
of	  dendritically	  localized	  mRNAs,	  LIMK1	  and	  Arc,	  to	  set	  up	  the	  method	  since	  there	  has	  not	  been	  a	  single	  
interactor	  known.	  	  
First	  experiments	  were	  carried	  out	  according	   to	  a	  protocol	   that	  was	  slightly	  modified	   from	  that	  
used	  in	  Müllner	  (2006)	  and	  is	  described	  in	  the	  methods	  section.	  The	  results	  of	  those	  first	  experiments	  
looked	  promising,	  as	  shown	  in	  Figure	  45A.	  From	  an	  SL1S-­‐coupled	  column,	  distinct	  protein	  bands	  were	  
identified	  from	  a	  silver-­‐stained	  gel	  and	  analyzed	  by	  mass	  spectrometry	  by	  our	  collaborators	  K.	  Bennett	  












































Actin, aortic smooth muscle
Actin, aplha, skeletal muscle
Actin, alpha, cardiac muscle
Actin, gamma, enteric smooth muscle







1                2                3                4                5      
Results	  
	  
Lucia	  Schoderböck	   	   107	  	   	  
Besides	   contaminations	   like	   Keratin	   and	   Glutathione-­‐S-­‐transferase,	   mainly	   cytoskeleton-­‐components	  
were	  identified:	  α-­‐	  and	  β-­‐	  Tubulin,	  and	  various	  forms	  of	  α-­‐	  and	  γ-­‐Actin.	  Only	  two	  potentially	  interesting	  
proteins	   were	   identified:	   Clathrin	   and	   Creatine	   Kinase.	   The	   results	   from	   this	   analysis	   lead	   us	   to	  
reconsider	   the	   methodological	   procedures,	   and	   perform	   additional	   optimization	   experiments.	   As	  
mentioned	  before,	  especially	  two	  areas	  were	  identified	  as	  critical:	  i)	  efficient	  RNA	  binding	  to	  the	  column	  







































Figure	   45.	  Mass	   spectrometry	   analysis	   of	   proteins	   eluted	   from	   an	   SL1S	   containing	   column.	   (A)	   Distinct	   bands	  
appeared	  in	  the	  elution	  fraction	  from	  a	  column	  that	  has	  SL1S	  RNA	  bound.	  Lane	  1:	  flow-­‐through	  after	  loaded	  brain	  
extract.	  Lanes	  2	  and	  3:	  high	  background	  concentrations	  of	  proteins	  washed	  out	  from	  column,	  still	  found	  in	  wash	  5.	  
Lane	  4:	  eluted	  proteins	   that	  were	   then	  analyzed	  by	   in	  mass	  spectrometry.	   (B	  List	  of	  proteins	   identified	  by	  mass	  
spectrometry	  analysis.	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3.4.5 	  Efficiency	  of	  RNA	  binding	  to	  the	  streptomycin-­‐sepharose	  columns	  
 
In	  an	  experiment	  performed	  in	  parallel	  to	  the	  positive	  control	  (SRS	  RNA,	  shown	  in	  Figure	  41B),	  I	  
was	  able	  to	  show	  that	  in	  principle	  SL1S	  RNA	  bound	  to	  the	  streptomycin	  column	  (Figure	  46A).	  In	  contrast	  
to	  SRS	  RNA,	  which	  was	  completely	  retained	  on	  the	  column,	  a	  prominent	  fraction	  of	  SL1S	  RNA	  was	  lost	  in	  
the	  flow-­‐through	  and	  wash	  fractions.	  There	  were	  two	  main	  steps	  in	  the	  procedures	  that	  were	  modified:	  
i)	  pre-­‐treatment	  conditions	  to	  optimize	  folding	  of	  the	  RNA,	  and	  ii)	  column	  binding	  buffer	  conditions.	  The	  
optimization	  experiments	  were	  performed	  without	  addition	  of	  protein	  (brain	  lysate),	  by	  directly	  eluting	  
the	  RNA.	  In	  the	  experiment	  shown	  in	  Figure	  46	  B,	  I	  varied	  both	  the	  conditions	  to	  pre-­‐treat	  the	  RNA	  as	  
well	  as	  the	  column	  binding	  buffer.	  The	  procedure	  as	  described	  in	  the	  methods	  section	  was	  modified	  in	  
following	  points:	  (i)	  300	  µl	  beads	  were	  not	  prepared	  in	  a	  column	  but	  in	  a	  1.5	  ml	  tube	  and	  buffers	  were	  
taken	  off	  after	  centrifugation	  steps	  of	  1	  min	  at	  500	  rpm	  in	  soft	  mode	  in	  a	  table	  top	  centrifuge.	  (ii)	  RNA	  
was	   pre-­‐treated	   in	   1	  ml	   buffer	   and	   then	   incubated	  with	   the	   beads	   for	   1	   hr	   at	   4	   °C.	   (iii)	   Elution	  was	  
performed	   in	  three	  subsequent	  steps	  of	  1	  mM	  Streptomycin,	  10	  mM	  Streptomycin	  and	  2	  M	  NaCl.	  For	  
most	  buffer	  conditions,	  pre-­‐folding	  of	  the	  RNA	  with	  an	  incubation	  for	  5	  min	  at	  37°C	  yields	  best	  results.	  
The	  most	  efficient	  method	  however,	  is	  to	  use	  brain	  extraction	  buffer	  and	  pre-­‐treamtent	  of	  the	  RNA	  by	  
incubation	  for	  5	  min	  each	  at	  65°C,	  37°C,	  and	  room	  temperature.	  Using	  these	  conditions,	  no	  RNA	  is	  lost	  in	  
the	  flow-­‐through	  or	  wash	  steps,	  but	  is	  efficiently	  retained	  on	  the	  column	  until	  elution	  with	  2	  M	  NaCl.	  	  
	  
To	   test	   whether	   some	   of	   the	   RNA	   constructs	  might	   exhibit	   better	   column	   binding	   than	   others	  
based	  on	  their	  folding	  structure,	  I	  compared	  different	  RNA	  constructs	  for	  their	  column	  binding	  capacity	  
(Figure	  46C	  and	  D).	  In	  this	  experiment,	  the	  same	  modifications	  to	  the	  protocol	  as	  described	  above	  were	  
applied.	  Best	  results	  were	  reached	  with	  SL3S	  RNA,	  incubated	  subsequently	  for	  5	  min	  each	  at	  65°C,	  37°C,	  
room	  temperature,	  and	  4°C	   (gradient	  between	  steps).	   Since	   these	  pre-­‐treatment	  conditions	  were	  not	  
equally	  good	  for	  all	  RNAs,	  I	  can	  conclude	  that	  the	  folding	  conditions	  would	  have	  to	  be	  adapted	  for	  each	  
RNA	  individually.	  
	  
Figure	  46.	  (right	  side)	  Optimization	  of	  RNA-­‐binding	  to	  the	  streptomycin	  column.	  (A)	  Proof	  that	  SL1S	  RNA	  bound	  
to	  the	  column,	  but	  significant	  amounts	  of	  RNA	  were	  lost	  in	  flow-­‐through	  and	  washing.	  Lane	  1:	  loading	  control	  (in	  
vitro	   transcribed	   RNA,	   50	   µg.	   Lane	   2:	   sample	   from	   beads	   before	   loading	   of	   RNA.	   Lane	   3:	   flow-­‐through	   after	  
blocking	  with	  tRNA	  and	  loading	  of	  RNA.	  SL1S	  and	  tRNA	  are	  detected.	  Lanes	  4	  and	  5:	  wash	  steps,	  RNA	  is	  lost	  in	  the	  
first	  wash	   step.	   Lane	   6:	   sample	   from	  beads	   before	   elution.	   Very	   light	   band	   of	   SL1S	   RNA	  was	   detected.	   Lane	   7:	  
eluted	  RNA.	  A	  strong	  band	  of	  SL1S	  RNA	  was	  detected.	  Lane	  8:	  wash	  step	  after	  elution,	  no	  RNA	  was	  detected	  any	  
more.	   Lane	  8:	   sample	   from	  beads	  after	  elution,	  no	  detectable	  amount	  of	  RNA	  was	   left	  on	  beads.	   (B)	  Testing	  of	  
different	   pre-­‐treatment	   and	   buffer	   conditions	   to	   optimize	   binding	   of	   SA4S	   RNA	   to	   the	   column.	   Lane	   1:	   flow-­‐
through	  after	  loading	  of	  RNA.	  Lanes	  2	  and	  3:	  wash	  steps.	  Lane	  4:	  RNA	  eluted	  with	  1mM	  streptomycin.	  Lane	  5:	  RNA	  
eluted	  with	  10	  mM	  streptomycin.	  Lane	  6:	  RNA	  eluted	  with	  2M	  NaCl.	  Conditions:	  1)	  original	  buffer	  (Windbichler	  and	  
Schroeder,	  2006),	  2)	  buffer	  suggested	  by	  E.	  Westhof,	  3)	  buffer	  suggested	  by	  S.	  Hüttelmaier,	  4)	  buffer	  used	  by	  P.	  
Lukavsky	  (Locker	  et	  al.,	  2006),	  5)	  brain	  extraction	  buffer;	  pre-­‐folding	  of	  RNA:	  a)	  incubation	  for	  5	  min	  each	  at	  65	  °C,	  
37	  °C,	  and	  room	  temperature,	  b)	  incubation	  for	  5	  min	  at	  37	  °C.	  (C)	  Testing	  of	  different	  pre-­‐treatment	  and	  buffer	  
conditions	  to	  optimize	  binding	  of	  different	  RNAs	  to	  the	  column.	  Lane	  1:	  flow-­‐through	  after	  loading	  of	  RNA.	  
a a b a b c UT 
SLFLS SL3S SL3S SA3S SA3S SA3S SA3S 
FT tRNA 6% 13% 23% 9% 4% 8% 7% 
FT/Wash 22% 52% 40% 57% 54% 35% 47% 
Eluted 1% 7% 15% 2% 1% 4% 9% 
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Lane	  2:	  wash	  step.	  Lane	  3:	  RNA	  eluted	  with	  1mM	  and	  10	  mM	  streptomycin	  (pooled).	  Conditions:	   	  original	  buffer	  
(Windbichler	   and	   Schroeder,	   2006);	   pre-­‐folding	   of	   RNA:	   a,	   incubation	   for	   5	   min	   each	   at	   65°C,	   37°C,	   room	  
temperature,	  and	  4°C	  (sharply	  defined	  steps),	  b,	  incubation	  for	  5	  min	  each	  at	  65°C,	  37°C,	  room	  temperature,	  and	  
4°C	   (gradient	  between	   steps),	   c,	   incubated	  at	   65°C	   for	   5	  min,	   then	   let	   cool	   down	  at	   room	   temperature,	  UT,	  no	  
treatment.	   (D)	   Quantification	   of	   experiment	   shown	   in	   panel	   C.	   RNA	   concentrations	   were	   measured	   by	  
photospectrometry	  and	  extrapolated	  to	  total	  RNA	  input	  of	  tRNA	  and	  tagged	  RNA.	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3.4.6 Reduction	  of	  unspecific	  protein-­‐binding	  to	  the	  streptomycin-­‐sepharose	  columns	  
 
After	   experiencing	   high	   background	   binding	   when	   protein	   was	   eluted	   from	   control	   columns	  
without	  RNA	  (data	  not	  shown),	   I	   tried	  to	  block	  the	  columns	  with	  BSA	  (concentrations	  up	  to	  10	  mg/ml	  
column	  material)	  and	  to	  pre-­‐clear	  the	  brain	   lysate	  by	  an	  additional	  centrifugation	  step.	  Both	  attempts	  
did	  not	  yield	  any	  significant	  improvement	  (data	  not	  shown).	  In	  an	  additional	  adaption	  of	  the	  procedure,	  
the	  column	  material	  was	  blocked	  with	  ethanolamine	  (Locker	  et	  al.,	  2006)	  (Figure	  47A	  and	  B).	  Basically,	  
after	   coupling	   of	   the	   Sepharose	   beads	   with	   Dihydrostreptomycin,	   the	   resin	   was	   incubated	   with	   6	   %	  
ethanolamine	   in	   water	   at	   42	   °C	   over	   night	   in	   the	   dark.	   In	   these	   experiments,	   brain	   lysate	   was	  
equilibrated	   for	   10	  min	   at	   37	   °C,	   then	   RNA	   was	   added	   and	   incubated	   for	   another	   10	  min	   at	   37	   °C;	  
elutions	   were	   performed	   in	   subsequent	   steps	   of	   10	   µM	   Streptomycin,	   1	   mM	   Streptomycin,	   10	   mM	  
Streptomycin	  and	  2	  M	  NaCl.	  In	  the	  experiment	  shown	  in	  panel	  B,	  the	  column	  was	  blocked	  additionally	  
with	   BSA.	   Although	   this	   procedure	   improved	   RNA	   binding	   to	   the	   column	   (data	   not	   shown),	   protein	  
background	  remained	  high	  (Figure	  47A	  and	  B).	  The	  main	  problem	  with	  high	  background	  is	  that	  subtle	  
changes	   for	   individual	  proteins	  can	  hardly	  be	  detected	   in	   the	  general	  pattern	  observed.	  An	  additional	  
protein	  band,	  only	  detected	  in	  the	  fractions	  eluted	  from	  RNA-­‐bound	  columns,	  but	  not	  from	  the	  no-­‐RNA	  
control	  column,	  is	  marked	  with	  an	  arrowhead	  in	  panel	  B.	  Although	  subtle	  differences	  could	  be	  detected	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Figure	   47.	   Optimization	   of	   unspecific	   protein	   binding	   to	   the	   column.	   (A)	   Comparison	   of	   non-­‐blocked	   and	  
ethanolamine	  (EA)-­‐blocked	  column	  material	  treated	  in	  parallel.	  Lane	  1:	  protein	  weight	  marker.	  Elution	  was	  done	  in	  
subsequent	   steps	   from	  10	  µM	  streptomycin	   	   (lane	  2,	   elution	  1,	   non-­‐blocked	   column),	   over	   1	  mM	  streptomycin	  
(lane	  3,	  elution	  2,	  non-­‐blocked	  column),	  to	  10	  mM	  streptomycin	  (lane	  4,	  elution	  3,	  non-­‐blocked	  column).	  Lane	  5:	  
protein	  eluted	  with	  2	  M	  NaCl	   (elution	  4,	  non-­‐blocked	  column).	  Lane	  6:	  protein	  eluted	  with	  10	  μM	  streptomycin	  
(elution	  1,	  EA	  -­‐blocked	  column).	  Lane	  7:	  protein	  eluted	  with	  1	  mM	  streptomycin	  (elution	  2,	  EA	  -­‐blocked	  column).	  
Lane	  8:	  protein	  eluted	  with	  10	  mM	  streptomycin	  (elution	  3,	  EA	  -­‐blocked	  column).	  Lane	  9:	  protein	  eluted	  with	  2	  M	  
NaCl	  (elution	  4,	  EA-­‐blocked	  column).	  (B)	  Comparison	  of	  elution	  fractions	  of	  SA1S	  RNA	  to	  SA4S	  RNA	  and	  to	  a	  column	  
without	  RNA.	  Elution	  was	  done	  in	  subsequent	  steps	  from	  10	  μM	  streptomycin	  (lane	  1,	  elution	  1,	  SA1S	  column;	  lane	  
3,	  elution	  1,	  SA4S	  column;	  and	  lane	  5,	  elution	  1,	  no-­‐RNA	  column),	  to	  1	  mM	  streptomycin	  (lane	  2,	  elution	  2,	  SA1S	  
column;	   lane	  4,	  elution	  2,	  SA4S	  column;	  and	   lane	  6,	  elution	  2,	  no-­‐RNA	  column).	  The	  arrowhead	  marks	  a	  protein	  
band	  that	  seems	  to	  be	  eluted	  only	  from	  RNA-­‐bound	  columns.	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3.4.7 In	  vivo	  expression	  of	  the	  tagged	  RNA	  
 
A	  drawback	  of	  the	  incubation	  of	  in	  vitro	  transcribed	  RNA	  with	  brain	  lysate	  is	  that	  under	  those	  non-­‐
physiological	  conditions,	  very	  likely	  artifactual	  complexes	  are	  formed.	  In	  addition,	  it	  is	  possible	  that	  the	  
added	  RNA	  cannot	  compete	  with	  the	  already	  bound	  endogenous	  RNA	  for	  protein	  interactors.	  For	  those	  
reasons,	  I	  decided	  to	  test	  the	  StreptoTag	  method	  in	  vivo,	  expressing	  the	  tagged	  RNA	  in	  cells.	  	  
On	  overview	  on	  the	  workflow	  of	  the	  modified	  method	  is	  given	  in	  Figure	  48A.	  Aptamer-­‐tagged	  RNA	  
is	  generated	  by	   in	  vivo	  expression	  from	  transfected	  plasmid	  DNA.	  Endogenous	  proteins	  are	  thought	  to	  
bind	  the	  RNA	  inside	  cells.	  After	  expression	  for	  three	  days,	  cells	  were	  lysed	  and	  applied	  on	  the	  column	  to	  
allow	   the	   tagged	   RNA	   to	   bind	   to	   the	   streptomycin-­‐column.	   It	   has	   to	   be	   taken	   into	   account	   that	   the	  
aptamers	   could	   be	  masked	   by	   bound	   proteins	   and	  would	   therefore	   not	   be	   binding-­‐competent.	   After	  
application	  of	  the	  lysate,	  several	  wash	  steps	  followed.	  Elution	  finally	  was	  performed	  by	  addition	  of	  free	  
streptomycin	  as	  described	  before.	  Afterwards,	  the	  eluents	  and	  other	  fractions	  of	  the	  procedure	  can	  be	  
analyzed.	  
A	  first	  test	  experiment	  was	  carried	  out	  as	  described	  in	  the	  materials	  section.	  Here,	  HeLa	  cells	  were	  
used	  for	  transfection,	  but	  in	  future	  projects,	  cultured	  neurons	  should	  be	  nucleofected	  with	  the	  plasmids	  
used	  to	  express	  tagged	  RNA.	  To	  test	  for	  successful	  transfection	  and	  expression	  of	  the	  tagged	  RNA,	  total	  
RNA	   was	   isolated	   from	   transfected	   HeLa	   cells	   and	   used	   as	   template	   for	   cDNA	   synthesis.	   By	   RT-­‐PCR	  
(Figure	  49A)	  experiments,	  I	  could	  show	  that	  Arc	  and	  LIMK1	  primers	  successfully	  detected	  elevated	  levels	  
of	  the	  expressed	  RNAs	  in	  the	  corresponding	  transfection	  conditions.	  Also	  StreptoTag-­‐RNA	  was	  detected	  
in	  the	  transfected	  cells,	  showing	  that	  the	  RNA	  is	  expressed	  in	  its	  full	  length.	  	  
When	   I	  performed	  the	  above-­‐mentioned	  experiment	  with	  the	  HeLa	  extracts,	  hardly	  any	  protein	  
was	  detected	  on	   the	   silver-­‐stained	   gels.	  No	  obvious	  differences	  were	   given	   for	   untransfected	   cells	   to	  







Figure	   48.	   (right	   side)	   Principle	   of	   the	   StreptoTag	  method	   in	   vivo.	   (A)	   Schematic	   overview	   on	   the	   subsequent	  
steps	  of	  the	  protocol.	  For	  in	  vivo	  expression	  of	  the	  tagged	  RNA,	  a	  plasmid	  encoding	  for	  the	  RNA	  and	  flanking	  tag	  
regions	  was	   cloned	   under	   the	   control	   of	   a	  mammalian	   expression	   promoter	   (step	   1).	   In	   step	   2,	   the	   plasmid	   is	  
transfected	   into	  cultured	  HeLa	  cells.	  The	  tagged	  RNA	  is	  expressed	   in	  cells	   for	  3	  days	  and	  bound	  by	   its	   interactor	  
proteins	  and	  RNAs	  there	  (step	  3).	  In	  step	  4,	  transfected	  cells	  are	  lysed	  and	  loaded	  onto	  the	  streptomycin-­‐coupled	  
column	  (step	  5).	  After	  incubation	  of	  the	  cell	  lysate	  with	  the	  column	  material,	  the	  column	  is	  washed	  several	  times	  
to	  remove	  unspecific	  binders	  (step	  6).	  Finally,	  RNA-­‐protein	  complexes	  are	  eluted	  from	  the	  column	  by	  competition	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Figure	  49.	  In	  vivo	  application	  of	  the	  StreptoTag	  method.	  (A)	  RNA	  was	  isolated	  from	  untransfected	  HeLa	  cells	  (lane	  
1)	   or	   cells	   transfected	   with	   the	   mammalian	   expression	   vectors	   pSA1S	   (lane	   2)	   or	   pSL1S	   (lane3).	   cDNA	   was	  
generated	  from	  the	  RNA	  and	  used	  in	  RT-­‐PCR.	  Arc	  was	  detected	  only	  when	  overexpressed,	  while	  LIMK1	  background	  
levels	  were	  also	  detected	  in	  untransfected	  cells	  and	  cells	  transfected	  with	  the	  Arc	  construct.	  StreptoTag	  RNA	  was	  
only	  detected	  in	  transfected	  cells.	  The	  positive	  control	  Tubulin	  was	  detected	   in	  all	  conditions.	  (B)	  Comparison	  of	  
elution	  fractions	  of	  SA1S	  extract	  to	  SL4S	  extract	  and	  to	  a	  column	  loaded	  with	  extract	  from	  untransfected	  cells.	  Lane	  
1:	   protein	   weight	   marker.	   Elution	   was	   done	   in	   subsequent	   steps	   of	   1	   mM	   streptomycin	   (lane	   2,	   elution	   1,	  
untransfected	  extract	  column;	  lane	  5,	  elution	  1,	  SA1S	  extract	  column;	  and	  lane	  8,	  elution	  1,	  SL1S	  extract	  column),	  2	  
M	  NaCl	  (lane	  3,	  elution	  2,	  untransfected	  extract	  column;	  lane	  6,	  elution	  2,	  SA1S	  extract	  column;	  and	  lane	  9,	  elution	  
2,	  SL1S	  extract	  column),	  and	  10	  mM	  streptomycin	  (lane	  4,	  elution	  3,	  untransfected	  extract	  column;	  lane	  7,	  elution	  
3,	  SA1S	  extract	  column;	  and	  lane	  10,	  elution	  3,	  SL1S	  extract	  column).	  
Results	  
	  
Lucia	  Schoderböck	   	   115	  	   	  
3.4.8 Conclusions	  of	  the	  experiments	  aiming	  to	  unravel	  the	  protein	  composition	  of	  RNPs	  
containing	  Arc	  or	  LIMK1	  mRNA	  	  
 
The	   StreptoTag	   approach	   (Windbichler	   and	   Schroeder,	   2006)	   was	   adapted	   to	   investigate	   the	  
composition	  of	  neuronal	  transport	  RNPs.	  The	  protocol	  was	  optimized	  and	  the	  in	  vivo	  approach	  seemed	  
to	   be	   promising.	   Nonetheless,	   the	   experiments	   described	   above	   lead	   to	   the	   conclusion	   that	   for	   the	  
question	   addressed	   here,	   there	   are	   probably	   more	   suitable	   methods	   than	   the	   StreptoTag	   approach.	  
StreptoTag	  might	  be	  useful	  in	  the	  investigation	  of	  high	  affinity	  interactions	  of	  protein	  and	  RNA	  and	  for	  
short	  RNA	  stretches.	  The	  RNAs	  used	  here	  did	  not	  efficiently	  bind	  to	  the	  column,	  and	  did	  not	  allow	  for	  
very	   stringent	   washes.	   Those	   would	   have	   been	   necessary	   considering	   the	   high	   background	   protein	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RNA	  localization	  in	  neurons	  is	  a	  key	  process	  that	  enables	  local	  protein	  synthesis	  both	  spatially	  and	  
temporally	   according	   to	   demand.	   This	   process	   allows	   polarization	   of	   the	   cells	   and,	   amongst	   other	  
functions,	   individual	   changes	   at	   specific	   synapses,	   which	   is	   necessary	   for	   learning	   and	   forming	  
memories.	   RNA	   localization	   is	   studied	   in	   a	   wide	   range	   of	   organisms	   and	   many	   cell	   types	   besides	  
neurons.	  These	  studies	  have	  provided	  novel	  insights	  into	  the	  underlying	  mechanisms	  (reviewed	  in	  Holt	  
and	  Bullock,	  2009;	  St	  Johnston,	  2005).	  However,	  many	  questions	  remain:	  How	  is	  the	  transport	  of	  mRNAs	  
achieved	   and	   what	   are	   the	   components	   of	   the	   transport	   machinery?	   Since	   it	   is	   believed	   that	   RNA	  
localization	  occurs	   in	   transport	  RNPs,	  what	   is	   their	  molecular	   composition?	  How	  much	  does	   this	   vary	  
depending	  on	  which	  RNA	  is	  transported?	  Which	  motors	  are	  responsible	  for	  transport,	  and	  how	  are	  they	  
recruited	   to	   those	   transport	   RNPs?	   What	   is	   the	   common	   feature	   of	   localized	   RNAs	   –	   structure	   or	  
sequence	  –	  and	  how	  are	   they	   recognized?	  How	  are	   specific	   localized	  RNAs	   regulated	  on	   the	   levels	  of	  
stability/degradation,	   translational	   repression	   and	   how	   is	   translation	   relieved?	   What	   are	   the	  
physiological	   roles	   of	   factors	   that	   have	   been	   implicated	   in	   RNA	   localization?	  Although	   some	  of	   these	  
questions	  have	  been	  addressed,	  many	  years	  of	  intensive	  research	  of	  several	  groups	  will	  be	  necessary	  to	  
fully	  understand	  this	  process.	  I	  am	  especially	  interested	  in	  the	  molecular	  machinery	  underlying	  neuronal	  
RNA	   localization	   to	   dendrites	   and	   axons.	  While	   RNA	   localization	   in	   axons	  mainly	   serves	   purposes	   of	  
outgrowth	   and	   pathfinding,	   dendritic	   RNA	   localization	   is	   of	   utmost	   interest	   for	   learning	   and	  memory	  
processeses.	  My	  aims	  for	  this	  thesis	  were	  to	  unravel	  the	  functions	  of	  factors	  implicated	  in	  this	  process.	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However,	   their	  physiological	   roles	   in	  neurons	   remain	   largely	  elusive	  up	   to	  now.	  Those	   include	  protein	  
trans-­‐acting	  factors	  as	  well	  as	  regulatory,	  non-­‐coding	  RNAs.	  Furthermore,	  I	  wanted	  to	  gain	  insight	  into	  
which	   additional	   factors	   could	   be	   involved	   by	   targeting	   the	   composition	   of	   RNPs	   containing	   specific	  
dendritically	  localized	  mRNAs.	  	  
Concerning	   known	   factors	   with	   assumed	   functions	   in	   neuronal	   RNA	   localization,	   two	   very	  
prominent	   ones	   are	   Pum2	   and	   Stau2.	   Both	   were	   identified	   to	   be	   involved	   in	   RNA	   localization	   in	  
Drosophila	  (St	  Johnston,	  2005;	  Wickens	  et	  al.,	  2002).	  Even	  more	  interestingly,	  they	  were	  also	  identified	  
among	  others	  in	  a	  Drosophila	  screen	  for	  mutants	  with	  memory	  defects	  (Dubnau	  et	  al.,	  2003).	  Based	  on	  
these	  studies,	  both	  Pum2	  and	  Stau2	  are	   interesting	  candidates	   for	   investigation	  of	  RNA	   localization	   in	  
mammalian	  neurons.	  Up	  to	  now,	  their	  physiological	  roles	  were	  not	  very	  clear.	  The	  work	  presented	  here	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4.1 eIF4E	  is	  regulated	  by	  the	  translational	  repressor	  Pumilio2	  and	  is	  
involved	  in	  dendritic	  arborization	  and	  spine	  development	  
	  
Pumilio2,	  as	  a	  member	  of	  the	  Pumilio	  family	  (PUF)	  of	  proteins,	  is	  a	  known	  translational	  repressor	  
and	  was	  shown	  to	  be	  essential	   for	  memory	   formation	   in	  Drosophila	   (Dubnau	  et	  al.,	  2003).	   It	  was	   first	  
shown	   to	   be	   involved	   in	   RNA	   localization	   in	   Drosophila	   embryos,	   where	   it	   is	   necessary	   to	   establish	  
polarity	   (Wickens	   et	   al.,	   2002).	   In	  Drosophila,	   Pumilio	   binds	   to	   a	  motif	   in	   the	   3’-­‐UTR	   of	  mRNAs,	   the	  
nanos-­‐response	  element	  (NRE)	  that	  has	  been	  shown	  for	  hunchback	  (Schweers	  et	  al.,	  2002)	  and	  paralytic	  
(Mee	  et	  al.,	  2004).	  In	  mammalian	  neurons,	  no	  specific	  targets	  for	  translational	  repression	  by	  Pum2	  have	  
been	  shown	  to	  date	  and	  also	  the	  involvement	  of	  Pum2	  in	  RNA	  transport	  in	  neurons	  remains	  elusive.	  The	  
composition	  of	  Pum2-­‐containing	  neuronal	  particles	  is	  unknown	  (Kiebler	  and	  Bassell,	  2006).	  	  	  	  
In	  my	  investigation	  of	  Pum2	  in	  rat	  neurons,	  I	  showed	  that	  Pum2	  and	  the	  translation	  factor	  eIF4E	  
can	  be	  efficiently	  up-­‐	  or	  downregulated	  by	  transfection	  of	  primary	  neurons	  using	  CaPi	  precipitation	  or	  
nucleofection	  with	  the	  Amaxa	  device.	  This	  can	  be	  done	  both	  at	  the	  single-­‐cell	  level	  (CaPi	  precipitation)	  
as	   well	   as	   in	   biochemical/large	   scale	   levels	   (nucleofection)	   where	   the	   outcome	   is	   measured	   from	   a	  
mixed	  population	  of	  transfected	  and	  untransfected	  neurons.	  Showing	  efficient	  transfection	  is	  of	  special	  
importance	  as	  in	  work	  with	  primary	  neurons	  usually	  only	  low	  transfection	  efficiencies	  can	  be	  achieved.	  
For	  hippocampal	  neurons,	  this	  issue	  has	  previously	  been	  addressed	  in	  our	  lab	  (Zeitelhofer	  et	  al.,	  2009;	  
Zeitelhofer	   et	   al.,	   2007).	   Critical	   parameters	   for	   good	   transfection	   efficiencies	   and	   good	   cell	   survival	  
were	  found	  to	  be	  high	  concentrated,	  pure	  and	  supercoiled	  DNA	  in	  the	  plasmid	  preparations,	  as	  well	  as	  a	  
suitable	  nucleofection	  program	  using	   the	  Amaxa	  device.	  We	  had	  only	   recently	   started	   to	  use	   cortical	  
neuron	  cultures,	  which	  mainly	  have	  ethical	  and	  economic	  advantages,	  as	  far	  more	  cells	  can	  be	  isolated	  
from	  rat	  embryos	  leading	  to	  a	  drastic	  reduction	  in	  the	  number	  of	  animals	  that	  have	  to	  be	  used.	  Typically	  
around	  2	  –	  4	  million	  hippocampal	  neurons	  can	  be	  obtained	  from	  the	  preparation	  of	  the	  embryos	  from	  
one	   pregnant	   rat,	   whilst	   more	   than	   50	  million	   cortical	   neurons	   can	   be	   isolated	   from	   the	   equivalent	  
number	   of	   embryos.	   As	   hippocampal	   cultures	   are	   already	   routinely	   prepared	   in	   the	   lab	   at	   least	   two	  
times	  a	  week,	  the	  cortical	  cultures	  can	  be	  prepared	  from	  the	  same	  animals	  without	  having	  to	  sacrifice	  
extra	   ones.	   Considering	   these	   advantages,	  we	   are	   now	  using	   cortical	   neurons	   for	   experiments	  where	  
high	   cell	   numbers	   are	   necessary,	   like	   protein	   isolation	   for	   Western	   blots,	   luciferase	   assays,	   or	   RNA	  
isolation	  for	  qPCR.	  I	  now	  optimized	  the	  nucleofection	  protocol	  so	  that	  efficiencies	  are	  now	  sufficient	  for	  
such	  experiments.	  The	  critical	  parameter	  that	  is	  distinct	  from	  nucleofections	  of	  hippocampal	  neurons	  is	  
the	  use	  of	  an	  alternative	  nucleofection	  program	  on	  the	  Amaxa	  machine	  (AK-­‐009	  for	  cortical	  neurons).	  
Although	   hippocampal	   neurons	   are	   distinct	   from	   cortical	   neurons,	   the	   principal	   cellular	   functions	   are	  
comparable	   and	   can	   therefore	   be	   used	   for	   investigation.	   It	   remains	   to	   be	   seen	   whether	   future	  
experiments	  will	  reveal	  any	  principal	  differences	  between	  both	  nerve	  cell	  preparations.	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Firstly,	  I	  focused	  on	  the	  potential	  effect	  of	  Pum2	  on	  translational	  regulation	  of	  eIF4E	  via	  its	  3’-­‐UTR.	  
For	  this,	   I	   took	  advantage	  of	  well-­‐established	   luciferase	  assays.	  Loss	  of	  Pum2	  led	  to	  an	   increase	   in	  the	  
activity	  of	   the	   luciferase	  reporter	  under	  control	  of	   the	  eIF4E	  3’-­‐UTR,	  while	   the	  same	  reporter	   showed	  
less	  activity	  upon	  overexpression	  of	  Pum2.	  These	  results	  support	  the	  hypothesis	  that	  the	  translational	  
repressor	   function	   of	   the	   Pumilio	   family	   (PUF)	   proteins	   is	   conserved	   across	   species	   (Wickens	   et	   al.,	  
2002).	  In	  Drosophila,	  translation	  of	  eIF4E	  had	  previously	  been	  shown	  to	  be	  regulated	  by	  Pumilio	  (Menon	  
et	   al.,	   2004)	   and	   was	   therefore	   a	   promising	   target	   for	   investigation	   in	   mammalian	   neurons.	   The	  
relationship	   between	  Pum2	  and	  eIF4E,	   however,	   seems	   to	   be	  more	   complex	   than	   sheer	   translational	  
control.	  It	  was	  recently	  shown	  in	  Xenopus	  that	  Pum2	  binds	  the	  5’-­‐cap	  of	  mRNAs	  and	  thereby	  competes	  
with	  eIF4E	  for	  RNA	  binding	  to	  control	  translation	  (Cao	  et	  al.,	  2010).	  This	  gives	  rise	  to	  the	  speculation	  that	  
Pum2	  could	  play	  a	  more	  general	  role	  in	  translational	  control.	  	  	  	  
In	   fact,	   it	   is	   very	   likely	   that	   eIF4E	   is	   not	   the	   sole	   target	   of	   regulation	   by	   Pum2	   in	  mammalian	  
neurons.	   Besides	   several	   targets	   in	  Drosophila	   embryos,	   earlier	   studies	   in	  Drosophila	   already	   proved	  
translational	  control	  of	  the	  para	  sodium	  channel	  gene	  by	  Pumilio	  (Mee	  et	  al.,	  2004),	  and	  our	  lab	  showed	  
first	  indications	  that	  also	  the	  rat	  sodium	  channel	  scn1a	  is	  translationally	  controlled	  by	  Pum2	  (Vessey	  et	  
al.,	   2010).	   Although	   no	   studies	   have	   further	   proven	   the	   regulation	   of	   distinct	   mRNAs	   by	   Pumilio	   in	  
mammals,	  there	  were	  estimations	  that	  mammalian	  Pum1	  and	  Pum2	  might	  regulate	  up	  to	  15	  %	  of	  the	  
cell’s	   transcriptome	   (Galgano	   et	   al.,	   2008).	   This	   would	   suggest	   a	   more	   general	   role	   for	   Pumilio	   in	  
translational	   control,	   which	   is	   in	   contrast	   to	   theories	   of	   other	   groups	   that	   suggest	   that	   Pumilio	   only	  
regulates	  specific	  transcripts	  (Menon	  et	  al.,	  2004).	  My	  results	  here	  show	  that	  Pum2	  also	  regulates	  the	  
translation	  of	  Pum2	  mRNA	  itself,	  and	  also	  the	  Arc	  mRNA.	  The	  3’-­‐UTR	  of	  Pum2	  contains	  NRE	  motifs,	  that	  
would	   justify	   the	   translational	   effects	   on	   reporter	   constructs	   upon	   misregulation	   of	   Pum2,	   but	   Arc	  
mRNA	  does	  not	   contain	  any	  obvious	  NRE	  motif.	  The	  effect	  on	   the	   reporter	   containing	   the	  Arc	   3’-­‐UTR	  
could	   possibly	   be	   a	   consequence	   of	   the	   interaction/competition	   of	   Pum2	   with	   eIF4E	   protein	   during	  
translational	   control	   and	   therefore	   be	   an	   indirect	   consequence	   of	   Pum2	   misregulation.	   Another	  
possibility	   would	   be	   that	   Pum2	   also	   recognizes	   other	   sequence	   elements	   than	   NRE	   motifs,	   or	   it	  
recognizes	  structural	  motifs	  rather	  than	  sequence	  ones,	  or	  the	  interaction	  is	  indirect	  via	  other	  factors.	  
Pumilio	   is	   not	   only	   known	   for	   its	   physiological	   roles	   as	   a	   translational	   regulator	   and	   in	   RNA	  
localization,	  but	  has	  also	  been	  shown	  as	  an	  important	  factor	  for	  memory	  formation.	  This	  role	  in	  memory	  
formation	   will	   very	   likely	   rely	   on	   its	   physiological	   functions,	   but	   mutational	   analysis	   in	   mammals	   is	  
missing	  up	  to	  now.	  A	  Pum2	  gene	  trap	  mouse	  has	  been	  generated	  (Xu	  et	  al.,	  2007),	  but	  investigation	  of	  
brain	  deficits	  has	  yet	  to	  be	  performed	  and	  is	  going	  to	  be	  initiated	  in	  our	  lab	  by	  a	  colleague.	  Formation	  of	  
long-­‐term	   memory	   in	   Drosophila	   requires	   Pumilio	   (Dubnau	   et	   al.,	   2003).	   In	   cultured	   hippocampal	  
neurons,	   Pum2	   localizes	   within	   the	   somatodendritic	   compartment	   near	   synapses	   and	   also	   to	   stress	  
granules	  (Vessey	  et	  al.,	  2006).	  John	  Vessey,	  a	  former	  PhD	  student	  in	  the	  lab,	  and	  myself	  could	  now	  show	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that	  dendritic	  spine	  morphogenesis	  and	  synaptic	  function	  are	  influenced	  upon	  misregulation	  of	  Pum2.	  In	  
addition,	  Pum2	  regulates	  the	  number	  of	  excitatory	  synapses	  and	  affects	  mEPSC	  frequency	  (Vessey	  et	  al.,	  
2010).	  This	  suggests	  a	  role	  for	  Pum2	  in	  mammalian	  memory	  information	  as	  well,	  but	  further	  evidence	  is	  
needed	  and	  will	  be	  the	  subject	  of	  future	  work	  of	  the	  lab.	  
Having	  shown	  that	  translation	  of	  eIF4E	   is	  regulated	  by	  Pum2,	   I	   investigated	  whether	  eIF4E	   itself	  
would	   exhibit	   effects	   on	   neuronal	   development	   and	   function.	   I	   found	   that	  misregulation	   of	   eIF4E	   in	  
cultured	   hippocampal	   neurons	   led	   to	   alterations	   in	   dendrite	   development,	   similar	   to	   those	   observed	  
upon	  misregulation	  of	  Pum2	  itself	  (Vessey	  et	  al.,	  2010).	  Sholl	  analysis	  (Sholl,	  1953)	  revealed	  that	  loss	  of	  
Pum2	   leads	   to	   increased	   arborization	   of	   the	   dendritic	   tree,	  while	   overexpression	   of	   Pum2	   leads	   to	   a	  
simplified	  dendritic	  tree.	   I	  had	  expected	  a	  result	  opposite	  to	  that	  gained	  from	  Pum2	  misregulation,	  as	  
Pum2	  is	  a	  negative	  regulator	  of	  eIF4E.	  Nevertheless,	  it	  is	  not	  surprising	  that	  this	  is	  not	  the	  case.	  First	  of	  
all	  the	  pathways	  regulating	  neuronal	  development	  are	  complex	  and	  already	  small	  changes	  in	  the	  levels	  
of	   important	   factors	   could	  disturb	  a	   fine-­‐tuned	  equilibrium.	  Pum2	  has	  additionally	  been	   shown	   to	  be	  
regulated	  by	  miR-­‐134	  (Fiore	  et	  al.,	  2009),	  which	  could	  be	  another	  factor	  fine-­‐tuning	  the	  levels	  of	  Pum2	  
and	   thereby	   its	   targets.	   As	   discussed	   above,	   Pum2	   appears	   to	   be	   a	   regulator	   of	  many	   transcripts	   in	  
mammalian	   neurons	   –	   as	   is	   eIF4E	   itself	   –	   and	   both	   the	   effects	   observed	   upon	   Pum2	   or	   eIF4E	  
misregulation	  could	  be	  caused	   indirectly.	   It	   is	   therefore	  emerging	   that	  Pum2	  and	  eIF4E	  are	   important	  
regulators	  of	  dendritic	  arborization,	  but	  which	  factors	  are	  directly	  responsible	  for	  the	  observed	  effects	  
will	  need	  to	  be	  further	  investigated.	  	  
Misregulation	   of	   eIF4E	   not	   only	   affects	   dendritic	   arborization	   but	   also	   alters	   the	   numbers	   and	  
morphology	  of	  dendritic	  spines.	  Both	  loss	  and	  overexpression	  of	  eIF4E	  led	  to	  a	  reduction	  in	  the	  number	  
of	   protrusions	   in	  mature	   hippocampal	   neurons,	   and	   an	   increase	   in	   the	   number	   of	   protrusions	   longer	  
than	  2	  µm.	  This	  indicates	  that	  the	  control	  of	  neuronal	  function	  that	  is	  probably	  indirectly	  carried	  out	  by	  
eIF4E	  is	  tightly	  controlled	  and	  alterations	  in	  both	  directions	  of	  the	  amount	  of	  eIF4E	  lead	  to	  severe	  effects	  
in	   the	   appearance	   of	   dendritic	   spines.	   The	   effects	   on	   dendritic	   spines	   that	   were	   observed	   upon	  
misregulation	  of	  Pum2	  (Vessey	  et	  al.,	  2010)	  could	  be	  caused	  by	  affecting	  eIF4E	  levels,	  or	  alternatively	  by	  
regulation	  of	  targets	  further	  downstream	  of	  Pum2	  and	  eIF4E.	  	  
Summing	   up,	   the	   effects	   observed	   upon	   loss	   or	   overexpression	   of	   eIF4E,	   suggest	   an	   important	  
role	  for	  eIF4E	  in	  neuronal	  function.	  Its	  mRNA	  could	  be	  transported	  to	  distal	  dendrites	  in	  a	  translationally	  
repressed	   state	  mediated	  by	   Pum2,	  where	  molecular	   triggers	  would	   then	   release	   this	   repression	   and	  
eIF4E	  protein	  regulates	  translation	  of	  other	  localized	  mRNAs.	  Further	  experiments	  will	  be	  carried	  out	  in	  
the	  lab	  to	  investigate	  the	  role	  of	  eIF4E	  locally	  at	  synaptic	  sites	  in	  dendrites.	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4.2 Investigation	  of	  microRNA-­‐dependent	  regulation	  of	  the	  
dendritically	  localized	  mRNAs	  LIMK1	  and	  Arc	  
	  
Translational	   control	   by	  miRNAs	   is	   an	   alternative	  means	   of	   translational	   control	   that	   was	   also	  
proposed	   to	   be	   involved	   in	   local	   restriction	   of	   protein	   synthesis	   as	   well	   (reviewed	   in	   Kosik,	   2006).	  
Dendritically	  localized	  mRNAs	  typically	  have	  long	  3’-­‐UTRs	  carrying	  signals	  for	  localization	  and	  translation	  
control,	  but	  also	  harboring	  numerous	  potential	  miRNA-­‐binding	  sites.	   I	  used	  different	  microRNA	  target	  
prediction	   software	   to	   identify	   potential	   binding	   sites	   in	   the	   3’-­‐UTRs	   of	   the	   most	   intensely	   studied	  
dendritically	   localized	  mRNAs.	   The	   predictions	   yielded	   different,	   but	   overlapping	   results	   and	   showed	  
potential	   binding	   sites	   for	   all	   dendritically	   localized	   mRNAs.	   Although	   various	   prediction	   software	  
packages	  exists	  to	  date,	  they	  are	  mostly	  based	  on	  similar	  algorithms	  searching	  for	  conservation	  across	  
species	  and	  complementarity	  in	  the	  seed	  sequence.	  One	  drawback	  that	  many	  algorithms	  do	  usually	  not	  
address	  is	  site	  accessibility:	  If	  the	  predicted	  site	  is	   located	  in	  a	  highly	  structured	  sequence	  stretch,	  it	   is	  
less	   likely	  to	  be	  accessible	  to	  the	  microRNA.	  Additional	  programs	  have	  to	  be	  used	  to	  address	  also	  this	  
issue,	  one	  is	  for	  example	  “RNAup”	  that	  is	  included	  in	  the	  Vienna	  RNA	  package.	  As	  first	  candidates	  for	  my	  
study	  I	  chose	  LIMK1	  and	  Arc	  mRNA.	  LIMK1	  was	  also	  included	  as	  positive	  control	  that	  was	  published	  to	  be	  
regulated	  by	  miR-­‐134	  (Schratt	  et	  al.,	  2006).	  	  
I	  used	  luciferase	  reporters	  fused	  to	  LIMK1	  and	  Arc	  3’-­‐UTR	  to	  assay	  for	  effects	  upon	  misregulation	  
of	  miRNAs,	  as	  well	  as	  GFP	  reporters	  set	  up	  in	  a	  similar	  way.	  Furthermore,	  I	  performed	  real-­‐time	  qPCR	  to	  
quantify	  potential	  candidate	  targets	  after	  misregulation	  of	  miRNAs.	  The	  effects	  observed	  on	  LIMK1	  and	  
Arc	  were	  small	  and,	  sometimes,	  contradicting.	  For	  LIMK1	  I	  tested	  the	  following	  three	  miRNAs:	  miR-­‐369-­‐
3p,	  miR-­‐106b	  and	  miR-­‐134.	  Overexpression	  of	  none	  of	  the	  tested	  miRNAs	  changed	  LIMK1	  mRNA	  levels	  
as	  assayed	  by	  qPCR.	  Nonetheless,	  fluorescence	  intensity	  of	  a	  GFP	  reporter	  in	  HeLa	  was	  decreased	  upon	  
mutations	   in	   the	   potential	   binding	   sites	   of	   miR-­‐369-­‐3p	   and	   miR-­‐134	   in	   the	   reporter	   constructs.	   In	  
contrast,	   overexpression	   of	  miR-­‐369-­‐3p	   unexpectedly	   led	   to	   an	   increased	   luciferase	   reporter	   activity.	  
LIMK1	  regulation	  by	  miR-­‐134	  was	  originally	  included	  to	  serve	  as	  positive	  control	  for	  these	  experiments.	  
Disappointingly,	  I	  could	  not	  reproduce	  the	  effects	  that	  had	  been	  observed	  before	  (Schratt	  et	  al.,	  2006).	  
The	   effects	   caused	   by	   miR-­‐134	   on	   LIMK1	   mRNA	   could	   be	   too	   small	   to	   be	   observed	   in	   my	   assays.	  
Alternatively	   it	   is	   possible	   that	   additional	  mechanisms	  might	  be	  necessary	   for	   translational	   control	   of	  
LIMK1.	  	  	  	  
Of	   the	  tested	  miRNAs	  potentially	   regulating	  the	  Arc	   transcript	   (miR-­‐326,	  miR-­‐19a	  and	  miR-­‐19b),	  
only	  miR-­‐19a	  showed	  any	  promising	  effect.	  Overexpression	  of	  miR-­‐19b	  did	  not	  lead	  to	  significant	  effects	  
in	   any	   of	   my	   experiments.	   Overexpression	   of	   miR-­‐326	   decreased	   the	   activity	   of	   luciferase	   reporters	  
under	   the	   control	   of	  Arc	   3’-­‐UTR,	   but	   did	   not	   yield	   a	   significant	   change	   in	   qPCR	   for	   endogenous	  Arc	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mRNA.	  Experiments	  misregulating	  miR-­‐19a	  yielded	   the	  most	   interesting	   results	  of	   the	  miRNAs	   tested.	  
Overexpression	  led	  to	  reduced	  Arc	  mRNA	  levels	  in	  qPCR,	  and	  to	  decreased	  luciferase	  reporter	  activities	  
in	  cortical	  neurons,	  arguing	  for	  a	  regulation	  of	  Arc	  mRNA	  by	  miR-­‐19a.	  However,	  luciferase	  assays	  in	  HeLa	  
showed	   the	   opposite	   effect	   and	   indicate	   that	   for	   miRNA-­‐dependent	   regulation	   of	   Arc	   additional	  
neuronal	  factors	  could	  be	  needed	  that	  are	  missing	  in	  a	  HeLa	  environment.	  	  	  	  
In	  most	  experiments,	  effects	  of	  miRNAs	  were	  rather	  subtle	  and	  especially	  experiments	  in	  primary	  
neurons	   showed	   high	   variations.	   That	   all	   effects	   observed	   were	   only	   subtle,	   and	   also	   in	   most	   cases	  
highly	   variable	   between	   biological	   repeats	   makes	   validation	   of	   miRNA-­‐mRNA	   pairs	   in	   neurons	   very	  
difficult.	  One	  cause	  for	  the	  subtlety	  of	  the	  effects	  could	  be	  explained	  that	  several	  miRNA-­‐binding	  sites	  –	  
of	  either	  the	  same	  or	  different	  miRNAs	  –	  are	  necessary	  for	  efficient	  translational	  regulation	  (Lee	  et	  al.,	  
2008).	  	  
Interestingly,	   there	  might	   be	   yet	   another	   level	   of	   regulation.	   For	   miR-­‐369-­‐3p	   action	   on	   LIMK1	  
mRNA,	  I	  observed	  an	  upregulation	  of	  the	  target	  upon	  overexpression,	  which	  is	  contradicting	  the	  general	  
hypothesis	   that	  miRNAs	  downregulate	   translation	  of	   their	   targets.	  However,	   recently	   a	   study	   showed	  
that	  depending	  on	  the	  cell	  cycle	  state,	  miRNAs	  can	  also	  lead	  to	  upregulation	  of	  their	  targets	  (Vasudevan	  
et	  al.,	  2007).	  This	  is	  especially	  interesting,	  as	  the	  cells	  that	  exhibited	  mRNA-­‐increasing	  effects	  of	  miRNAs	  
in	  that	  study	  were	  post-­‐mitotic.	  The	  primary	  neurons	  that	  we	  are	  using	  in	  culture	  are	  also	  post-­‐mitotic	  
cells	  and	  could	  therefore	  harbor	  this	  pathway	  as	  well.	  	  
As	  mentioned	  above,	  regulation	  of	  Arc	  mRNA	  by	  miR-­‐19a	  seems	  to	  be	  the	  most	  promising	  miRNA-­‐
mRNA	  pair	  of	  those	  screened	  in	  this	  study.	  Besides	  being	  able	  to	  bind	  its	  target,	  a	  miRNA	  also	  has	  to	  be	  
expressed	   in	   the	   same	   tissue	   at	   the	   same	   time	   in	   development,	  which	   could	   be	   a	   drawback	   for	   this	  
suggested	  pair,	  as	  miR-­‐19a	  does	  not	  seem	  to	  be	  expressed	  in	  hippocampus	  (Landgraf	  et	  al.,	  2007).	  Since	  
Arc	  as	  an	  immediate-­‐early	  gene	  is	  expressed	  at	  very	  low	  levels	  in	  non-­‐active	  neurons,	  it	  is	  possible	  that	  
also	  the	  miRNA	  regulating	  it	  is	  only	  upregulated	  upon	  stimulation.	  This	  will	  have	  to	  be	  tested	  in	  future	  
experiments.	  
While	  protein	  factors	  like	  Pum2	  seem	  to	  induce	  large-­‐scale	  effects	  on	  the	  translation	  of	  its	  targets,	  
miRNA-­‐dependent	   regulation	   seems	   to	   act	   in	   a	  more	   subtle	   way.	   This	   could	   have	  major	   advantages	  
especially	  in	  a	  process	  like	  local	  protein	  synthesis	  at	  synaptic	  sites,	  as	  modification	  of	  the	  synapse	  can	  be	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4.3 Staufen2	  is	  a	  regulator	  of	  the	  actin	  cytoskeleton	  in	  developing	  
neurons	  
	  
Drosophila	  Staufen	  was	  one	  of	  the	  first	  factors	  identified	  to	  be	  involved	  in	  oskar	  mRNA	  transport	  
and	   translational	   control	   (reviewed	   in	   St	   Johnston,	   2005).	   In	   mammals,	   both	   Stau1	   and	   Stau2	   were	  
implicated	   in	   dendritic	   RNA	   transport	   (Kiebler	   and	   DesGroseillers,	   2000),	   but	   their	   target	  mRNAs	   are	  
poorly	  defined.	  In	  Drosophila,	  several	  target	  mRNAs	  for	  Stau	  are	  known,	  most	  prominently	  bicoid,	  oskar,	  
and	  prospero	  mRNAs	  (reviewed	  in	  St	  Johnston,	  2005).	  In	  mammals,	  only	  β-­‐actin	  mRNA	  was	  suggested	  as	  
a	   target	  mRNA	   (Goetze	  et	  al.,	  2006).	  Staufen	   is	  a	  double-­‐stranded	  RNA-­‐binding	  protein	  and	   therefore	  
target	  sequences	  are	  hard	  to	  identify	  as	  dsRBDs	  do	  not	  have	  primary	  sequence	  specificity.	  dsRBDs	  are	  
rather	  thought	  to	  target	  elements	  that	  consist	  of	  a	  complex	  secondary	  or	  tertiary	  structure	  that	  is	  hard	  
to	  predict.	  No	  consensus	  sequence	  for	  a	  Staufen	  binding	  site	  has	  been	  identified	  so	  far.	  RNAs	  that	  were	  
enriched	   in	   Stau2	   immuno-­‐precipitations	   have	   been	   identified	   in	   our	   lab	   by	   microarray	   analysis	   and	  
deep	   sequencing	   and	   some	  have	  been	   validated	  by	   real-­‐time	  qPCR	   (Heraud	  and	  Doyle,	   unpublished).	  
The	  Kiebler	   lab	   is	   currently	   investigating	  which	  of	   those	  are	  biologically	   relevant.	  Taken	   together,	   this	  
approach	   will	   allow	   for	   a	   systematic	   comparison	   of	   potential	   Stau2	   targets	   and	   could	   lead	   to	   the	  
identification	  of	  common	  features	  and	  potentially	  a	  consensus	  site.	  	  
What	  could	  be	  potential	   functions	   for	  mammalian	  Staufen	  proteins?	  While	  Stau1	  was	  shown	  to	  
play	   a	   role	   in	   translational	   control	   (Dugre-­‐Brisson	   et	   al.,	   2005)	   as	  well	   as	   in	  mRNA	  decay	   (Kim	   et	   al.,	  
2005;	  Kim	  et	  al.,	  2007),	  no	  molecular	  function	  for	  Stau2	  has	  yet	  been	  defined,	  except	  its	  involvement	  in	  
RNA	   transport	   (Tang	  et	   al.,	   2001).	   It	  was	   suggested	   that	   Stau2	   could	   exhibit	   a	   scaffolding	   function	   to	  
bring	  mRNAs	   in	  a	  certain	  conformation	  that	  could	  be	  necessary	  for	  recognition	  by	  other	  factors,	  or	  to	  
increase	  transcript	  stability	  (Goetze	  et	  al.,	  2006;	  Nam	  et	  al.).	  This	  view	  is	  supported	  by	  data	  showing	  that	  
Stau2	  is	  present	  in	  the	  nucleus	  (Macchi	  et	  al.,	  2004),	  possibly	  suggesting	  that	  it	  already	  binds	  its	  target	  
mRNAs	  there	  and	  regulates	  their	  assembly	  into	  transport	  particles.	  	  
In	  this	  work,	  I	  wanted	  to	  systematically	  extend	  previous	  studies	  by	  a	  former	  graduate	  student	  in	  
the	  lab,	  Bernhard	  Goetze	  	  (Goetze	  et	  al,	  2006).	  Therefore,	  I	  investigated	  the	  localization	  of	  Stau2	  during	  
the	  different	   stages	  of	  neuronal	  development	  as	  described	  before	   (Dotti	   et	   al.,	   1988).	   Throughout	   all	  
stages,	  Stau2	  was	  found	  in	  neurites	  of	  all	  kinds,	  both	  axons	  and	  dendrites.	  This	  is	  in	  contrast	  to	  previous	  
findings,	  where	  Stau2	  was	  only	  detected	  in	  dendrites,	  but	  not	  axons	  (Duchaine	  et	  al.,	  2002).	  This	  could	  
possible	   arise	   from	   the	  use	   of	   better	   antibodies	   now,	   as	   compared	   to	   the	   older	   publication.	   Another	  
important	  question	  is	  whether	  Staufen	  complexes	  are	  dependent	  on	  the	  cytoskeleton	  in	  neurons.	  Stau2	  
localization	   upon	   depolymerization	   of	   microtubules	   was	   altered	   and	   appeared	   more	   patch-­‐like,	  
supporting	  the	  view	  that	  Stau2	  travels	  along	  microtubules	  (Kiebler	  et	  al.,	  1999;	  Köhrmann	  et	  al.,	  1999b).	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As	   Stau2	   was	   shown	   to	   influence	   β-­‐actin	   in	   mature	   neurons	   (Goetze	   et	   al.,	   2006),	   I	   also	   tested	   its	  
influence	  on	   the	   actin	   cytoskeleton	   in	   developing	  neurons.	   F-­‐actin	   staining	  was	   reduced	  upon	   loss	   of	  
Stau2	   in	  developing	  neurons	   (confirmation	  and	  extension	  of	  Xie,	  unpublished).	  β-­‐actin	  mRNA	  was	  not	  
enriched	  in	  the	  microarray	  previously	  mentioned	  (Heraud	  and	  Doyle,	  unpublished).	  As	  β-­‐actin	  mRNA	  is	  
one	  of	  the	  most	  abundant	  mRNAs	   in	  cells,	   the	  enrichment	   in	  an	   immunoprecipitation	  could	  simply	  be	  
not	   strong	   enough	   to	   be	   counted	   as	   enriched.	   Clearly,	   further	   experiments	   have	   to	   be	   performed	   to	  
investigate	  this	  in	  more	  detail.	  In	  the	  meantime,	  I	  decided	  to	  focus	  on	  another	  important	  mRNA	  coding	  
for	  a	  cytoskeleton	  binding	  protein.	  	  	  
An	  RNA	  that	  has	  been	   identified	  via	  microarray	  analysis	   is	  the	  GTPase	  RhoA	   (Heraud	  and	  Doyle,	  
unpublished),	   whose	   mRNA	   localizes	   to	   axons	   and	   encodes	   for	   a	   known	   regulator	   of	   the	   actin	  
cytoskeleton	   (reviewed	   in	   (Van	   Aelst	   and	   D'Souza-­‐Schorey,	   1997)).	   Stau2	   affects	   the	  mRNA	   of	  RhoA:	  
Interestingly,	  RhoA	  levels	  rose	  upon	  loss	  of	  Stau2.	  In	  future	  experiments,	  the	  effects	  on	  other	  members	  
of	  the	  Rho	  family	  –	  Rac	  and	  Cdc42	  –	  will	  be	  investigated	  to	  test	  whether	  Stau2	  specifically	  acts	  on	  RhoA	  
or	  on	   several	  monomeric	  GTPases	   that	  are	  crucial	   for	  neuronal	  development	   (Van	  Aelst	  and	  D'Souza-­‐
Schorey,	  1997).	  
Returning	   to	   the	   functional	   analysis	   of	   Stau2,	   one	   suggested	   function	   of	   this	   protein	   is	   in	  
translational	   control.	   In	   luciferase	   assays,	   I	   was	   able	   to	   show	   an	   effect	   of	  misregulation	   of	   Stau2	   on	  
reporters	   fused	   to	   β-­‐actin	   constructs	   of	   either	   5’-­‐UTR,	   coding	   sequence	   or	   3’-­‐UTR.	   This	   effect	   was	  
specific	   for	  reporters	  containing	  the	  coding	  sequence	  of	  β-­‐actin;	   this	   led	  to	  an	   increased	  activity	  upon	  
overexpression	   of	   Stau2.	   Luciferase	   assays	   reflect	   all	   levels	   of	   regulation	   of	   gene	   expression,	   so	   the	  
effect	   observed	   could	   occur	   before	   the	   level	   of	   translational	   control.	   Experiments	   involving	   real-­‐time	  
qPCR	   actually	   demonstrated	   that	   the	   effect	   occurs	   at	   the	   RNA	   level,	   suggesting	   that	   this	   is	   not	   a	  
translational	  effect	  but	  rather	  an	  effect	  on	  the	  stability	  of	  the	  RNA.	  These	  experiments	  give	  rise	  to	  the	  
hypothesis	   that	   the	  coding	  sequence	  of	  β-­‐actin	   carries	  a	  Coding	  Region	   instability	  Determinant	   (CRD),	  
similar	  to	  that	  shown	  for	  myc	  mRNA	  (Weidensdorfer	  et	  al.,	  2009).	  Stau2	  could	  be	  the	  factor	  recognizing	  
this	  CRD	  and	  stabilizing	  the	  RNA,	  or	  it	  could	  also	  only	  be	  the	  chaperone	  that	  makes	  this	  motif	  accessible	  
to	  other	   factors.	  This	   is	   in	  accordance	  with	  my	  experiments	   for	  RhoA,	  as	   the	  effect	  of	  Stau2	  on	  RhoA	  
seems	   to	   be	   carried	   out	   on	   the	   RNA	   level,	   rather	   than	   on	   a	   translational	   level.	   Taken	   together,	   it	   is	  
possible	   that	   Stau2	   might	   regulate	   the	   actin	   cytoskeleton	   via	   RhoA	   and/or	   via	   additional	   unknown	  
factors.	  	  
All	  those	  experiments	  suggest	  a	  role	  of	  Stau2	  in	  neurite	  outgrowth.	  A	  former	  graduate	  student	  in	  
the	  lab,	  Yunli	  Xie,	  showed	  that	   loss	  of	  Stau2	  led	  to	  a	  defect	   in	  axon	  outgrowth	  (Xie,	  unpublished).	   It	   is	  
likely	   that	   this	   effect	   is	   caused	  by	   an	   alteration	  of	   the	   actin	   cytoskeleton	   that	   has	   been	   shown	   to	   be	  
critical	  for	  axon	  outgrowth	  (Ahnert-­‐Hilger	  et	  al.,	  2004;	  Bradke	  and	  Dotti,	  1999;	  Lee	  et	  al.,	  2000;	  Wu	  et	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al.,	  2005).	  I	  am	  planning	  to	  repeat	  and	  extend	  the	  experiments	  investigating	  axon	  outgrowth	  upon	  loss	  
of	  Stau2,	  to	  further	  investigate	  how	  and	  if	  the	  actin	  cytoskeleton	  is	  affected	  by	  Stau2	  and	  whether	  this	  
leads	  to	  an	  axon	  outgrowth	  phenotype.	  I	  experienced	  that	  very	  young	  neurons	  –	  axon	  outgrowth	  starts	  
at	  1	  –	  3	  DIV	  –	  are	  hard	  to	  transfect	  and	  efficient	  knockdown	  requires	  at	  least	  3	  days	  of	  expression	  of	  the	  
shRNA.	   I	   will	   now	   change	   the	   strategy	   from	   transfection	   of	   shRNA	   expressing	   plasmids	   via	   CaP-­‐
precipitation	   to	  nucleofection	  of	  double-­‐stranded	  siRNA	  oligos.	   In	   initial	  experiments,	   those	  were	   less	  
detrimental	   for	  neuronal	  morphology	  than	  nucleofection	  of	  plasmids.	  The	  drawback	  of	   this	  method	   is	  
the	  identification	  of	  Stau2-­‐depleted	  cells	  in	  a	  mixed	  pool,	  in	  contrast	  to	  sh-­‐plasmid	  transfected	  cells	  that	  
co-­‐express	   GFP.	   These	   experiments	   will	   yield	   interesting	   insight	   into	   whether	   and	   how	   Stau2	   affects	  
axon	  outgrowth	  and	  the	  regulatory	  connection	  between	  Stau2	  and	  the	  actin	  cytoskeleton.	  This	  will	  be	  
intensely	  investigated	  in	  the	  future.	  	  
Furthermore,	  more	   potential	   target	  mRNAs,	  which	  were	   identified	   by	  microarray	   analysis	   from	  
Stau2-­‐IPs	  (Heraud	  and	  Doyle,	  unpublished)	  will	  be	  closely	  investigated.	  The	  identification	  of	  Stau2	  target	  
mRNAs	  will	  yield	  novel	  insights	  into	  the	  various	  physiological	  roles	  of	  Stau2	  during	  neural	  development	  
and	  synaptic	  function.	  	  
 
4.4 Investigating	  the	  protein	  composition	  of	  transport	  RNPs	  
 	  
The	  composition	  of	  neuronal	  transport	  granules	  is	  still	  a	  matter	  of	  debate,	  and	  scientific	  data	  are	  
sparse	   and	   conflicting	   (Bassell	   &	   Kiebler,	   2006).	   I	   was	   especially	   interested	   in	   the	   composition	   of	  
granules	   in	   which	   specific,	   dendritically	   localized	   mRNAs	   are	   transported	   to	   distal	   dendrites.	   My	  
hypothesis	  was	  that	  those	  granules	  would	  have	  common	  core	  components	  –	  probably	  motor	  proteins,	  
and	  proteins	  targeting	  the	  granules	  to	  dendrites	  –	  as	  well	  as	  factors	  that	  are	  specific	  for	  certain	  mRNAs.	  
Those	   specific	   factors	   could	   include	   proteins	   and	   RNAs	   that	   regulate	   the	   stability	   and	   repress	   the	  
translation	  of	   individual	  mRNAs	  during	   transport,	   as	  up	   to	  now	  mainly	   sequence-­‐specific	   translational	  
repressors,	   but	   less	   general	   TAFs	   that	   act	   on	   each	   RNA	   have	   been	   identified.	   Specific	   factors	   for	  
individual	   translational	   control	  also	  make	  more	  sense	  as	   relief	  of	   translation	  can	  be	  more	   individually	  
regulated.	  	  
I	  chose	  the	  StreptoTag	  approach	  (Windbichler	  and	  Schroeder,	  2006)	  as	  the	  method	  to	  address	  the	  
question	  of	  the	  composition	  of	  transport	  RNPs.	  The	  candidate	  mRNAs	  of	  choice	  were	  LIMK1	  (based	  on	  
previous	  work	  by	  Schratt	  and	  colleagues	  (Schratt	  et	  al.,	  2006)	  and	  the	  Arc	  3’-­‐UTR,	  which	   is	  one	  of	  the	  
best-­‐studied	  dendritic	  mRNAs.	  I	  could	  show	  that	  the	  StreptoTag	  approach	  is	  principally	  working	  by	  using	  
a	  well	  established	  mRNA-­‐protein	  pair:	  Rev	  protein	  and	  the	  RRE	  element	  as	  bait	  (Malim	  et	  al.,	  1989).	  To	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investigate	   neuronal	   RNA	   granules,	   I	   had	   to	   adopt	   the	   approach	   and	   performed	   optimization	  
experiments	   to	   increase	   mRNA	   binding	   to	   the	   Sepharose	   column,	   as	   well	   as	   experiments	   to	   reduce	  
protein	  background	  in	  the	  eluted	  fractions.	  RNA	  binding	  efficiency	  is	  a	  critical	  parameter	  that	  was	  also	  
addressed	   by	   the	   group	   that	   initially	   published	   the	   approach	   (Piganeau	   and	   Schroeder,	   2003;	  
Windbichler	  et	  al.,	  2008).	  As	  the	  StreptoTag	  aptamer	  binds	  the	  streptomycin-­‐coupled	  beads	  with	  lower	  
affinity	   than	   for	   example	   the	  MS2-­‐binding	   protein	   binds	   to	   the	  MS2-­‐binding	   site	   aptamers,	   this	   is	   a	  
major	  drawback	  of	  the	  method.	  The	  high	  background	  of	  unspecific	  protein	  in	  the	  eluted	  fractions	  could	  
be	  caused	  by	  post-­‐lysis	  artifacts	  which	  has	  also	  been	  reported	  before	  (Mili	  and	  Steitz,	  2004).	   I	  tried	  to	  
avoid	   those	   artifacts	   by	   transcribing	   an	   RNA	   in	   vivo,	   using	   HeLa	   cells.	   I	   could	   efficiently	   express	   the	  
StreptoTagged	   RNAs	   in	   cultured	   cells,	   but	   the	   amount	   of	   protein	   eluted	   was	   too	   small	   for	   efficient	  
analysis.	  Furthermore	  RNA	  binding	  to	  the	  column	  was	  not	  efficient.	  Large	   increases	   in	  the	  amounts	  of	  
cells	   would	   be	   a	   first	   step	   in	   optimization.	   However,	   even	   with	   higher	   amounts	   of	   total	   lysate,	   it	   is	  
questionable	  whether	  the	  StreptoTag	  aptamers	  in	  the	  endogenous	  particles	  can	  be	  made	  accessible	  for	  
binding	  to	  the	  beads.	  	  	  
Although	  the	  optimization	  experiments	  led	  to	  an	  improved	  protocol,	  and	  in	  vivo	  expression	  of	  the	  
RNA	   is	   potentially	   promising,	   I	   concluded	   from	  my	   experiments	   that	   the	   StreptoTag	   approach	   is	   not	  
suited	   for	   isolating	   transport	   RNPs.	   Also	   for	   other	   approaches	   it	   will	   nonetheless	   be	   necessary	   to	  
optimize	   the	   procedure	   for	   each	   individual	   candidate	   RNA,	   especially	   if	   it	   is	   a	   long,	   highly	   structured	  
sequence,	   as	   it	   is	   usually	   the	   case	   for	   localized	  mRNAs.	   Then	   interesting	   results	   can	   be	   expected	   to	  
unravel	   the	   composition	   of	   specific	   particles.	   Recently	   our	   lab	   started	   to	   use	   a	  modified	  MS2-­‐system	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RNA	   Lokalisierung	   ist	   ein	   häufig	   verwendeter	   Mechanismus	   um	   Genexpression	   zu	   regulieren.	  
Dadurch	   wird	   verschiedenen	   Zellen	   die	   Möglichkeit	   gegeben,	   Protein	   auf	   bestimmte	   subzelluläre	  
Domänen	  zu	  verteilen	  und	  Zellpolarität	  zu	  etablieren.	  In	  Neuronen	  dienen	  RNA	  Lokalisierung	  und	  lokale	  
Translation	  in	  Axonen	  und	  Dendriten	  dazu,	  um	  die	  Proteinzusammensetzung	  in	  Wachstumskegeln	  und	  
an	   postsynaptischen	   Stellen	   ständig	   zu	   modifizieren	   und	   auf	   Reize	   aus	   der	   zellulären	   Umwelt	   zu	  
antworten.	   Dadurch	   kommen	   ihnen	   wichtige	   Rollen	   beim	   Auswachsen	   von	   Axonen,	   dem	   Finden	   der	  
Axonpfade,	   dendritischer	   Verzweigung,	   sowie	   der	   Morphogenese	   dendritischer	   Dornenfortsätze	   zu.	  
Außerdem	   tragen	   die	   Lokalisierung	   von	   mRNAs	   nahe	   Synapsen,	   sowie	   die	   strenge	   räumliche	   und	  
zeitliche	  Kontrolle	  der	  Translation	  zur	  autonomen,	  unabhängigen	  und	  schnellen	  Modifikation	  einzelner	  
Synapsen	   bei.	   So	   ist	   RNA	   Lokalisierung	   von	   höchster	   Wichtigkeit	   für	   Mechanismen	   in	   Lernen	   und	  
Gedächtnisbildung	  und	  fand	  daher	  in	  letzter	  Zeit	  zunehmend	  Interesse.	  	  
mRNAs	  werden	   in	   translationell	   reprimierter	   Form	   in	   Ribonukleoprotein-­‐Partikeln	   (RNPs)	   an	   jene	  
Stellen	  transportiert,	  an	  denen	  sie	  benötigt	  werden.	  Die	  Zusammensetzung	  neuronaler	  Transport-­‐RNPs,	  
die	  Funktionen	  spezifischer	  Komponenten,	  sowie	  die	  Mechanismen	  des	  RNA	  Transports	  in	  Richtung	  von	  
Axonen	  und	  Dendriten,	  sowie	  deren	  translationelle	  Kontrolle	  sind	  noch	  Gegenstand	  von	  Diskussionen.	  In	  
dieser	  Arbeit	   untersuchte	   ich	  die	   funktionellen	  Rollen	  bestimmter	  RNP	  Komponenten	   im	  Kontext	   von	  
Translations-­‐Kontrolle	   und/oder	   RNA	   Stabilität	   während	   der	   RNA	   Lokalisierung.	   Zusätzlich	   habe	   ich	  
Werkzeuge	   generiert,	   die	   für	   die	   Untersuchung	   von	  microRNA-­‐abhängiger	   Translations-­‐Kontrolle	   und	  
die	   Isolierung	   von	   neuen	   RNA-­‐bindenden	   Proteinen,	   die	   im	   RNA	   Transport	   beteiligt	   sind,	   notwendig	  
sind.	  	  	  
In	   meiner	   Arbeit	   konnte	   ich	   zeigen,	   dass	   Säuger-­‐Pumilio2	   (Pum2)	   spezifisch	   die	   Translation	   des	  
Initiationsfaktors	   eIF4E	   in	   Neuronen	   reguliert.	   Erhöhte	   bzw.	   verminderte	   Mengen	   an	   eIF4E	   selbst	  
beeinflussen	   die	   Entwicklung	   von	   Dendriten	   und	   die	   Morphologie	   dendritischer	   Dornenfortsätze	   in	  
hippokampalen	  Neuronen,	  ähnlich	  den	  Effekten,	  die	  für	  Pum2	  beobachtet	  wurden.	   Ich	  folgere	  daraus,	  
dass	  die	   Effekte,	   die	   aufgrund	  erhöhter	  Pum2-­‐Mengen	  auftreten,	   nicht	  direkt	  durch	  Pum2	  verursacht	  
sein	   könnten,	   sondern	   durch	   die	   translationelle	   Regulation	   anderer	   Faktoren,	   die	   an	   der	   neuronalen	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Das	  Doppelstrang-­‐RNA	  bindende	  Protein	  Staufen2	  (Stau2)	  spielt	  eine	  wichtige	  Rolle	  bei	  der	  mRNA-­‐
Lokalisierung.	   Für	   Säugetier-­‐Stau2	   sind	   bisher	   keine	   spezifischen,	   direkt	   interagierenden	   mRNAs	  
bekannt,	  und	  auch	  die	  Funktion	  von	  Stau2	   ist	  unklar.	  Hier	   zeige	   ich,	  dass	  Stau2	   in	  allen	  Neuriten	   sich	  
entwickelnder	  Neuronen	  lokalisiert	  ist,	  wobei	  es	  sowohl	  in	  den	  Wachstumskegeln	  zukünftiger	  Dendriten	  
als	  auch	  Axone	  vorkommt.	  Das	  Aktin-­‐Zytoskelett	  wird	  durch	  das	  Ausschalten	  von	  Stau2	  beeinträchtigt.	  
Da	  die	  mRNA	  des	  Aktin-­‐Regulators	  RhoA	  in	  Stau2	  Immunpräzipitationen	  angereichert	  war,	  untersuchte	  
ich,	  ob	  RhoA	  das	  funktionelle	  Bindeglied	  zwischen	  der	  Rolle	  von	  Stau2	  und	  seinem	  Effekt	  auf	  das	  Aktin-­‐
Zytoskelett	  sein	  könnte.	  Eine	  Verminderung	  von	  Stau2	  führte	  zu	  erhöhten	  RhoA	  mRNA	  Mengen,	  sowie	  
zu	   erhöhter	   Expression	   eines	   EGFP-­‐RhoA	  Konstrukts.	  Da	   vorläufige	  Daten	   im	   Labor	   darauf	   hindeuten,	  
dass	  verminderte	  Mengen	  an	  Stau2	  zu	  einem	  Defekt	  beim	  Auswachsen	  der	  Axone	  führen,	  legen	  meine	  
Daten	  einen	  neuen	  Mechanismus	  für	  Staufen	  in	  auswachsenden	  Axonen	  nahe,	  der	  	  auf	  der	  Regulierung	  
des	  Zytoskeletts	  via	  Stabilisierung	  der	  β-­‐actin	  mRNA	  und	  dem	  Effekt	  auf	  RhoA	  basieren	  könnte.	  
Zusammenfassend	   gelang	   es	   mir	   in	   dieser	   Arbeit,	   die	   Funktionsweise	   zweier	   wichtiger	   RNA-­‐
bindender	   Proteine,	   Pum2	   sowie	   Stau2,	   näher	   zu	   definieren.	   Ob	   diese	   Funktionen	   auch	   auf	   die	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  focus	  
on	  cell	  biology,	  biochemistry	  and	  neurosciences.	  	  
Diploma	  thesis:	  "Molecular	  Characterization	  of	  Microglia	  Cells	  in	  
the	  Central	  Nervous	  System."	  Supervisor:	  Monika	  Bradl	  
	   	   	  
	   Publication	  derived	  from	  this	  work:	   	  
Lucia	  Schoderboeck*,	  Milena	  Adzemovic*,	  Eva-­‐Maria	  Nicolussi,	  Claudia	  Crupinischi,	  
Sonja	  Hochmeister,	  Marie-­‐Therese	  Fischer,	  Hans	  Lassmann	  and	  Monika	  Bradl.	  “The	  
“window	  of	  susceptibility”	  for	  inflammation	  in	  the	  immature	  central	  nervous	  system	  is	  
characterized	  by	  a	  leaky	  blood–brain	  barrier	  and	  the	  local	  expression	  of	  inflammatory	  
chemokines”	  
Neurobiology	  of	  disease,	  2009	  Sep,	  35(3):368-­‐375.	  Epub:	  9	  Jun	  2009.	  *	  Authors	  
contributed	  equally.	  
Roland	  Grundtner,	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  Michael	  Kiebler,	  	  Hartmut	  Wekerle,	  	  Hans	  Lassmann	  and	  	  Monika	  Bradl.	  
“Transition	  from	  enhanced	  T	  cell	  infiltration	  to	  inflammation	  in	  the	  myelin-­‐degenerative	  
central	  nervous	  system.”	  Neurobiology	  of	  disease,	  2007	  Dec,	  28(3):261-­‐75.	  Epub:	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  Aug	  
2007.	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Teaching	  (during	  doctorate	  studies)	   	  
	   	  
	   Supervision	  and	  training	  of	  undergraduate	  students.	  	  
	   Practical	  courses	  in	  neuronal	  cell	  biology	  in	  cooperation	  with	  colleagues	  in	  the	  lab.	  	  
	   Lecture	  in	  the	  “Brain	  Awareness	  Week”.	  
	   	  
Honors	  and	  awards	  
	  
	   2009	   “Kapsch	  Award”	  Scholarship	  awarded	  to	  the	  5	  best	  master	  theses	  of	  the	  year	  
(University	  of	  Applied	  Sciences	  Technikum	  Vienna)	  
	   2009	   “1000	  Euro	  statt	  Blumen”	  Award	  given	  to	  the	  5	  best	  female	  students	  of	  the	  year	  
(University	  of	  Applied	  Sciences	  Technikum	  Vienna).	  	  
	   2007/2008	   Performance	  scholarship	  of	  the	  University	  of	  Applied	  Sciences	  Technikum	  Vienna.	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